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Retinoic acid (RA) is critically required for pancreas specification in Xenopus and 
other vertebrates. However, the gene network that is directly induced by RA-
signaling in this context remains to be defined. We identified 22 RA-target genes 
through RNA-sequencing of in vitro generated pancreatic organoids. One of these is 
Hnf1b, which has been shown to be associated with a monogenic form of diabetes 
in humans and with pancreas hypoplasia in vertebrates. Functional analyses of 
Hnf1b in pancreatic organoids and whole Xenopus embryos revealed its early 
requirement for pancreatic progenitor formation. However, we also found that Hnf1b 
alone is not sufficient to substitute for RA in pancreas specification, indicating a 
requirement of one or more additional RA-responsive activities. Furthermore, we 
identified the Wnt-receptor Fzd4 as direct RA-target and novel regulator in pancreas 
development. Loss-of-function experiments in pancreatic organoids reveal a role of 
this Wnt-signaling component in pancreas development. Additional experimental 
data suggest that a modulation of non-canonical Wnt-signaling activity by RA, 













The pancreas is an organ of the vertebrate digestive system that accomplishes two 
distinct functions based on its heterogenous composition. It promotes a proper food 
digestion and maintains glucose homeostasis. The digestive enzyme producing 
exocrine tissue represents the major component, where clusters of hormone 
producing endocrine cells are embedded that control glucose homeostasis (Slack, 
1995). Pancreas related diseases have encouraged the research on embryonic 
pancreas development for decades. Several studies showed that the early pancreas 
development in Xenopus is very similar to that of mice and that the same set of 
genes used in Xenopus is also involved in mammalian pancreas development 
(reviewed in Pearl et al., 2009). Lineage tracing experiments in Xenopus revealed 
that during gastrulation a pancreatic progenitor cell population is specified in the 
dorsal endoderm (Chalmers and Slack, 2000), considerably earlier than the 
expression of known pancreatic progenitor markers Ptf1a and Pdx1 (Afelik et al., 
2006). It has been demonstrated that signals from the adjacent mesoderm, namely 
retinoic acid (RA), define a cell population in the dorsal endoderm during 
gastrulation. Later in development, these cells are capable to respond signals from 
the notochord which promotes pancreatic fate (Wells and Melton, 2000; Chen et al., 
2004; Pan et al., 2007). An overview of the important aspects of pancreas 
development from endoderm formation over regional specification by mesodermal 
signals to budding and differentiation is given in the following sections, emphasizing 
the role of RA- and Wnt-signaling in pancreas development. Furthermore, the 
progress in research of in vitro organ formation and its relevance for clinical 
applications will be described.  
1.1 Pancreas morphology and morphogenesis 
The pancreas is 95% to 99% an exocrine gland, containing acinar cells that secrete 
a variety of digestive enzymes. Through a highly branched ductal epithelium, 
enzymes and bicarbonate ions are transported to the intestine (Slack, 1995). A 
small percentage of this gland consists of hormone secreting endocrine tissue. Five 
endocrine cell types, organized in clusters called the islets of Langerhans, are 
described for mammals, birds, reptiles and amphibians. The main part of the islets is 
formed by insulin-producing β-cells. Furthermore glucagon-producing α-cells, 




(Maake et al., 1998) and ε-cells that secrete ghrelin (Rindi et al., 2004; Wierup et al., 
2014) are included in the islets (reviewed in Brereton et al., 2015). Like other organs 
of the digestive tract, the pancreas originates from the endodermal germ layer. 
During embryogenesis, the endoderm forms the gut epithelium that is regionalized 
by various mesodermal signals into overlapping presumptive organ territories from 
anterior to posterior. The developing pancreas becomes evident as epithelial 
evaginations of the foregut endoderm.  
In Xenopus, one dorsal bud can be detected at stage 35 and two ventral buds at the 
junction of the liver bud and duodenum at stage 37 (Kelly and Melton, 2000). The 
earliest known pancreatic markers Ptf1a and Pdx1 are detectable by WMISH before 
the budding starts at stage 32 (Fig. 1.1 A). Ptf1a expression in the endoderm is 
restricted to the regions of dorsal and ventral pancreatic tissue, whereas Pdx1 is 
more broadly expressed in the endoderm including the prospective duodenal and 
stomach tissue. It was shown that epithelium co-expressing these two transcription 
factors adopts a pancreatic fate (Afelik et al., 2006). During the evagination process, 
pancreatic progenitor proliferation and differentiation take place. Like in mouse and 
zebrafish, the Pdx1 expression gets restricted to β-cells, whereas Ptf1a expression 
remains only in the exocrine tissue (Krapp et al., 1998; Kawaguchi et al., 2002; 
Hesselson et al., 2011). In Xenopus, the first endocrine differentiation marker Insulin 
appears around stage 30 (Fig. 1.1 C) and is detectable only dorsally until stage 45 
(Horb and Slack, 2002). Exocrine enzyme Pdia2 gene expression can be detected 
at stage 39 in both, dorsal and ventral pancreas (Afelik et al., 2004). Pdia2 staining 
by WMISH is used in Fig. 1.1 B to illustrate the fusion of the three pancreatic 
primordia at stage 40 caused by gut rotation. The fused pancreas is located 
predominantly in the left half of the embryo embedded between stomach and 
duodenum (Fig. 1.1 B panel 5). Transcripts of most of the exocrine marker genes 
(Amylase, Trypsinogen, Elastase) are first detectable at stage 41 exclusively in the 
ventral pancreas. Further endocrine markers and a second wave of Insulin 





























 Fig. 1.1 Pancreas organogenesis in Xenopus laevis 
(A) Expression of Pdx1 and Ptf1a at stage 32. (B) Pdia2 expression before (1,2) and 
after (3 to 5) fusion of the dorsal and two ventral pancreatic buds. Panels 2 and 4 
show transversal sections across the white dotted line indicated in panels 1 and 3. 
(C) Temporal expression profile of pancreatic genes. dP = dorsal pancreatic bud; Du 
= duodenum; St = stomach, vP = ventral pancreatic buds. ((B) and (C) modified from 




1.2 Endoderm formation and regional specification 
Although the process of endoderm, mesoderm and ectoderm segregation during 
gastrulation is different in mice, chicken, fish and frogs, the molecular pathway that 
directs endoderm formation is evolutionary conserved across these species 
(reviewed in Zorn and Wells, 2009). Maternal determinants initiate a gene network 
responsible for endoderm formation. However, these maternal factors differ between 
the species, while the induced network is conserved (reviewed in Grapin-Botton and 
Constam, 2007). In Xenopus, the pathway leading to endoderm formation is 
activated by the maternally provided transcription factor Vegt that is localized to the 
vegetal cortex of the egg (Fig. 1.2 A) (Hyde and Old, 2000; Xanthos et al., 2001). 
Vegt is a crucial regulator of endoderm formation in Xenopus as embryos developed 
from Vegt-depleted eggs lack the endodermal germ layer (Zhang et al., 1998). Vegt 
induces the expression of early endodermal genes like the transcription factors Sox7 
(Zhang et al., 2005), Sox17a (Engleka et al., 2001), several Mix-type homeodomain 
factors (like Mix.1 and Mixer), GATA-factors (Xanthos et al., 2001) and Nodal-
related genes (Xnrs) (Takahashi et al., 2000) (reviewed in Fukuda and Kikuchi, 
2005; Heasman, 2006; Skirkanich et al., 2011).   
Xnrs encode for secreted factors of the TGFβ-family, which regulate the gene 
expression via transmembrane serine-threonine kinase receptors mediated by 
intracellular Smad proteins. In all vertebrates, the Nodal signaling pathway is 
essentially required for endoderm development as it induces additional endodermal 
genes and is capable of restoring the endodermal gene expression in Vegt-depleted 
embryos (Yasuo and Lemaire, 1999; Xanthos et al., 2001 and reviewed in reviewed 
in Grapin-Botton and Constam, 2007). Moreover, Nodal signaling also induces 
mesodermal genes depending on the level of signaling (Clements et al., 1999; Shen 
2007). Vegt acts synergistically with dorsally stabilized β-Catenin for the activation 
of Xnr genes resulting in a gradient of high Nodal-signaling in the dorsal endoderm 
and lower levels in the ventral endoderm (Fig. 1.2 B, Agius et al., 2000). 
Furthermore, Nodal signaling cooperates with β-catenin/Tcf3-targets Siamois and 
Twin to induce mesodermal organizer genes like Noggin, Chordin and Follistatin 
(Brannon et al., 1997; Moon and Kimmelman, 1998; Bae et al., 2011). These 
secreted organizer molecules act as BMP-inhibitors and establish a dorso-ventral 
BMP-signaling gradient in all three germ layers (Fig. 1.2 C, Piccolo et al., 1996; 
Zimmerman et al., 1996). Thereby, dorsal endoderm, from which the pancreatic 





was shown that RA is sufficient to induce pancreatic gene expression in dorsal 
endodermal explants but not in ventral. Only when BMP-signaling was 
downregulated by Noggin, ventral endodermal explants expressed pancreas-













During gastrulation all three germ layers become patterned along the anterior-
posterior axis by the organizer. While endoderm and mesoderm involute, the dorsal 
anterior endoderm is positioned at the prospective ventral foregut whereas the more 
posterior dorsal endoderm becomes the future dorsal foregut (Fig. 1.3 A, light green 
and yellow, Keller, 1991). The initial anterior-posterior pattern of the endoderm is not 
committing as the endoderm remains able to respond to signals released from the 
overlaying or subjacent mesoderm (Zeynali et al., 2000; Horb and Slack, 2001; 
McLin et al., 2007 and reviewed in McCracken and Wells, 2012). These include 
Wnt-, FGF-, BMP- and RA-signaling, which are associated with posteriorizing effects 
(Dessimoz et al., 2006; Rankin et al., 2011; Sherwood et al., 2011). The resulting 
gut tube is segmented into foregut, midgut and hindgut domains, whereby Pdx1 is 
expressed in the posterior foregut and anterior midgut (Wright et al., 1989). 
However, so far it is not known how FGF-, Wnt-, BMP- and RA-signaling co-operate 
during endoderm patterning. 
 
Fig. 1.2 Model for dorsal endoderm patterning, mesoderm induction and 
organizer formation in Xenopus 
(A) At blastula stage, Vegt is localized at the vegetal hemisphere while β-catenin is stabilized 
dorsally. (B) At late blastula stage, a Xnr-gradient (Nodal-related) is generated by the 
synergistic activity of Vegt and β-catenin. (C) The mesoderm is specified by the Xnr-gradient 
and at early gastrula stage, the organizer is specified by synergistic activity of Xnr and β-
catenin-targets Siamois and Twin. A BMP-gradient is generated by BMP-antagonists (for 
instance Noggin) secreted from the organizer (Adapted from Gilbert and Singer 8th edition 




1.3 Pancreas organogenesis 
1.3.1 Pancreas specification 
Through cell movements during foregut morphogenesis the dorsal and ventral 
foregut epithelium are placed into very different environments. This fact already 
indicates that the extrinsic signals and genetic programs that promote pancreas 
development in the dorsal and ventral foregut are different. A further difference is 
the derivation of several organs from the ventral foregut, whereas the dorsal foregut 
gives rise exclusively to the dorsal pancreas. This suggests that dorsal pancreas 
formation is a matter of induction, whereas ventral pancreas needs to be segregated 
from multiple organ lines (reviewed in McCracken and Wells, 2012). Several studies 
confirmed these assumptions. In chick, Kim and colleagues demonstrated in 1997 
that presumptive dorsal pancreatic endoderm when cultivated in isolation showed no 
pancreatic gene expression, whereas ventral pre-pancreatic endoderm does (Kim at 
al., 1997). Extensive studies in ectodermal, mesodermal and endodermal explants 
from Xenopus embryos supplied the evidence that the dorsal pancreatic foregut 
endoderm initially receives inductive signals from the mesoderm at the onset of 
gastrulation. Retinoic acid (RA) could be identified as such an inductive signal and 
the involvement of one or more further signals is assumed (RA-source indicated in 
Fig. 1.3 A (red)) (Chen at al., 2004; Pan et al., 2007).  
During foregut morphogenesis the dorsal foregut epithelium has initially contact with 
the notochord and subsequently with the dorsal aorta. Both tissues have been 
shown to be sources of permissive signals for pancreas formation (Kim et al., 1997; 
Lammert at al., 2001). In chicken, dorsal pancreas development could be prevented 
by the removal of the notochord at an early stage (Kim et al., 1997). However, the 
notochord is not able to induce pancreatic gene expression in early gastrula stage or 
non-pancreatic somite-stage endoderm (Wells and Melton, 2000), which is in 
accordance with the finding that pre-pancreatic foregut endoderm obtained the 
ability, at an earlier time, to react to permissive signals from the notochord. These 
permissive signals were identified as Activin-βB and FGF2 (Fig. 1.3 B). Hebrok and 
colleagues found them as secreted factors from the notochord that suppress the 
expression of Sonic hedgehog (Shh) in the pancreatic endoderm. Shh is broadly 
expressed in the endodermal epithelium but is excluded from pancreatic endoderm 
(Hebrok at al., 1998; Hebrok et al., 2000). The removal of the notochord leads to an 
ectopic Shh expression that inhibits dorsal pancreas development (Hebrok et al., 





Pdx1 expression in a dose dependent manner (Hebrok at al., 1998). With continuing 
embryonal development, the notochord is displaced by fused dorsal aortae that 
further signals to the dorsal pre-pancreatic endoderm (Lammert at al., 2001). These 
signals are required for the maintenance of Pdx1 expression and for the induction of 
Ptf1a expression (Yoshitomi and Zaret, 2004). It is assumed that aortic endothelial 
signals in addition act indirectly on pancreatic endoderm as they promote the 
survival of dorsal mesenchyme (reviewed in Edlund, 2002). Dorsal mesenchyme 
secretes FGF10 that is required for the maintenance of Pdx1 and Ptf1a expression 
(Jacquemin et al., 2006).  
The ventral foregut gets in proximity to two mesodermal derivatives, the cardiac 
mesoderm and septum transversum (Fig. 1.3 B). The posterior region of the ventral 
foregut was shown to give rise to the ventral pancreas and liver. Explant studies in 
zebrafish and mouse support the presumption of a common bi-potential cell 
population in the ventral foregut endoderm that differentiate into liver and ventral 
pancreas (Deutsch et al., 2001; Bort et al., 2006; Chung et al., 2008). In several 
studies, signaling pathways have been identified which are involved in the 
segregation of hepatic and pancreatic fate, most of them appear to repress 
pancreas formation and promote liver development. FGF-signaling from the cardiac 
mesoderm (Jung et al., 1999) and BMP-signaling from the septum transversum 
(Rossi et al., 2001) induce hepatic fate. Deutsch and colleagues found an 
expression of Pdx1 in cultures of isolated mouse ventral foregut endoderm, whereas 
the expression of liver marker Hhex required signals from the cardiac mesoderm 
(Deutsch et al., 2001). These findings suggest the pancreas as a default state of the 
ventral foregut. Furthermore, a BMP antagonist TGIFβ-induced factor 2 (TGIF2) was 
found to be expressed in the posterior ventral foregut counteracting the expression 
of Hhex (Spagnoli and Brivanlou, 2008). Moreover, the assumption of pancreas as a 
default state is supported by the presence of a pre-existing chromatin modification 
pattern that promotes pancreas development in the ventral foregut endoderm (Xu et 
al., 2011; Arnes and Sussel, 2015).  
Independent of the way of specification, both dorsal and ventral pancreatic 
progenitor cell populations are characterized by the co-expression of Pdx1 and 
Ptf1a (Afelik et al., 2006). During this early phase of pancreatic development, also 
referred to as primary transition, the pancreatic progenitors proliferate (Pictet et al., 
1972). Thus, pancreatic foregut epithelium evaginates and forms the dorsal and two 
ventral buds. Furthermore, the first Insulin-expressing cells in Xenopus and 
Glucagon-expressing cells in mouse can be detected. In mouse, the primary 

































Fig. 1.3 Fate maps of Xenopus endoderm from gastrula to early somite stage 
and overview of signals involved in pancreas specification 
(A) Gastrula stage (left) and early somite stage (right) Xenopus embryos with indicated 
colored domains that correspond to fate-map studies. The arrows indicate the 
migration/folding direction of the foregut. (modified after Zorn and Wells, 2009) 
(B) Overview of signals involved in pancreas specification in an early somite stage embryo. 
In the dorsal foregut endoderm, permissive signals from the notochord (FGF2 and Activin-
βB) repress Shh transcription in the pre-pancreatic epithelium and allow Pdx1 expression. 
FGF- and BMP-signaling from the cardiac mesoderm/septum transversuim promote liver 
(Hhex) and inhibit pancreas fate (Pdx1) in the ventral foregut epithelium. (modified after 





Genetic lineage-tracing experiments in mice revealed that all pancreatic cell- 
subtypes arise from a common pool of multipotent progenitor cells co-expressing 
Pdx1 and Ptf1a (Gu et al., 2002; Kawaguchi et al., 2002; Burlison et al., 2008). In 
Xenopus, ectopic co-expression of Ptf1a and Pdx1 is sufficient to convert duodenal 
precursor cells into pancreatic tissue (Afelik et al., 2006). Furthermore, it was shown 
that constitutively active forms of Pdx1 or Ptf1a can push liver progenitors to a 
pancreatic fate (Horb et al., 2003, Jarikji et al., 2007). As soon as the ventral and 
dorsal pancreatic domains in the foregut epithelium are specified, a set of 
transcription factors becomes specifically expressed in these regions (Fig. 1.4 A). 
Beside Pdx1 and Ptf1a, the earliest transcription factor that marks pancreatic 
progenitor cells is Sox9 (Lioubinski et al., 2003; Lee and Saint-Jaennet, 2003). In 
mice, Sox9 was shown to be essential for proliferation and maintenance of 
pancreatic progenitors (Seymour et al., 2007; Seymour, 2014). Moreover, during the 
proliferation and expansion of the pancreatic progenitor field, Sox9 regulates a set of 
additional transcription factors in pancreatic progenitors including Hnf1b (Lynn et al., 
2007). Genetic studies in mice revealed that Sox9 acts in cooperation with Pdx1 for 
the induction of pancreatic fate and the repression of the intestinal lineage 
differentiation (Shih et al., 2015). 
1.3.2 Pancreas differentiation  
At the end of the primary transition, pancreatic buds are still composed of 
undifferentiated multipotent progenitors expressing a set of transcription factors 
including Pdx1, Ptf1a, Sox9, Hnf1b, Nkx6.1 and Gata4 (Fig. 1.4 A) (reviewed in 
Shih et al., 2013; Seymour, 2014). The next phase of pancreas development, also 
referred to as secondary transition, is characterized by continuing proliferation and 
step-wise differentiation. This process starts with the segregation of a tip and trunk 
domain (Zhou et al., 2007; Villasenor et al., 2010). Lineage tracing experiments in 
mice showed that endocrine and ductal cells arise from bi-potential cells in the trunk 
domain whereas the tip regions are restricted to an acinar fate (reviewed in Pan and 
Wright, 2011). During the separation of tip and trunk, the expression of some 
transcription factors becomes restricted to only one of the two domains. Trunk 
specific expressed are Hnf1b, Sox9 and Nkx6.1, whereas Ptf1a and its target Cpa1 
become restricted to the tips (Fig. 1.4 B, Zhou et al., 2007; Schaffer et al., 2010; 
Kopp et al., 2011b). The reciprocal repression between Nkx6.1 and Ptf1a is a critical 
mechanism through which the progenitors achieve distinct tip or trunk identity 




later regulates acinar cell differentiation (Kawaguchi et al., 2002; Masui et al., 2010). 
Ptf1a acts in a trimeric pancreas transcription factor complex (Ptf1) together with the 
bHLH-protein E2A and suppressor of hairless RBP-j or its paralog RBP-jl (Obata et 
al., 2001; Beres et al., 2006). Prior to acinar cell differentiation Ptf1a interacts with 
RBP-j, which is replaced by RBP-jl during the secondary transition (Masui et al., 
2007; Miyatsuka et al., 2007). This complex, termed PTF1-L, directs the activation of 
acinar-specific genes (Rose et al., 2001; Masui et al., 2010). In Xenopus, the 
exocrine marker pancreatic protein disulfide isomerase (Pdia2) can be first observed 
at stage 39, whereas other exocrine markers are not detected before stage 41 
(Afelik et al., 2004; Horb and Slack 2002). In the adult exocrine pancreas of mice, 
lineage-tracing experiments indicate the existence of a low number of Ptf1a-positve 
multipotent pancreatic cells that can be induced upon injury (Pan et al., 2013). 
The trunk domain is bi-potential and gives rise to ductal and endocrine cells (Solar 
et al., 2009; Kopp et al., 2011a). A subset of progenitor cells within the trunk express 
the transcription factor Neurogenin 3 (Ngn3) which indicates the onset of endocrine 
cell differentiation (Gradwohl et al., 2000; Gu et al., 2002). Cells within the trunk that 
do not activate Ngn3 probably contribute to ductal tissue (Magenheim et al., 2011). 
Several studies suggest that the Notch-signaling target Hes1 plays an important role 
in repressing Ngn3 expression and preventing extensive Ngn3 activation (Apelqvist 
et al., 1999; Jensen et al., 2000; Lee et al., 2001; Shih et al., 2012) (Fig. 1.4 C). 
Once Ngn3 is expressed, progenitors exit the cell cycle and delaminate from the 
epithelium to form the islet structures (Gouzi et al., 2011). Ngn3 activates the 
endocrine differentiation program by inducing pro-endocrine transcription factors 
including NeuroD1 and further factors involved in the delamination process (Huang 
et al., 2000; Mellitzer et al., 2006; Rukstalis and Habener, 2007; Soyer et al., 2010). 
Johansson and colleagues have shown in mice that the competence of endocrine 
precursors to produce different endocrine cell types is temporally controlled 
(Johansson et al., 2007). In mice the progenitors first differentiate into α-cells, then 
β- and δ-cells, and finally PP-cells, each cell-type characterized by a distinct set of 
transcription factors caused by cross-regulation mechanisms between the single 
factors (reviewed in Pan and Wright, 2011; Beucher et al., 2012; Napolitano et al 
2015). Despite the fact that in Xenopus endocrine progenitors first differentiate into 
β-cells (Kelly and Melton, 2000; Horb and Slack, 2002), the mechanism of subtype 
segregation may proceed in Xenopus similar to mice (Fig. 1.4 D). The formation of 
islets is completed in mice at E18.5 (Gittes, 2009) whereas in Xenopus a stable islet 





(Maake et al., 1998). Moreover, a complex ductal system in the frog pancreas is not 




























Fig. 1.4 Overview of pancreas organogenesis and lineage decisions 
(A) During primary transition, pancreatic progenitors express transcription factors, including 
Pdx1, Ptf1a, Sox9, Hnf1b, Nkx6.1 and Gata4/6, which mediate proliferation and promote the 
maintenance of pancreatic identity. Thereby, pancreatic epithelium bulges out from the 
foregut epithelium to form a bud (orange). (B) At the onset of the secondary transition, the 
epithelial bud expands and branches. Pancreatic progenitors turn either into tip (red) or trunk 
(green) cells mediated by the cross-repression between Ptf1a and Nkx6.1. (C) Tip cells are 
restricted to an acinar fate (red) expressing Ptf1a and later enzymes like Pdia2. Bi-potential 
trunk cells adopt either ductal (green) or endocrine cell fate (blue). Ductal versus endocrine 
fate decision is regulated by Notch activity. High Notch signaling mediates ductal fate by the 
induction of the Ngn3-repressor Hes1. In endocrine progenitors, Ngn3 activates a set of 
transcription factors including NeuroD1 that regulate the endocrine differentiation.  
(D) Endocrine progenitors subsequently delaminate from the trunk epithelium. Subsequently, 
they differentiate into five endocrine cell subtypes (marked by different colors) expressing 
distinct sets of transcription factors (+ present, - absent) and hormones. In mouse, at the end 
of embryogenesis, the pancreas consists of a highly branched ductal tree, connecting acinar 
cells with the intestine. Endocrine islets are scattered throughout the organ. In Xenopus, 
these histological structures are not observed before the end of metamorphosis (modified 




1.4 Role of RA-signaling in pancreas development 
Retinoic acid (RA) is essential for normal embryogenesis of all vertebrates 
(reviewed in Rhinn and Dolle, 2012). RA is a vitamin A-derived, small non-peptic, 
lipophilic molecule. This molecule differs strongly from other signaling factors as it 
does not need any cell-surface receptors for signal transduction. RA is able to enter 
the nucleus and binds to target genes through nuclear receptors that recognize RA-
response elements (RAREs), thus switching from repressors to transcriptional 
activators (Germain et al., 2002). Vitamin A is absorbed from the food, stored in the 
liver and circulates as its alcohol form Retinol which is bound to a carrier protein, 
retinol-binding protein 4 (RBP4) (Quadro et al., 1999). During embryogenesis 
Retinol is maternally provided (Ismadi and Olson, 1982). Retinol-RBP4 enters cells, 
which is facilitated by the RA-inducible transmembrane protein STRA6 (stimulated 
by retinoic acid 6) (Kawaguchi et al., 2007) (Fig. 1.5 A). Within the cell, Retinol can 
be converted to RA in two enzymatic reactions. First, Retinol is reversibly oxidized 
by retinol dehydrogenases (ROLDH) to Retinal and subsequently irreversibly 
oxidized by retinal dehydrogenases (RALDH) to retinoic acid (RA) (reviewed in 
Duester, 2008). Therefore, Retinol is available to all cells of an embryo, but only 
cells which express one of the RALDHs can generate RA. In vertebrates, three 
isotypes of RALDH are described, whereby RALDH2 is earliest expressed 
(Niederreither et al., 1997). RA leaves the RA-generating cells and enters 
neighbouring cells where it has two main destinies. In cells which express one of the 
CYP26 genes (cytochrome P450 enzyme) at a high level, RA is converted into 
inactive metabolites (Ray et al., 1997; White et al., 1996; Hollemann et al., 1998). In 
cells without or low levels of CYP26, RA enters the nucleus and binds the 
heterodimeric receptors RAR/RXR (retinoic acid receptor/retinoid X receptor), 
thereby activating the transcription of genes containing RAREs (reviewed in Mark et 
al., 2006).  
Several early studies in mice and quail using Vitamin A deficiency or RA-receptor 
mutations indicate the requirement of RA for the development of various organs 
(Dersch and Zile, 1993; Lohnes et al., 1994; Mendelsohn et al., 1994; Dickman et 
al., 1997; Clagett-Dame and DeLuca, 2002). Further studies revealed that the 
requirement of RA for pancreas development is conserved among the vertebrates. 
Two independent studies in mouse using RALDH2 mutants demonstrated the 
necessity of RA for dorsal pancreas development (Martin et al., 2005; Molotkov et 
al., 2005). In zebrafish, additionally to its requirement for dorsal pancreas 





al., 2002). In Xenopus, studies using the synthetic RA-antagonist BMS453, which 
binds RA-receptors, show that like in mouse, RA is essential for dorsal pancreas 
development. Upon the inhibition of RA-signaling, expression of Shh was expanded 
into the prospective dorsal pancreatic endoderm, thereby repressing pancreatic fate. 
However, these effects of RA-inhibition were only observed when BMS453 was 
added before the end of gastrulation, indicating that RA acts at the onset of 
gastrulation in pancreas specification (Chen et al., 2004). Before that, in 2000 
Asashima and colleagues already demonstrated the RA-dependent induction of 
pancreatic marker gene expression in dorsal lip explants from early gastrula stage 
Xenopus embryos (Moriya et al., 2000a). The assumption of a RA-gradient within 
the dorsal endoderm during gastrulation is supported by the expression pattern of 
RALDH2 and CYP26a1 during Xenopus gastrulation. These two enzyme-encoding 
genes show a non-overlapping expression in the dorsal mesoderm (Fig. 1.5 B). 
Thereby, RALDH2 is expressed in the internal involuting mesoderm, directly 
adjacent to the dorsal endoderm (Hollemann et al., 1998; Chen et al., 2001). 
Extensive combination experiments with endodermal and mesodermal explants 
revealed that RA acts directly on the dorsal endoderm as well as indirectly via the 
dorsal mesoderm (Pan et al., 2007). However, the RA-induced gene network that 
















































Fig. 1.5 Paracrine RA-signaling and expression of RA-metabolizing enzymes 
during Xenopus gastrulation 
(A) Retinol is transported by the retinol-binding protein (RBP4) and enters the cells via the 
receptor Stra6 (Stimulated by retinoic acid 6). In RA-generating tissues, ROLDH (retinol 
dehydrogenases) is expressed which reversibly oxidize Retinol to Retinal. Retinal is further 
irreversibly oxidized to retinoic acid (RA) by RALDH (retinaldehyde dehydrogenases). RA is 
released and enters neighboring cells where it either gets oxidized by CYP26 (cytochrome 
P450) into inactive metabolites or it reaches the nucleus and bind to nuclear RA-receptor 
dimers RAR/RXR. RAR/RXR dimers are bound to RA-response elements (RARE) within the 
DNA and act as repressors until they form a complex with RA. The ternary RA-RAR/RXR 
complex acts as transcriptional activator recruiting further co-activators (modified from 
Duester, 2008). (B) Expression pattern of CYP26a1 and RALDH2 in a gastrula stage 
Xenopus embryo by WMISH. The pattern suggests the formation of a RA-gradient within the 
dorsal endoderm that specifies an area of putative dorsal pancreatic progenitors (modified 





1.5 Role of Wnt-signaling in pancreas development 
During embryonal development in vertebrates, Wnt-signaling has diverse functions. 
These involve both Wnt-signaling pathways, canonical as well as non-canonical, 
both initiated by Wnt ligands and Frizzled receptors (Logan and Nusse, 2004).  Early 
in development, maternal β-catenin is dorsally stabilized, thereby promoting 
organizer formation and anterior endoderm fate during gastrulation (Zorn et al., 
1999; Schier and Talbot, 2005; Rankin et al., 2011). Shortly after gastrulation at 
early somite stage, zygotic Wnt-signaling has an opposite effect on anterior 
endoderm. Several studies in Xenopus demonstrated that Wnt-signaling must be 
inhibited to maintain foregut identity which is essentially required for pancreas 
development. McLin and colleagues found that foregut gene expression is 
repressed by Wnt8-overexpression, while in contrast the Pdx1 domain is expanded 
by over-expression of Wnt-antagonist Dkk1 (McLin et al., 2007). Furthermore, Li and 
colleagues identified the secreted Wnt-antagonist Sfrp5 (secreted frizzled-related 
protein 5) which is expressed in the early foregut epithelium. Embryos with 
downregulated Sfrp5 developed smaller foregut domains, while ectopic Sfrp5 
expression leads to an expanded foregut domain at the expense of the hindgut (Li et 
al., 2008).  
However, recent studies strongly indicate that the suggested model of a complete 
absence of Wnt-signaling for foregut development and high Wnt-signaling levels for 
hindgut development might be too simple. Two Wnt-signaling components, Wnt11 
and Fzd7, were found to be expressed in the foregut endoderm, both mediating 
canonical as well as non-canonical Wnt-signaling (Wheeler and Hoppler, 1999; 
Djiane et al., 2000; Medina et al., 2000; Li et al., 2008). The depletion of Fzd7 in the 
foregut results in liver and pancreas agenesis. Therefore, low levels of Wnt/Fzd7 
activity are found to be essential for foregut maintenance (Zhang et al., 2013a). 
Furthermore, Sfrps are shown to act biphasic on Wnt-signaling in a concentration 
dependent manner (Mii and Taira, 2009). A moderate dose of Sfrp5 was found to 
expand the foregut domain, whereas too low or too high concentrations lead to a 
reduction of foregut endoderm (Zhang et al., 2013a). Moreover, a comparative 
transcriptome analysis in mouse between liver and pancreas progenitors revealed a 
pancreas specific expression of Wnt-signaling components (Rodriguez-Seguel et al., 
2013). These findings suggest the requirement of low Wnt-signaling activity for 
foregut maintenance and thereby pancreas development. Later in pancreas 
development, Wnt-signaling is essential for the expansion of pancreatic epithelium 




how Wnt-signaling is regulated during pancreas specification and how it promotes 
the pancreatic fate remains unclear. 
1.6 Potential of organoids in research and clinical applications 
Organoids are defined as multicellular structures containing multiple organ-
characteristic cell types. Moreover, organoids recapitulate the in vivo organogenesis 
including the temporal program of lineage specification and the expression of cell-
type specific marker genes (reviewed in Lancaster and Knoblich, 2014; Rookmaaker 
et al., 2015). Since decades, Amphibians and especially Xenopus were used as 
model system for in vitro organ formation as they provide a source of pluripotent 
cells. Already in the 1960s, Nieuwkoop and colleagues demonstrated the pluripotent 
state of blastocoel roof cells (Nieuwkoop, 1963). Blastocoel roof cells can be 
cultivated for weeks in a simple salt solution and without any further treatment they 
form an “atypical epidermis” (Jones, 1985). Thus, they are also named ectodermal 
explants. These pluripotent cells can be programed by RNA-injections or chemical 
treatments to differentiate into the derivatives of all three germ layers. In several 
studies, Asashima and colleagues demonstrated the in vitro formation of various 
organoids and tissues from Activin A-treated dissociated and re-aggregated 
ectodermal explants (reviewed in Okabayashi and Asashima, 2006; Asashima et al., 
2009). Activin A is a TGFß-family member which mimics nodal signaling in mouse 
(Conlon et al., 1994; Kubo et al., 2004). Asashima and colleagues found Activin A 
as concentration-dependent inducer of endodermal and mesodermal tissue 
(Ariizumi et al., 1991). Thereby, a high Activin A concentration induced the formation 
of head structures (Ariizumi and Asashima, 1995), whereas a moderate 
concentration leads to notochord structures and a low concentration to muscle 
tissue formation (Tamai et al., 1999). They further demonstrated that the additional 
treatment with RA induces pronephric or pancreatic gene expression (Chan et al., 
1999; Moriya et al., 2000b; reviewed in Kurisaki et al., 2010). A later study in our lab 
applied a refined protocol for the in vitro generation of pancreatic structures from 
pluripotent ectodermal explants using Vegt and β-catenin as dorsal endoderm 
inducers and the BMP-inhibitor Noggin in addition to RA (Chen et al., 2004). A 
further notable study by Asashima and colleagues is the formation of ectopic beating 
hearts. Explants were treated with a high concentration of Activin A and started to 
beat after a few days. These beating structures were transplanted into neurula-stage 
embryos where they developed into ectopic beating hearts consisting of at least two 





As vertebrate organogenesis is highly conserved between Xenopus and mammals 
at the molecular level, the knowledge about factors required for the formation of 
Xenopus-derived organoids were applied to protocols for the in vitro generation of 
mouse- and human-derived organoids. For the formation of mouse- and human-
derived organoids the use of a matrigel was shown to promote organoid formation. 
The matrigel is an extracellular matrix containing collagen and lamins and it allows 
the use of the self-organization potential of stem cells. This was first demonstrated 
for epithelial intestine stem cells (Lgr5 positive) (Li et al., 1987). Cultures of these 
cells in a three-dimensional matrigel-system lead to the formation of structures 
comparable to intestinal crypts comprising of cell subtypes found in the intestine in 
vivo (Sato et al., 2009). This system has been adapted to form other organs 
including stomach (Barker et al., 2010) as well as organs with low self-renewal 
potential like prostate (Karthaus et al., 2014). The addition of distinct factors to the 
culture medium drives lineage determination and differentiation. For example, 
mouse pancreatic organoids could be generated from pancreatic ductal cells 
expressing Lgr5 induced by injury and treated with EGF, RSPO1, Noggin, FGF10 
and Nicotinamide. These organoids differentiate into duct and endocrine cells upon 
transplantation (Huch et al., 2013a). The 3D matrigel-system was also applied to 
form organoids from human cells. Several human adult and embryonic stem-cell 
derived organoids have been generated including stomach (McCracken et al., 
2014), small intestine (Sato et al., 2011), lung (Rock et al., 2009), liver (Huch et al., 
2013b) and pancreas (Boj et al., 2015). However, most of the organoids are not 
“perfect” as they miss characteristic cell types or recapitulate only the earliest stages 
of organogenesis (reviewed in Willyard, 2015).  
As the availability of human adult stem cells is limited and the use of human 
embryonic stem cells is associated with ethical concerns, several studies used 
induced pluripotent stem cells (iPSCs) as additional source for the generation of 
organoids. Human iPSCs have been used to generate kidney- (Takasato et al., 
2015) and intestine-organoids (Finkbeiner et al., 2015). The remarkable discovery of 
in vitro generated "mini brains" was made by Lancaster and colleagues. They found 
that iPSCs treated with growth factors self-organize into cerebral organoids with 
distinct forebrain, midbrain and hindbrain regions, cell layers that resemble the 
cortical layers of a brain and rudiments of eye tissue. These cerebral organoids 
could be maintained for several months under supply of nutrients (Lancaster et al., 
2013). 
The ability of in vitro generated organoids to recapitulate the normal organogenesis 




material can be cultivated in matrigel to form organoids. These can be used for 
studies of molecular pathogenesis in cancer-derived organoids as it was done for 
prostate cancer (Gao et al., 2014). Moreover, patient-derived organoids can serve 
for drug screens for high efficiency and low toxicity to allow a personalized 
medication. Furthermore, a recent study with organoids derived from patients with 
cystic fibrosis demonstrated the potential for gene therapy applications. Schwank 
and colleagues could repair the CFTR-mutation in patient-derived organoids by the 
use of CRISPR/Cas system (Schwank et al., 2013). This procedure is a promising 
method to provide patients with functional tissue. Further applications for research 
purposes are also conceivable. Some gene knockouts are lethal for mice and could 
be done in mice-derived organoids to allow functional analysis of these genes. 
Furthermore, the use of organoids could reduce the number of animals sacrificed for 
experiments. For instance, conditions can be tested in organoids first and the 


















Fig. 1.6 Therapeutic potential of in vitro generated organoids 
Biopsy material or patient-derived iPSCs can be used for in vitro organogenesis. The self-
organizing potential through cell sorting and spatial restricted lineage determination promotes 
to the formation of organoids. These organoids can be used as model system for studies of 
molecular pathogenesis, drug testing or gene therapeutic applications. The image is adapted 





1.7 Aim of this study 
As described in the previous sections, various studies in Xenopus, zebrafish and 
mouse revealed that the requirement of RA for pancreas specification is conserved 
among these species. However, the gene network that is induced by RA and 
promotes pancreas fate is unknown so far. Therefore, the main goal of this study 
was the identification of early direct RA-target genes in the endoderm. To reach this 
aim, pancreatic organoids, in vitro generated from ectodermal explants, were used. 
For this, pancreatic organoids were first verified for their potential to recapitulate 
pancreas development. The second goal was the validation of identified RA-target 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Model Organism 
For experimental studies, the African clawed frog Xenopus laevis was used. The 
frogs were purchased from Nasco (Ft. Atkinson, USA). The embryonic staging was 
based on the descriptions of Nieuwkoop and Faber (Nieuwkoop and Faber, 1967). 
2.1.2 Bacteria 
The following E.coli bacteria received from Stratagene GmbH (Heidelberg, 
Germany) were used for molecular biology standard methods: XL1-Blue recA1, 
endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac[F´proAB, lacIqZ∆M15, Tn10(Tetr)]c 
(Stratagene). 
2.1.3 Constructs 
2.1.3.1 Constructs for sense and anti-sense RNA 
2.1.3.1.1 Constructs prepared during this study 
 
Hnf1b-pCS2+ 
The open reading frame of Hnf1b was amplified from XHnf1b-pGEM7Z(-) (Vignali et 
al., 2000) using oligonucleotides MG102 and MG103  and cloned into the ClaI and 
XbaI sites of pCS2+ vector (Rupp et al., 1994; Turner and Weintraub, 1994). This 
construct served as template for Hnf1b antisense RNA preparation and was 
linearized with BamHI and transcribed with T7-polymerase. 
HNF1b-GRpCS2+ 
For the generation of a hormone-inducible Hnf1b for the purpose of gain of function 
experiments, the open reading frame of Hnf1b was amplified from XHnf1b-
pGEM7Z(-) (Vignali et al., 2000) without the stop-codon using the oligonucleotides 
MG102 and MG156. The PCR-product was then cloned into the ClaI and XhoI sites 
of GRpCS2+, a pCS2+ derivate (Gammill and Sive, 1997), containing the sequence 
of the human glucocorticoid receptor (GR). For sense RNA preparation the construct 
was linearized with NotI and Hnf1b-GR transcribed with Sp6-polymerase. 




For Fzd4-knockdown rescue experiments, the Fzd4s sequence was amplified from 
cDNA of stage 13 embryos using oligonucleotides MG169 and MG170 and cloned 
into the pGem®-T Easy vector (Promega). The amplified sequence contained the 
ATG and 920 nucleotides downstream reaching the stop codon within the intron. 
From this construct the Fzd4s sequence was amplified with oligonucleotides MG173 
and MG174 and cloned into the ClaI and XbaI sites of pCS2+. For sense RNA 
preparation, the construct was linearized with NotI and transcribed with Sp6-
polymerase.  
Fzd4_intron-pGEMTeasy 
For specific Fzd4s-RNA detection in WMISH, a 600 nucleotide sequence of the 
Fzd4-intron was amplified from cDNA of stage 13 embryos using oligonucleotides 
MG165 and MG170 and cloned into pGem®-T Easy vector. Antisense RNA was 
prepared by SalI linearization and transcription with T7-polymerase. 
 
2.1.3.1.2 Provided constructs for sense and antisense RNA 
 
Tab. 2.1 Provided constructs for sense RNA 
Designation Vector Acession reference 
sense RNA 
Cut Pol. 
Beta-Gal pCS2+ NC_000913.3 Chitnis et al., 1995 NotI Sp6 
Cyp26a1 pBK-CMV O93323 Hollemann et al., 1998 MluI T3 
Fzd4-3´MT MT/pCS2+ NM_001090453 Swain et al., 2005 NotI Sp6 
GFP MTpCS2+ NC_011521.1 Rubenstein et al., 1997 NotI  SP6 
Noggin pGEM5ZF M98807 Smith et al., 1993 NotI SP6 
Vegt pCS2+ AAB93301 Zhang and King, 1996 NotI SP6 
Wnt5a MTpCS2+ M55056.1 Damianitsch et al., 2009 NotI Sp6 
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Tab. 2.2 Provided constructs for anti-sense RNA 
Designation Vector Accession reference/source 
anti-sense RNA 
Cut Pol. 
Cebpd pCMV-Sport6 BC093576 
(Ikuzawa et al., 2005) 
Thermo Scientific 
(7007767) 
cloned with shortened 
3´UTR 
EcoRI T7 








183 bp from 
ATG) 
(Kofron et al., 2004) EcoRI T7 
Fst pCMV-Sport6 BC068649 




Fzd4 pCS2+ NM_001090453 (Swain et al., 2005) BamHI T7 
Gbx2 pGem-Teasy AF395825 (Maczkowiak et al., 2010) ApaI SP6 
Hnf1b pCS2+ NM_001089811 (Vignali et al., 2000) BamHI T7 
Hoxa1-b pCMV-Sport6 CF28664 




Hoxb1 pGEM-3ZF(-) FJ422584 (Nieto et al., 1992) EcoRI SP6 
Hoxd1 MT/pCS2+ Q08820 (Sive and Cheng, 1991) EcoRI T7 
Hoxd4 pExpress BC110765 




Igf3 pCMV-Sport6 AAL06242 (Richard-Parpaillon et al., 2002) SalI T7 
Ins pGem-Teasy P12706 (Shuldiner et al., 1989) Not T7 
Lhx1 pBluescript NM_001090659 (Taira et al., 1994) XhoI T7 
Meis3a pSP64T AF072895 (Salzberg et al., 1999) ClaI T3 
Nkx6.2 pBluescript NM_001096886 +270 to +990  
(Dichmann and Harland, 
2011) XhoI T7 
Pdia2 pBK-CMV AY351916 (Sogame et al., 2003) BamHI T7 
Pdx1 pGem-Teasy NM_001172211 (Wright et al., 1989) ApaI SP6 
Prph pCMV-Sport6 BC056020 




Ptf1a pGem-Teasy DQ007931 (Afelik et al., 2006) Not T7 





Xl.47239 pCMV-Sport6 IRAK288Co6 Source BioScience (IRBHp990G0486) SmaI T7 
Xl.51509 pCMV-Sport6 DY570900 Source BioScience (IMAGp998L119296Q) SalI T7 
Xl.57926 pCS111 C0387168 Source BioScience (IMAGp998C1718900Q) ClaI T7 
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Designation Vector Accession reference/source 
anti-sense RNA 
Cut Pol. 
Znf703-b pExpress DR726975 






2.1.3.2 Constructs for Luciferase reporter assay 
Tab. 2.3 Luciferase assay constructs 
Designation Vector Reference 
Atf2-firefly pGL3B (van der Sanden et al., 2004) 
Renilla pRL-TK (Promega) 
Siamois-firefly pGL3B (Brannon et al, 1997) 
 
 
2.1.3.3 Constructs for CRISPR/Cas system 
Tab. 2.4 CRISPR/Cas system constructs 
Designation Vector Reference 
Sense RNA 
Cut Pol. 
Cas9 pCasX (Blitz et al., 2013) Acc651 T7 




2.1.3.4 Constructs for real-time RT-PCR standard curves 
Tab. 2.5 Real-time PCR constructs 
Designation Vector Reference 
Insulin pGem-T (Shuldiner et al., 1989) 
Odc pGem-T (Klisch, 2006 PhD) 
Pdx1 pGem-T (Wright et al., 1989) 
Ptf1a pGem-T (Afelik et al., 2006) 
 
 




The oligonucleotides for cloning, sequencing and RT-PCR were purchased from 
SIGMA and dissolved in dH2O to 100 µM stock solution. The antisense morpholino 
oligonucleotides were purchased from Gene Tools, LLC (Philomath, USA) and 
dissolved in RNase-free water to a concentration of 1 µM or 2 µM. 
 
2.1.4.1 Cloning oligonucleotides 
Tab. 2.6 Cloning oligonucleotides 
(the digestion enzyme target site is underlined)  
Label oligonucleotide Sequence 5´ → 3´ 
MG102 XHNF1b_ClaI_fw ccATCGATggATGGTGTCCAAGCTATCGCC 
MG103 XHNF1b_stXba1_rev GgTCTAGAGCTCACCATGCTTGCAAAGGACACTG 
MG156 xHNF1b_Xho_rev gcgCTCGAGcggCCATGCTTGCAAAGGACACTG 
MG165 fz4_intron1_fw GTTACGCGCAGCAAGTCATT 
MG169 fz4S_sense_fw ATGGGGGCAAGATCGCTGACC 
MG170 fz4S_sense_rev CACAGTCACTTTTTGTGGACG 
MG173 fz4S_senseCla_fw ccATCGATggATGGGGGCAAGATCGCTGACC 
MG174 fz4S_senseXba_rev gcTCTAGAgcCACAGTCACTTTTTGTGGACG 
MG171 fz4_5UTRfl_fw GATTGTCCGGGAGTGTGCTA 
MG248 Fzd4s_P2_rev GAAAGTAAACCCCCTGTGCTGAG 
MG273 fzd7_fw GTTACGTGGGCATCAACAGC 
MG274 fzd7_rev TTGTAGTTGGGACAGGGCAC 
MG275 kremen2_fw TCACGGTGAATGGGAGAGAC 
MG294 kremen2_rev3 ACAGTTTATTCATAGTGGAAGCTCA 
MG297 impad1_fw4 ATGACCTGAAATGGCTGCCT 
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2.1.4.2 Sequencing nucleotides 
Tab. 2.7 Sequencing oligonucleotides 







T7 (pCS2+) TCTACGTAATACGACTCACTATAG 
T7 (pGem-T) TAATACGACTCACTATAGGGCGA 
 
2.1.4.3 Reverse transcriptase (RT) – PCR oligonucleotides 
Tab. 2.8 RT-oligonucleotides and working conditions 
 
Oligonucleotide Label  Sequence TAnnealing [°C] Cycles 
Amylase_fw LP1 CAAGCTCTGCACTCGTTCTG 
55 34 
Amylase_rev LP1 GTTTTCTATTTCGCCATCGC 
Bmp4-F 338 GCATGTACGGATAAGTCGATC 
58 32 
Bmp4-R 339 GATCTCAGACTCAACGGCAC 
Cer1-F 009 TGCCCATGGAAACAAAAGTGC 
57 28 
Cer1-R 010 AGCGTCAGGTGGTTCAGGGTAA 
CYP26_2C8_link_F MG039 GTCGACCTGTGGATCCAAAGA 
60 28 
CYP26_2C8_link_R MG040 GATGCGTCTTGTAGATGCGAC 
CYP26_3´UTR_F MG025 CCCGGAGATTCCTCGAGGTT 
56 30 
CYP26_3´UTR_R MG026 GACACCACGACCAAGACCCG 
Darmin_RT_fw MG005 GGTTACCGATTACTTGGAGG 
60 33 
Darmin_RT_rev MG006 AGCATCATCTGGTCCACCAA 
Fzd4s_fw MG247 CATCAGGATCACCATGTGCCAG 
60 28 
Fzd4s_rev MG248 GAAAGTAAACCCCCTGTGCTGAG 
Glucagon_RT_F LP1 AGAATTTATTGAGTGGTTGA 
56 35 
Glucagon_RT_R LP1 ATCGGCATGTCTTCTGTCC 
H4_RT_fw 35 CGGGATAACATTCAGGGTATCACT 
56 26 
H4_RT_rev 36 ATCCATGGCGGTAACTGTCTTCCT 




Oligonucleotide Label  Sequence TAnnealing [°C] Cycles 
HNF1b_E1_fw MG138 GGACAGGTGCTCTGGGACAAG 58/56 28/31 
HNF1b_E2_rev MG139 CCCTTTGTTTCCTCACATACC 58 28 
HNF1b_E3_rev MG141 GTCCTTGAACTTGATTTTGCT 56 31 
HNF1b_inj_R MG149 CGGGGACATGTGCAAGTTCT 54 30 
HNF1b_RT_F MG075 AAAGGGCAGAAGTGGACAGG 
58 32 
HNF1b_RT_R MG076 ATGCAGCACGTTTTTGGGTC 
Hnf4a_RT_fw MG157 AGACTCCCCAACCATCTCCA 
60 33 
Hnf4a_RT_rev MG158 CGCTTTCCCAAAGAGGCAAC 
Insulin_RT_F LP1 ATGGCTCTATGGATGCAGTG 56 
 
33 
33 Insulin_RT_F LP1 AGAGAACATGTGCTGTGGCA 
ODC_RT_F 324 GCCATTGTGAAGACTCTCTCCATTC 
56 24 
ODC_RT_R 325 TTCGGGTGATTCCTTGCCAC 
pCS2_RT_F PB CAAGCTACTTGTTCTTTTTGC 54 30 
Pdx1_RT_fw MG256 GTCCTCCAGACATCTCACCG 
60 33 
Pdx1_RT_rev MG257 AGCATGACTGCCAGCTCTAC 
Pia2_RT_F LP1 GGAGGAAAGAGGGACCAA 
60 33 
Pia2_RT_R LP1 GCGCCAGGGCAAAAGTG 
Ptf1a_UTR_F 348 GTTGTCAGAACGGCCAAAGT 
60 33 
Ptf1a_UTR_R 349 GGTACCGAGTGGAACCAAAG 
Sox17a_RT_F MG063 CAAGAGACTGGCACAGCAGA 
60 33 
Sox17a_RT_R MG064 CTGCTTGGGGTTCCCTGTAG 
Sox2_fw 266 GAGGATGGACACTTATGCCCAC 
58 29 
Sox2_rev 267 GGACATGCTGTAGGTAGGCGA 
Xfz4_RTE1_fw MG163 CCAAAATGCCCAACCTGGTG 
64 26 
Xfz4_RTE2_rev MG164 TTGTGGTCATTCTGGGGTGG 
Xfz4S_RT_fw MG161 TTGTTGTACCTCCTGTGCTGCCTC 
60 29 
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2.1.4.4 Real-time PCR oligonucleotides 
Tab. 2.9 Real-time PCR oligonucleotides 
Oligonucleotide Label Sequence target region (bp) 
ODC_RT_F 324 GCCATTGTGAAGACTCTCTCCATTC 
+222 to +441 ODC_RT_R 325 TTCGGGTGATTCCTTGCCAC 
Insulin_RT_F LP1 ATGGCTCTATGGATGCAGTG 
+1 to +291 Insulin_RT_F LP1 AGAGAACATGTGCTGTGGCA 
Pdx1_fw MG256 GTCCTCCAGACATCTCACCG 
+170 to +551 
Pdx1_rev MG257 AGCATGACTGCCAGCTCTAC 
Ptf1a_fw MG271 GGTACAGTCCGATCTGCCGC 
+522 to +732 
Ptf1a_rev MG272 GGAGTCCACACTTTGGCCGT 
 
2.1.4.5 sgRNA oligonucleotides 
Target site in the Fzd4 gene GGCACATG[GTGATCCTGATG] 
Forward (5´Phos) TAGGCACATGGTGATCCTGATG 
Reverse (5´Phos) AAACCATCAGGATCACCATGTG 
 
 
2.1.4.6 Morpholino oligonucleotides 
Tab. 2.10 Morpholino oligonucleotides 
Designation Target RNA Sequence 5´ → 3´ 
HNF1b-MO 
Xenopus laevis HNF1β  
intron 1/exon2 boundary 
ATCCTCGCTGTGAACAAAACACAAA 
Fzd4-MO 
Xenopus laevis Fzd4 
ATG region (Gorny et al., 2013) 
ATTATTCTTCTTCTGTTGCCGCTGA 
Fzd4-mmMO 
mutated Fzd4-MO, which does not 
bind target 
ATTATTaTTaTTCTaTTGCaGCTaA 
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2.2 Methods  
2.2.1 DNA methods 
2.2.1.1 Chemical transformation and cultivation of bacterial cells 
LB-medium:  Bacto Trypton 10g (1 %); Bacto Yeast Extract 5g (0.5 %); 
NaCl 10g (17.1 mM); dH2O to 1 l; pH to 7.5 
LB-agar:  Agar 15g (1.5 %) to 1 l LB-medium 
Amplicillin:   stock solution 100 mg/ml in dH2O; stored at -20 °C;  
working solution 100 µg/ml  
Kanamycin:  stock solution 100 mg/ml in dH2O; stored at -20 °C; working 
solution 50 µg/ml  
 
In order to increase the amount of DNA for analytical and preparative methods, 
chemically competent E.coli XL1blue were used. 200 µl of bacterial cell suspension 
were thawed on ice, mixed with 100 ng of plasmid DNA or 5 µl of ligation mix, 
incubated for 30 min on ice and heat-shocked for 90 sec at 42 °C and 1 min on ice. 
800 µl LB-medium was added and the solution was incubated with mild shaking for 
1h at 37 °C. The bacterial cells were then pelleted by 30 sec centrifugation at 
10,000 rpm, re-suspended in 100 µl LB-medium and seeded on LB-agar plates 
supplemented with ampicillin or kanamycin. Colonies were grown over night at 37 
°C. Single colonies were picked and cultivated in LB-medium containing the 
appropriate antibiotic (Sambrook and Russel, 2001). 
 
2.2.1.2 Plasmid DNA preparations 
For the plasmid preparation in analytical amounts, the “GeneJETTM Plasmid 
Miniprep” kit (Thermo Scientific) was used. For the isolation of plasmid DNA in 
preparative amounts the “NucleoBond®Xtra Midi” kit (Machery-Nagel) was used 
according to the manufacturer´s instructions. The DNA concentration was measured 
with the NanoDrop-2000c spectrometer (Thermo Scientific). 
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2.2.1.3 DNA restriction digestion 
Restriction digests for the purpose of cloning or linearization were carried out with 
restriction enzymes from Thermo Scientific according to the manufacturer´s 
protocol. The digestions were performed with 2 to 5 U of the appropriate enzyme per 
µg DNA and incubated at 37°C for at least 1 h. 
 
2.2.1.4 Agarose gel electrophoresis 
TAE (Tris/Acetat/EDTA):  40 mM Tris Acetate; 2 mM EDTA; pH 8.5 
6x DNA loading dye:  10 mM Tris-HCL (pH 7.6); 0,03 %  Bromophenol Blue; 
0,03 % Xylene Cyanol FF; 60 % Glycerol; 60 mM 
EDTA 
2x RNA loading dye:  95% Formamide; 18 mM EDTA; 0.025% of each SDS, 
Xylene Cyanol and Bromophenol Blue (Ambion) 
 
The agarose gel electrophoresis was used for the analysis of DNA-restriction or 
PCR products as well as for the quality control of sense and antisense RNA (Sharp 
et al., 1973). Agarose was boiled in 1x TAE buffer to prepare a 0.7 % to 2% (w/v) 
gel, depending on the size of the DNA/RNA fragments. Standard DNA ladders were 
used to define the size of DNA fragments (Fermentas High, Middle or Low Range). 
DNA loading dye was added to DNA samples and RNA-samples were mixed with 
RNA loading dye prior to loading. To visualize the DNA/RNA, ethidium bromide (0.5 
µg/ml) was added. For the documentation the ChemiDoc video documentation 
system (EASY view) was used. 
 
2.2.1.5 Purification of DNA fragments from agarose gel or digestions 
For the purification of DNA fragments from agarose gels or restriction digestions, the 
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2.2.1.6 Polymerase chain reaction (PCR) 
The amplification of DNA- or cDNA-fragments was done by PCR (Saiki et al., 1985; 
Mullis et al., 1986). The reaction needs oligonucleotides complementary to the ends 
of the sequence that is to be amplified, nucleotides and a DNA-polymerase. The 
reaction proceeds in three steps that are repeated. Initially, the DNA template is 
heated to 95°C to render it single-stranded (Denaturation). Next, the 
oligonucleotides bind to the complementary sequence at a lower temperature 
specific for their size and composition (Annealing). Finally, the bound 
oligonucleotides are extended by the DNA-polymerase at 72 °C (Elongation). The 
DNA-Polymerase as well as the length and composition of the oligonucleotides 
varied depending on the purpose of amplification.  
 
2.2.1.6.1 Cloning PCR 
For the purpose of molecular cloning, DNA fragments were amplified by the use of 
the High Fidelity PCR enzyme Mix (Thermo Scientific). This Mix contains Taq DNA 
Polymerase and an additional thermostable DNA polymerase that possesses 3´→ 5´ 
exonuclease “proof-reading” activity. This “proof-reading” activity reduces the 
occurrence of point mutations during the amplification process.  
The PCR reaction mixture contained the following components: 
µl  final conc.  component                                     _     
   1  100 ng   100 ng/µl template DNA 
10  1x   5x High Fidelity Buffer with 15 mM  
MgCl2 
1   0.2 mM (each) 10mM dNTP Mix (Thermo Scientific) 
1  0.2 µM   10 µM oligonucleotide mix each 
0.5  0.02 U   High Fidelity PCR enzyme Mix  
(Thermo Scientific) 
 Add water to 50 µl 
The following cycling conditions were used for the amplification: 
 Initial denaturation  95 °C  5 min           
 Denaturation   95 °C  45 sec 
 Annealing   x °C  45 sec   35 cycles 
 Elongation   72 °C  1 min / 1 kb 
 Final elongation  72 °C  5min 
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2.2.1.6.2 Semi-quantitative PCR  
For the semi-quantitative PCR, cDNA was used (preparation described in chapter 
2.2.2.4). Thus, the semi-quantitative PCR was used to analyze temporal gene 
expression patterns or alterations of gene expression upon microinjections or 
chemical treatments. The following components and conditions were used. 
 
µl  final conc.  component                                             
2.5  ~ 125ng  ~ 50 ng/µl cDNA 
2.5  1x   5x Flexi GoTaq buffer with 25 mM  
MgCl2 
0.625  0.5 µM   10 µM gene specific oligonucleotide  
mix  
 0.1  0.5 U   GoTaq polymerase (Promega) 
 
 Add water to 12.5 µl 
 Initial denaturation  95 °C  5 min           
 Denaturation   95 °C  45 sec 
 Annealing   x* °C  45 sec   x** cycles 
 Elongation   72 °C  45 sec 
 Final elongation  72 °C  5min 
 x*  = oligonucleotide specific annealing temperature 
 x**= cycle number depends on the mRNA copy number  
 
2.2.1.6.3 Quantitative real-time PCR  
For the quantification of gene expression levels, cDNA was applied to the real-time 
PCR. To detect the amplified DNA the fluorescent dye SYBR Green was used that 
intercalates into double stranded DNA. The fluorescence is measured each cycle 
and increases in correlation with the increase in PCR-product. For this purpose, a 
PCR reaction mix containing SYBR Green was used (Biorad) and the detection took 
place in the IQ5 Biorad machine. All measurements were performed as duplicates 
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µl  final conc.  component                                             
2.5  ~ 250ng  ~100 ng/µl cDNA 
10  1x   2x SYBRGreen supermix (Biorad) 
 0.4  0.2 µM   10 µM gene specific oligonucleotide  
mix  
 Add water to 20 µl 
 
 Initial denaturation  95 °C  3 min                    
 Denaturation   95 °C  10 sec 
 Annealing   59 °C  15 sec  60 cycles 
 Elongation   72 °C  30 sec       
 Melting curve           56 – 95 °C     + 1 °C/sec 39 cycles 
 
2.2.1.7 DNA sequencing analysis 
To confirm correct DNA sequences, the Dye-termination sequencing method, based 
on Sanger´s chain-termination sequencing, was used (Sanger et al., 1977).  The 
Sequencing was performed with the “Big Dye Terminator Cycle Sequencing” kit 
(Applied Biosystems). The following sequencing PCR reaction components and 
conditions were applied.  
µl  final conc.  component                                             
1  500 ng   500 ng/µl DNA 
1.5     seq mix 
1.5  1x   seq buffer 
 0.625  0.625 µM  10 µM sequencing oligonucleotide 
 
 Add water to 10 µl 
 
 Denaturation   95 °C  2 min           
 Denaturation   95 °C  10 sec 
 Annealing   x °C  15 sec     25 cycles 
 Elongation   60 °C  4 min 
 x = oligonucleotide specific annealing temperature 
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The DNA fragments, obtained from the sequencing reaction, were purified by the 
addition of the following components to the 10 µl reaction mix. 
 1 µl  125mM EDTA (pH 8.0) 
 1 µl  3 M sodium acetate (pH 5.4) 
 50 µl   100 % ethanol 
The mixture was incubated for 5 min at room temperature following a centrifugation 
for 15 min at 14000 rpm. DNA pellets were washed with 70 µl 70 % ethanol. The air-
dried DNA pellets were dissolved in 15 µl HiDiTM buffer (Applied Biosystems). The 
obtained sequencing PCR products were analyzed by the ABI 3100 Automated 
Capillary DNA Sequencer (Applied Biosystems). 
2.2.2 RNA methods 
2.2.2.1 In vitro synthesis of capped and uncapped sense mRNA 
Capped sense mRNAs for the microinjection into Xenopus embryos were in vitro 
synthesized using the SP6, T7 or T3 mMessage mMachine Kits TM (Ambion). 1 µg of 
linearized plasmid DNA template was used in 20 µl reaction mixture. For uncapped 
sgRNA preparation, 2 µg of linearized plasmid DNA were used in 25µl reaction 
mixture with components indicated in section 2.2.2.2 devoid of Dig-UTP. After an 
incubation of 3 hours at 37 °C the DNA template was removed by 5 U of Turbo 
DNase I (Ambion) for 30 min at 37 °C. The synthesized RNA was purified by the use 
of the Illustra TM RNAspin Mini RNA Isolation Kit (GE Healthcare). RNA 
concentration was measured by the NanoDrop and the quality was analyzed on a 1 
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2.2.2.2 In vitro synthesis of labeled antisense RNA 
Anti-sense RNA probes were used to detect endogenous transcripts by whole 
mount in situ hybridization (see chapter 2.2.4.). 1 µg of linearized plasmid DNA was 
used in 25 µl reaction. Following components were included in the reaction to 
generate Dig-labeled anti-sense RNA: 
 µl   component                 
 5   5x transcription buffer (Fermentas) 
 4   ATP, GTP, CTP, UTP, Dig-UTP (10mM each)  
(Boehringer) 
 1   DTT (0.75 M) 
 1   Ribolock RNase inhibitor (40 U/µl) (Thermo  
Scientific) 
 1.5   RNA polymerase (20 U/µl Fermentas) 
The reaction mixture was incubated for 3 h at 37 °C. The DNA template was 
removed using 2 U/µl Turbo DNaseI (Ambion) for 30 min at 37 °C. Anti-sense RNA 
was purified with the RNeasy® Mini Kit (Qiagen). The RNA was eluted in 100 µl 
RNase-free water at 80 °C for 2 min. The RNA quality was analyzed on a 1 % 
agarose gel. 1ml of hybridization mix was added to the prepared anti-sense RNA 
and stored at -20°C.  
2.2.2.3 RNA isolation from whole embryos and ectodermal explants 
Trizol:  peqGOLD TriFast reagent (peQlab) 
For total RNA extraction, two to five embryos and 20 to 50 ectodermal explants were 
fixated in liquid nitrogen and stored at -80 °C. Total RNA was isolated with trizol. 
Embryos and explants were macerated in 400 µl trizol using a sterile Omnican® 40 
syringe (Braun). Samples were vortexed for 30 sec, 80 µl of Chloroform (Roth) were 
added and again vortexed for 30 sec. To separate the phases, the samples were 
centrifuged for 10 min at 4 °C with maximum speed. The upper phase was 
transferred into a new tube and mixed with 200 µl of Chloroform for 30 sec. After a 
second centrifugation step for 5 min the upper phase was transferred into a new 
tube and 180 µl of 2-propanol (Roth) were added to precipitate nucleic acids over 
night at -20 °C. The next day, the nucleic acids were pelleted by a centrifugation for 
30 min. The pellet was washed with 75 % ethanol. The air-dried pellet was dissolved 
in 12.5 µl RNase-free water. To remove genomic DNA, the sample was incubated 
with 1 U/µl DNaseI (Thermo Scientific) for 1.5 h at 37 °C. The DNaseI activity was 
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inactivated by heating to 70 °C for 10 min. For the confirmation of complete removal 
of genomic DNA, a PCR was performed with 1 µl RNA sample (50 ng/µl) described 
in 2.2.1.6.2 Semi-quantitative PCR using oligonucleotides for housekeeping gene 
H4.  
2.2.2.4 Reverse transcription and PCR 
For cDNA synthesis, 50 to 100 ng total RNA was used for a reaction volume of 10 
µl. The following additional components were contained in the reaction mix. 
µl  final conc.  component                                             
 2  1x   5x Go Taq flexi buffer (Promega) 
2  5 mM   25 mM MgCl2 
0.5  2.5 ng    50 ng random hexamer  
oligonucleotides (Invitrogen) 
1  1 mM   10 mM dNTP mix 
0.2  0.8 U    Ribolock RNase inhibitor 
0.4  20 U    MuLV reverse transcriptase (Roche) 
cDNA synthesis was performed under the following conditions. 
 step  temperature (°C)  time (min) 
1  20     20  
 2  42    60 
 3  95      5 
From 10 µl cDNA reaction, 2.5 µl were used for semi-quantitative PCR (see chapter 
2.2.1.6.2). 
2.2.2.5 Quantitative Nanostring analysis 
For the simultaneous quantification of different transcripts, the digital multiplexed 
expression analysis system Nanostring was used with 600 ng of total RNA. The 
analyzed genes as well as the target region are shown in the appendix (Tab. 6.25 
and Tab. 6.26). For data analysis, the counts were normalized in two steps using 
the nSolver software program provided by Nanostring. First, the counts were 
normalized with respect to the mean of positive control counts. Second, the counts 
were normalized to the geometric mean of the housekeeping gene ornithine 
carboxylase (odc). Finally, to consider the background, the mean and two-fold of the 
standard deviation of the eight negative controls were substracted. Negative values 
were set to 1. Data from two independent experiments (A and B) were used to 
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calculate a mean value. Error bars indicate the standard error of the mean (SEM) 
which results from the division of the standard deviation by square of two. 
2.2.2.6 RNA-sequencing 
2.2.2.6.1 RNA isolation 
To isolate total RNA for RNA-sequencing, the trizol-based method, described in 
chapter 2.2.2.3 (p.47), was used with the following modifications. Ectodermal 
explants were lysated in 360 µl trizol and incubated for 10 min at RT. Next, 72 µl 
chloroform were added and incubated for additional 5 min at RT. After a 
centrifugation step of 20 min at 4 °C, the upper phase was transferred to a new 
tube, mixed with 1 volume of chloroform and centrifuged for 10 min. Again, the 
upper phase was transferred to a new tube, mixed with 1 volume of 2-propanol and 
incubated over night at -20 °C. Next day, the nucleic acids were pelleted by 
centrifugation for 30 min at 4 °C. The pellet was washed with 500 µl 75 % ethanol, 
air dried and dissolved in 20 µl RNase-free water. To remove the genomic DNA, 1 µl 
DNaseI (Thermo Scientific), 0.5 µl RNase inhibitor (Thermo Scientific) and 1x 
DNase reaction buffer were added to a total volume of 50 µl and incubated for 1 h at 
37 °C. To eliminate the DNaseI, 100 µl RNase-free water and 200 µl phenol-
chloroform-isoamylalcohol were added. After a centrifugation of 20 min at 4 °C, the 
upper phase was transferred to a new tube. 1/10 vol. 5 M ammoniumacetate and 1 
vol. 2-propanol were added and incubated over night at -20 °C. Next day, the RNA 
was pelleted by a centrifugation for 30 min at 4 °C. The pellet was washed twice 
with 75 % ethanol, air-dried and dissolved in 12.5 µl RNase-free water. RNA quality 
was analyzed by use of the 2100 Bioanalyzer (Agilent). To confirmation the 
complete removal of genomic DNA, a PCR was performed with 1 µl RNA sample 
(100 ng/µl) using oligonucleotides for housekeeping gene H4.  
 
2.2.2.6.2 Sample preparation and sequencing 
RNA-samples were prepared in two independent experiments. For sequencing the 
RNA-samples were handled with the “TruSeq RNA Sample Prep Kit v2” according to 
the manufacturer instructions. The samples were sequenced via HiSeq 2000 
(Ilumina). The sequence reads consist of 50 base pairs from the single-end mode 
and the quality of this reads was checked by FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).  
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2.2.2.6.3 Sequence alignment 
The sequence images were transformed to bcl files by the use of the Ilumina 
software BaseCaller and were de-multiplexed to fastq files with CASAVA (version 
1.8.2). The obtained sequence reads were aligned to the transcript reference 
sequences of Xenopus tropicalis (kindly provided by Michael J. Gilchrist; Gilchrist et 
al., 2004). In addition, the reads were also aligned to selected Xenopus laevis 
transcriptome sequences (UniGene) for genes which were not found in the Xenopus 
tropicalis transcriptome. The alignment was performed using Bowtie2 (version 2.1.0) 
in local alignment mode allowing 6 mismatches within 50 bases (Langmead and 
Salzberg, 2012). The resulting SAM files (Sequence Alignment/Map) were 
converted to sorted BAM files (binary version of SAM files) and unique hits were 
filtered. That means reads mapped to more than two genes were removed to 
facilitate the analysis.  
2.2.2.6.4 Statistical analysis  
The counting of mapped reads was conducted with samtools (Li et al., 2009). The 
obtained data were pre-processed and analyzed in the R/Bioconductor environment 
(http://www.bioconductor.org), loading edgeR (Robinson et al., 2010) and biomaRt 
packages. The counts were normalized to trimmed mean of M-values and the 
dispersion was estimated. For the detection of differentially expressed genes, a test 
based on a generalized linear model likelihood ratio assuming negative binominal 
data distribution was performed via edgeR. Candidate genes were filtered to a 
minimum of two fold change difference to the control and a FDR-corrected p-value 
of <0.05. Gene annotation was enriched by data from Xenbase 
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2.2.3 Xenopus laevis embryo culture and micromanipulations 
2.2.3.1 Preparation of Xenopus laevis testis 
10x MBS: 880 mM NaCl; 10 mM KCl; 10 mM MgSO4; 25 mM NaHCO3; 50 mM 
HEPES (pH 7.8) 
 
1x MBS:  1x MBS; 0.7 mM CaCL2 
Frog narcotic: 2.5 % Tricaine methanesulfonate in tap water; adjusted to a  
    neutral pH by Na2HPO4; reviewed in (Guenette et al., 2013) 
 
For in vitro fertilization of the eggs, a male frog was narcotized and sacrificed. The 
isolated testis was washed in 1x MBS and stored at 4 °C. A small part of the testis 
was minced and diluted in 1x MBS. This solution was stored on ice until it was 
needed.  
2.2.3.2 Stimulation of eggs 
HCG:  2000 U/ml human chorionic gonadotropin (HCG) (SIGMA) 
In the evening, the female frogs were stimulated for the next day´s egg deposition 
by the injection of 1000 U HCG subcutaneously close to the dorsal lymph sac. The 
frogs were kept at 16 °C over night so that ovulation started approximately 10 hours 
later. For a later egg deposition, the frogs were stimulated first with 500 U HCG in 
the evening and 1000 U HCG in the next morning.  
2.2.3.3 Fertilization 
Laid eggs were collected and in vitro fertilized with minced testis in 1x MBS.  By the 
addition of water to dilute the testis-salt solution 1 to 10, the sperm movement was 
activated. 20 min after the fertilization the clutch of eggs was covered with 0.1x 
MBS.  
2.2.3.4 Embryo culture and microinjections 
Cysteine:  2 % L-cysteine hydrochloride in 0.1x MBS; pH 8.0 
Injection buffer:  2 % Ficoll in 1x MBS 
To remove the jelly coat, the fertilized eggs/ embryos were treated with 2 % cysteine 
hydrochloride, pH 8.0. After the removal of the jelly coat, the embryos were washed 
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three times with 0.1x MBS and cultivated at 12.5 °C until the microinjections. The 
injections were performed on a cooling plate at 12.5 °C. The developmental stage 
as well as the position of injection was dependent on the purpose of the approach. 
The solutions for the microinjections were loaded into glass needles prepared on a 
needle puller (PN-30, Science Products GmbH). The Microinjector 5242 (Eppendorf) 
was used to inject 4 nl of injection mixture per blastomere. Injected embryos were 
kept in injection buffer at 12.5 °C until the next morning. This allowed the heeling of 
the injection opening. Afterwards, the embryos were transferred into 0.1x MBS and 
either prepared for ectodermal explants or further cultivated to the desired 
developmental stage. The developmental stages were defined according to 
Nieuwkoop and Faber Table of Xenopus laevis (Nieuwkoop and Faber, 1967). 
2.2.3.5 Xenopus laevis ectodermal explants  
5x MBS EE:  440 mM NaCl; 5 mM KCl; 4.1 mM MgSO4; 12 mM NaHCO3;  
   2.05 mM CaCl2; 1.65 mM Ca(NO3)2; 50 mM HEPES; pH 7.8 
 
Agarose dish: 0.7 % agarose in 0.8x MBS EE 
First, the vitelline membrane of a micro-manipulated or un-manipulated stage 8 to 9 
embryo was removed. Then, the centre of the pigmented animal hemisphere 
(=blastocoel roof tissue) was isolated by the use of the gastromaster system 
(Xenotek Engeneering, Bellville, USA). The explants were washed in 0.8x MBS EE 
on a 0.7 % agarose-coated Petri-dish and cultivated over night at 12°C. The next 
day, at the equivalent of stage 11, the explants were treated with RA and/or CHX or 
DEX for a defined time span and were subsequently washed in 0,8x MBS EE. The 
explants were then cultivated in 0,8x MBS EE containing Ampicillin (100 µg/ml), 
Kanamycin (10µg/ml) and Gentamycin (10 µg/ml) at 12 to 14 °C and were daily 
provided with fresh buffer solution until the control embryos reached the desired 
developmental stage (Nieuwkoop, 1963; Fukui et al., 2003).  
2.2.3.6 Xenopus laevis embryo and explant treatments 
2.2.3.6.1 Dexamethasone (DEX) treatment 
Dexamethasone:  stock solution 4 mg/ml in 100 % ethanol  
 working solution 10 µM 
To induce protein activity at a certain time point during embryonic development, 
hormone-inducible constructs were injected. Therefore, the ligand-binding domain of 
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the glucocorticoid receptor (GR) was fused to the coding regions (Gammill and Sive, 
1997). In the absence of the hormone dexamethasone (DEX), the fusion protein is 
held in an inactive state. This inactive state is caused by complex formation with a 
chaperone protein (Hutchison et al., 1993). Upon the addition of DEX a 
conformational change is caused that dissociates the chaperone (Tsai and O'Malley, 
1994). Injected embryos or ectodermal explants were cultivated in the dark in the 
presence of 10 µM DEX until the desired stage was reached. 
2.2.3.6.2 Retinoic acid (RA) treatment 
Retinoic acid: stock solution 100 mM in DMSO (stored at -80 °C, SIGMA);  
10 mM in 100% ethanol (stored at -20 °C in the dark) 
   Working solution 5 µM in 0.1x MBS or 0.8x MBS EE  
Ectodermal explants and whole embryos at stage 11 were incubated in 5 µM RA 
(all-trans-RA) in the corresponding buffer for 1 h at 12 °C under light protection. 
After the treatment, embryos and explants were cultivated until the controls reached 
the desired developmental stage.  
2.2.3.6.3 BMS453 treatment  
BMS453:  stock solution 10 mM in DMSO (stored at -20 °C, gift from Bristol 
Myers Squibb). 
working solution 0.25 µM in 0.1x MBS or 0.8x MBS EE 
To inhibit endogenous RA-signaling, the synthetic retinoid BMS453 was used. 
BMS453 specifically binds the RA-receptor RARβ thereby blocking the binding of 
RA (Chen et al., 1995). Whole embryos were incubated with 0.25 µM BMS453 in 
0.1x MBS at stage 8/9 until stage 12. Afterwards, embryos were cultivated in 0.1x 
MBS until they reached the desired stage. 
2.2.3.6.4 Cyclohexamide (CHX) treatment 
Cycloheximide:  stock solution 100 mg/ml in DMSO (Sigma-Aldrich) 
   working solution 10 µg/ml 
To inhibit protein biosynthesis Cycloheximide (CHX) was used. CHX blocks the 
translocation step in elongation (Schneider-Poetsch et al., 2010). Ectodermal 
explants were treated with 10 µg/ml CHX in 0.8x MBS EE 30 min prior to additional 
treatments (Perron et al., 1999). 
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2.2.4 Whole mount in situ hybridization (WMISH) 
To visualize the spatial and temporal pattern of endogenous transcripts, a whole 
mount in situ hybridization (WMISH) was performed. The performance essentially 
based on (Harland, 1991; Hollemann and Pieler, 1999; Nieber et al., 2009). For the 
detection, a Digoxygenin-11-UTP (Dig) labeled anti-sense RNA probe was used. 
The visualization was done by the use of an alkaline phosphatase-coupled anti-Dig 
antibody. All steps were performed at ambient temperature with mild shaking. 
2.2.4.1 Fixation and X-Gal staining 
10x MEM:  1 M Mops; 20 mM EGTA; 10 mM MgSO4; pH 7.4 (stored light  
   protected) 
10x PBS:  1.75 M NaCl; 1 M KCl; 65 mM Na2HPO4; 18 mM KH2PO4;  
pH 7.4 
 
K3FE(CN)6: 0.5 M in H2O (stored light protected) 
K4FE(CN)6: 0.5 M in H2O (stored light protected) 
MEMFA: 4% (v/v) formaldehyde (37%) in 1x MEM 
X-Gal:   40 mg/ml 5-Bromo-4-chloro-3-indolyl-b-D-galactopyranoside in 
formamide (stored -20 °C light protected) 
 
X-Gal staining solution:  1 mg/ml X-Gal; 5 mM K3FE(CN)6; 5 mM  
K4FE(CN)6; 2 mM MgCl2 in 1x PBS 
 
Embryos were fixated with MEMFA in glas vials for 1 hr at RT following three 
washing steps with 100 % ethanol for 5 min. β-gal injected embryos were fixated in 
MEMFA for only 25 min following three washing steps with 1x PBS for 10 min. The 
co-injection of RNA encoding for β-galactosidase (glb1) was used as a control for 
the purpose of knockdown and over-expression studies. To visualize the β-gal 
presence, X-Gal staining was performed (Bourguignon et al., 1998). Therefore, the 
embryos were incubated in X-Gal staining solution under light protection until the 
desired staining level was achieved. To stop the staining reaction, the embryos were 
washed three times for 10 min in 1x PBS and refixated for 25 min in MEMFA. 
Finally, the embryos were washed three times for 5 min in 100 % ethanol and stored 
at -20 °C. 




PTw:  0.1 % Tween-20 in 1x PBS 
Embryos were rehydrated with an ethanol series (75 %, 50 %, 25 %) to PTw and 
washed three times in PTw for 10 min each at RT. 
2.2.4.3 Proteinase-K treatment 
Proteinase-K: 10 µg/ml in PTw 
To allow a better penetration of the anti-sense RNA probe, embryos were treated 
with Proteinase-K. The embryos were incubated in 2 ml of PTw/proteinase-K 
solution for a defined time period and temperature depending on the developmental 
stage. 
stage time [min] temperature 
explants 1 RT 
10 to12 4 RT 
32 to 35 18 RT 
39 to 41 15 37°C 
 
2.2.4.4 Acetylation and refixation 
Triethanolamine: 0.1 M (0.93 g in H2O); pH 7.5 (SIGMA) 
Acetic anhydride: (SIGMA) 
PTw-FA:  4 % formaldehyde (v/v) in PTw 
The proteinase-K treatment was stopped by two washing steps with triethanolamine 
for 5 min. To prevent an unspecific reaction of the Dig-labeled anti-sense RNA 
probe, free amino-acid ends were blocked by the treatment with 25 µl acetic 
anhydride in triethanolamine. Next, the embryos were washed two times with PTw 
for 5 min and refixated in PTw-FA for 20 min. Afterwards the embryos were washed 
5 times with PTw for 5 min.  
 
 




Hybridization Mix:    50 % (v/v) formamide; 1 mg/ml Torula RNA (SIGMA);  
 100 µg/ml Heparin, 1x Denhardt´s; 0.1 % (v/v) Tween-   
 20; 0.1 % (w/v) CHAPS; 10 mM EDTA in 5x SSC 
 
100x Denhardt´s:       2 % BSA; 2 % Polyvinylpyrollidone (PVP); 2 % Ficoll  
 400 in H2O (w/v) 
 
20x SSC:              3 M NaCl; 0.3 M NaCitrate; pH 7.2-7.4 
The Hybridization with the anti-sense RNA probe was preceded by a pre-
hybridization with 1 ml hybridization mix for 5 min followed by incubation with fresh 
hybridization mix for at least 5 h at 65 °C. Afterwards the embryos were incubated in 
1 ml Dig-labeled anti-sense RNA containing Hybridization mix over night at 65 °C. 
2.2.4.6 Washing 
20x SSC:  3 M NaCl; 0.3 M NaCitrate; pH 7.2-7.4 
MAB:   100 mM maleic acid; 150 mM NaCl; pH 7.5 
RNase solution: 20 µg/ml RNase A and 10 U/ml RNase T1 (Fermentas) in  
2x SSC 
The next day, the anti-sense RNA probe was collected and stored at -20°C for 
reuse. The embryos were washed in hybridization mix for 10 min at 65 °C and three 
times with 2x SSC for 15 min at 65 °C. To remove the non-hybridized RNA 
molecules, the embryos were incubated in RNase solution for 1 h at 37 °C. 
Afterwards the embryos were washed once in 2x SSC at 37 °C and twice in 0.2x 
SSC at 65 °C. Next, the buffer was exchanged to MAB.  
2.2.4.7 Blocking and antibody incubation 
MAB:   100 mM maleic acid; 150 mM NaCl; pH 7.5 
MAB/BMB:  2 % BMB (Bohringer Mannheim blocking reagent) in 1x  
MAB 
MAB/BMB/HS: 20 % heat-treated horse serum (HS) in MAB/BMB 
MAB/BMB/HS/AK: 1:5000 sheep-anti-Dig antibody linked to alkaline  
phosphatase (AP) in MAB/BMB/HS (SIGMA) 
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To minimize unspecific binding of the AP-linked anti-Dig antibody, embryos were 
blocked in MAB/BMB for 20 min and in MAB/BMB/HS for 40 min. For the detection, 
the embryos were incubated with anti-Dig antibody containing MAB/BMB/HS/AK for 
4h at RT. Next, the embryos were extensively washed with MAB, first three times for 
10 min and then overnight at 4 °C. 
2.2.4.8 Staining reaction 
APB:   100 mM Tris-HCL; 50 mM MgCl2; 100 mM NaCl; 0.1 %  
Tween-20; pH 9.0 
 
NBT:   100 mg/ml in 70 % Dimethylformamide (light sensitive) 
BCIP:   50 mg/ml in 100 % Dimthylformamide (light sensitive) 
Staining solution: 0.8 µl NBT and 3.5 µl BCIP in 1 ml APB 
MEMFA:  4% (v/v) formaldehyde (37%) in 1x MEM 
The washing with MAB was continued by three times for 10 min with MAB. Then the 
caps of the glas vials were exchanged and three additional washing steps with MAB 
followed. Next, the embryos were two times washed in APB for 5 min at 4 °C and 
then the staining solution was added. This solution contained NBT and BCIP, 
substrates for the alkaline phosphatase that were converted to a colored product. 
The staining reaction was performed in the dark at 4 °C until the staining was 
sufficient. To stop the colour reaction and to remove background staining, the 
embryos were transferred to 100 % methanol. Then the embryos were rehydrated 
with a methanol series (75 %, 50 %, 25 %) to MEMFA and incubated for 30 min.  
2.2.4.9 Bleaching 
20x SSC:   3 M NaCl; 0.3 M NaCitrate; pH 7.2-7.4 
MEMFA:   4% (v/v) formaldehyde (37%) in 1x MEM 
Bleaching solution: 50 % formamide and 1 – 2 % H2O2 in 5x SSC 
To remove the pigments for an easier documentation of the staining, the embryos 
were first washed twice in 5x SSC and then incubated with the bleaching solution. 
Afterwards, the embryos were washed again twice in 5x SSC and re-fixated with 
MEMFA.  
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2.2.5 CRISPR/Cas system  
 
The CRISPR/Cas system (Clustered Regularly Interspaced Short Palindromic 
Repeats/CRISPR-associated) was first identified as part of the bacterial adaptive 
defense mechanism against virus and plasmid DNA (Fineran and Dy, 2014; Hsu et 
al., 2014; Terns and Terns, 2014). There, the RNA-guided DNA endonuclease Cas9 
causes double-strand breaks at the DNA target site that were often imperfectly 
repaired by non-homologous end-joining (NHEJ). As a result, deletion or insertion 
mutations occur frequently (reviewed in Waters et al., 2014). Most recently, this 
system has been successfully applied for genome modification in numerous 
organisms (Blitz et al., 2013; Nakayama et al., 2013; Guo et al., 2014; Sander and 
Joung, 2014; Wang et al., 2015). In this study the CRISPR/Cas technology was 
used for fzd4-gene disruption. The Cas9 protein forms a complex with two short 
non-coding RNAs, a CRISPR RNA (crRNA) that has complementary sequence to 
the target DNA and a trans-activating CRISPR RNA (tracrRNA) that base pairs with 
the crRNA. For genome editing applications, a synthetic guide RNA (sgRNA) was 
designed by ZiFiT Targeter version 4.1 (Sander et al., 2007; Sander et al., 2010) 
where the minimal features of both RNAs were combined and the target sequence 
of 20 bp was added.  
2.2.5.1 sgRNA preparation 
1x annealing buffer: 40mM Tris, 20mM MgCl2, 50mM NaCl, 10mM EDTA; 
pH 8.0 
For the generation of the sgRNA, the DR274 vector (Hwang et al., 2013) was used 
containing a T7 promotor for in vitro transcription. The pDR274 plasmid (Addgene) 
was digested with BsaI. Forward and reverse oligonucleotides, containing the 
sgRNA sequence with overhangs compatible to the BsaI-digestion sites, were 
annealed (see sequence in section 2.1.4.5, p.40). 100µM of each oligonucleotide 
were heated to 95 °C and cooled (-1 °C per 30 sec) to 4 °C in a volume of 50µl 1x 
annealing buffer. 15 µM of the annealed oligonucleotides were used for the cloning 
into the pDR274 vector. For the co-injection with cas9 RNA the sgRNA was 
transcribed as uncapped RNA (described in section 2.2.2.1). 
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2.2.5.2 Target- and potential off- target-mutation analysis 
For mutation analysis of CRISPR/Cas treated explants, the genomic DNA was 
isolated by the use of the "DNeasy Blood & Tissue Kit" (Qiagen). The region around 
the Fzd4-gRNA target site was amplified from genomic DNA using oligonucleotides 
MG171 and MG248. The Fzd4 amplicon was cloned into the pGem®-T Easy vector 
and ten to twelve clones were sequenced using the SP6 oligonucleotide. Obtained 
sequences were aligned to Fzd4 genomic sequence. The CRISPR/Cas target 
sequence is characterized by twenty nucleotides followed by a protospacer adjacent 
motif (PAM) (Hsu et al., 2013). Since a stretch of twenty nucleotides can occur 
multiple times in a genome and mismatches can be accepted by the CRISPR/Cas 
system depending on their position, it was necessary to predict potential off-targets. 
For this purpose, the CRISPR/Cas Target online predictor (CCTop) was used 
(http://crispr.cos.uni-heidelberg.de; Stemmer et al., 2015). The potential off-target 
sites of Impad1 (MG297/MG298), Kremen2 (MG275/294) and Fzd7 
(MG273/MG274) were amplified with the indicated oligonucleotides, cloned and 
analyzed for mutations. 
2.2.6 Luciferase assay 
For the quantification of Wnt-signaling activities, embryos were either injected with 
50 pg Siamois-Luc (Firefly luciferase) (Brannon et al., 1997) or 100 pg atf2-Luc 
(Firefly luciferase) (Ohkawara and Niehrs, 2011) and 10 pg pRL-TK (Renilla 
luciferase) (Promega) reporter DNA in combination with respective mRNAs animal 
at two-cell stage. Ectodermal explants were fixated in liquid nitrogen and stored at -
20 °C. Duplicates for each sample were taken using 2x 30 explants. For the 
preparation of lysates and measurement of Firefly- and Renilla-luciferase activity, 
the Dual Luciferase Assay Kit (Promega) was used according to the manufacturer´s 
instructions. Measurements were performed with the Centro LB 960 Luminometer 
(Berthold Technologies). The ratio of Firefly- to Renilla-light units was calculated and 
was adjusted to 1 for the sample with injected reporter RNA only. The resulting data 
were presented as relative luciferase activity. Thereby, either the highest activity is 
set to 100 % or the fold inductions are shown.  
  









3.1 Formation of pancreatic organoids from Xenopus explants 
The aim of this study is the identification of the gene network responsible for 
pancreas specification. For this purpose, Xenopus laevis was used as model system 
as it provides a rich source of pluripotent cells which can be programed to 
differentiate into endodermal, mesodermal and neuro-ectodermal derivatives 
(reviewed in Borchers and Pieler, 2010). Furthermore, known factors involved in 
pancreas organogenesis appear to be conserved between Xenopus and mammals 
(reviewed in Zaret and Grompe, 2008). For the identification of novel key players in 
pancreas specification, in vitro generated pancreatic organoids were used.  
3.1.1 RA-dependent induction of pancreatic marker genes in Vegt/Noggin-
programed ectodermal explants 
A previous study demonstrated that ectodermal explants from Xenopus embryos 
injected with vegt and β-catenin RNA express liver specific genes and that the 
addition of RA at the equivalent of gastrula stage further induces various pancreatic 
marker genes. Moreover, the co-injection of RNA coding for the BMP-inhibitor 
Noggin significantly increased the expression of these pancreatic markers at the 
expense of liver specific markers (Chen at al., 2004). In order to further optimize this 
procedure, we first asked if a combined Vegt/Noggin activity is able to induce 
pancreatic markers, so that β-catenin can be omitted. RNAs coding for vegt and 
noggin were injected into the animal pole of a two-cell stage embryo. Blastocoel roof 
tissue was explanted at the late blastula stage and treated with RA for one hour at 
the equivalent of gastrula stage. Explants were cultivated to the equivalent of stage 
30. Total RNA was isolated and analyzed by RT-PCR (Fig. 3.1 A). Indeed, the co-
injection of vegt and noggin is sufficient to drive pancreatic gene expression in 
ectodermal explants. The induction of the pancreatic progenitor markers Ptf1a and 
Pdx1, the endocrine marker Insulin and the endodermal markers Darmin and 
Sox17a is observed. Moreover, the addition of RA further increases the level of 
pancreatic gene expression (Fig. 3.1 B). For Noggin it was shown that it induces the 
expression of the RA-generating enzyme Raldh2 which leads to elevated RA-levels 
in this system (Pan et al., 2007). Thus, we next asked if endogenous RA-signaling 
can be blocked in this system in order to allow a temporally controlled activity of RA-




induction of pancreatic genes can be blocked by the use of Cyp26a1, a RA-
degrading enzyme (Hollemann et al., 1998). The co-injection of cyp26a1 with vegt 
and noggin RNA almost completely blocks the expression of pancreatic genes. 
Importantly, this can be fully rescued by the addition of RA (Fig. 3.1 B). These data 
show that the used explant system allows a controlled activation of RA-signaling and 

























Fig. 3.1 RA-dependent induction of pancreatic marker genes in Vegt/Noggin-
programed explants 
(A) Co-injection of vegt (500pg), noggin (500pg) and cyp26a1 (2000pg) RNA into the animal 
pole of two-cell stage embryos. Tissue of the blastocoel roof was isolated at stage 8, 
cultivated and treated with 5µM RA at the equivalent of stage 11. Explants were cultivated 
until stage 30 and extracted RNA was analyzed by RT-PCR. (B) RT-PCR with indicated 
markers for endoderm (Darmin and Sox17a), pancreatic progenitors (Ptf1a and Pdx1) and 
endocrine tissue (Ins). 
 




3.1.2 Formation of pancreatic organoids that recapitulate the in vivo program 
of pancreas development 
We could show that ectodermal explants can be programed to express pancreatic 
marker genes. In Xenopus embryos, the earliest known pancreatic progenitor 
marker genes can be detected at stage 29 by whole mount in situ hybridization 
(WMISH). The first endocrine marker is detected shortly after that at stage 32. 
Further endocrine and first exocrine differentiation marker genes were found at 
stage 39 and later (reviewed in Pieler and Chen, 2006). Therefore, we asked if our 
programed explants show the same temporal expression profile of pancreatic 
progenitor and differentiation marker genes as observed in vivo. For this purpose, 
Vegt/Noggin/RA-programed explants (pancreatic organoids/PO) were examined for 
pancreatic gene expression at different time points during development (Fig. 3.2 A). 
RT-PCR and the quantitative method of Nanostring analysis were used for the 
detection of selected transcripts. Transcript levels of tested marker genes in the 
pancreatic organoids were compared to whole embryos (embryo), Vegt/Noggin-
programed explants with blocked RA-signaling (ØRA) and un-programed explants 
(C) (Fig. 3.2 B). As observed in whole embryos, at the equivalent of stage 17, 
pancreatic organoids express endodermal marker genes Sox17a (Fig. 3.2 B), 
Sox17b and Darmin as well as mesodermal marker Xbra (Fig. 6.1). Unlike Sox17a 
and Sox17b, Darmin expression is RA-dependent enhanced in pancreatic organoids 
compared to explants with blocked RA-signaling. Transcripts of Gata4, a 
transcription factor involved in endoderm (Rehorn et al., 1996; Xanthos et al., 2001) 
and pancreas formation in mouse (Carrasco et al., 2012; Xuan et al., 2012), are 
detected at stage 17 (Fig. 6.2). Gata4 expression is RA-dependent maintained and 
further induced in pancreatic organoids at stage 24 together with the start of the 
expression of the pancreatic progenitor marker genes Ptf1a (Fig. 6.2) and Pdx1 
(Fig. 3.2 B). The expression of the pancreatic endocrine progenitor marker Ngn3 
(Fig. 6.2) is observed together with the start of Insulin expression (Fig. 3.2 B) at 
stage 24 in pancreatic organoids. The expression of Ngn3 appears to be transient 
and is detected only at low levels from stage 24 to 32. In contrast to pancreatic 
organoids, in whole embryos, Insulin expression is detected at stage 32 the earliest. 
Further differentiation marker genes for endocrine (Glucagon) and exocrine (Pdia2) 
tissue are detected at later stages (Fig. 3.2 B and Fig. 6.2). Moreover, the ventral 
pancreatic marker gene Tm4sf3, which is involved in the fusion of the ventral 
pancreatic buds with the dorsal bud, (Jarikji et al., 2009) is expressed together with 




In summary, the temporal expression profile of analyzed markers in pancreatic 
organoids correlates with that in whole embryos (Fig. 3.2 C). Interestingly, the levels 
of endodermal and mesodermal markers detected in embryos and programed 
explants with blocked RA-signaling are mostly higher than in pancreatic organoids. 
Furthermore, the pancreatic progenitor markers Pdx1 and Ptf1a as well as the 
pancreatic differentiation markers Amy2a and Pdia2 are more than 10 fold and 
Insulin more than 100 fold increased in pancreatic organoids as compared to control 
embryos. This observation argues for a very efficient conversion of the pluripotent 
blastocoel roof tissue into a pancreatic fate. Notably, the neuronal progenitor marker 
Sox2 (Ellis et al., 2004) was also induced in pancreatic organoids (Fig. 6.1) which 
might reflect the innervation of pancreas by neurons as observed in vivo 
(Kirchgessner and Gershon, 1990). Detailed Nanostring data sets are shown in the 

































Fig. 3.2 Formation of pancreatic organoids that recapitulate the process of 
pancreas development 
(A) RNAs coding for Vegt (500pg), Noggin (500pg) were co-injected into two-cell stage 
embryos. In order to block endogenous RA-signaling cyp26a1 RNA (2000pg) was co-
injected. Tissue from the blastocoel roof was explanted and cultivated. Explants were treated 
with 5 µM RA at the equivalent of gastrula stage. Explants were fixated at the equivalent of 
stage 17 to 43 and total RNA was isolated and analyzed by RT-PCR and Nanostring.  
(B) Diagrams show the number of counts detected by Nanostring nCounter for the indicated 
marker genes from two independent experiments. Figures on the right side show the results 
of the RT-PCR.  (C) Summary of the temporal expression profile of indicated marker genes 
for embryos and pancreatic organoids. E = embryo; C = un-programed explants; PO = 
pancreatic organoid, ØRA = programed explants with blocked RA-signaling 
 









































In order to detect how large the proportion of pancreatic progenitor and endocrine 
tissue in the organoids is, a WMISH was performed on the programed explants at 
the equivalent of stage 35. Vegt/Noggin-programed explants were not only treated 
with 5 µM RA but also with 15 µM and 30 µM RA in order to see if the amount of 
pancreatic tissue is RA-concentration dependent increased (Fig. 3.3 A). For each 
RA concentration, explants with a different strength and distribution of pancreatic 
marker gene expression are observed and were grouped into the three phenotypes, 
weak, moderate and strong. Transcripts of progenitor marker genes ptf1a and pdx1 
are detected in larger domains whereas insulin transcripts are detected in single 
cells scattered within the organoid (Fig. 3.3 B). Indeed, a distinct increase in Ptf1a-, 
Pdx1- and Insulin-positive cells and percentage of explants showing an expression 
is observed with 15 µM but no further clear increase is detected using 30µM RA. 
However, already the usually used concentration of 5µM RA leads to positive 
staining signals of tested marker genes in approximately 30% to 50% of the explants 
(Fig. 3.3 C).  
In summary, we could show that Vegt/Noggin-programed ectodermal explants 
promote pancreatic development in an RA-dependent manner. Therefore, this in 
vitro system of pancreatic organoids was further used for the identification of RA-









































































Fig. 3.3 Formation of pancreatic organoids from RA-programed explants 
(WMISH) 
(A) Co-injection of vegt (500pg) and noggin (500pg) RNA into the animal pole of two-cell 
stage embryos. Tissue of the blastocoel roof was isolated at stage 8, cultivated and treated 
with different concentrations of RA (5µM to 30µM) at the equivalent of stage 11. Explants 
were cultivated until the equivalent of stage 35 and used for WMISH against Ptf1a, Pdx1 and 
Insulin transcripts. Explants from un-injected embryos were used as negative control.  
(B) Different phenotypes according to the intensity and distribution of pancreatic marker 
gene expression from weak to strong are presented. (C) The diagram shows the percentage 
of explants positive for pancreatic marker gene expression with the indicated phenotype. 





3.2 Identification, verification and expression characteristics of early 
RA-responsive genes  
RA is known to be required at the onset of gastrulation for pancreas development in 
mice, zebrafish and Xenopus (Stafford and Prince, 2002; Stafford et al., 2004; Chen 
et al., 2004; Huang et al., 2014a). However, the gene network induced by RA that 
promotes pancreas development is still unknown. For the identification of RA-target 
genes in the context of pancreas development, the in vitro system of pancreatic 
organoids was used. 
3.2.1 Induction of the direct RA-target gene Cyp26a1 within one hour after 
RA-addition 
It has been shown that RA-activity at gastrula stage is required for pancreas 
specification in vivo (Chen et al., 2004). This observation correlates with the 
expression of the RA-generating enzyme Raldh2 in the dorsal involuting mesoderm 
during gastrulation (Hollemann et al., 1998; Chen et al., 2001). However, the first 
known pancreatic progenitor markers Pdx1 and Ptf1a are not detected before stage 
24 (Fig. 3.2). In order to identify early direct RA-targets that mediate pancreas 
specification, it was essential to analyze the RA-response in a temporal manner. For 
this issue, we analyzed the temporal induction of the RA-hydroxylase Cyp26a1, a 
known direct RA-target gene (Ray et al., 1997; Abu-Abed et al., 1998). For this 
purpose, embryos were co-injected with RNA coding for Cyp26a1 that effectively 
blocks endogenous RA-signaling in pancreatic organoids (see above). Ectodermal 
explants were treated with RA at the equivalent of gastrula stage. In order to detect 
only direct targets, explants were further treated with the translational inhibitor 
cycloheximide (CHX) 30 min before RA-addition. Explants were fixated one and two 
hours after RA-addition. Endogenous cyp26a1 transcripts were visualized using 
oligonucleotides targeting the 5´UTR of cyp26a1 RNA. Endogenous cyp26a1 was 
detected already one hour after RA-addition in the absence as well as in the 
presence of CHX. Levels of cyp26a1 transcripts are further increased within two 
hours after RA addition (Fig. 3.4). In conclusion, the known direct RA-target 






































Fig. 3.4 Direct RA-target gene Cyp26a1 is induced within one hour 
Vegt (500pg), noggin (500pg) and cyp26a1 (2000pg) RNAs were co-injected into the animal 
pole of a two cell stage embryo. Blastocoel roof tissue was explanted at blastula stage. 
Explants were treated with RA and cycloheximide (CHX) at the equivalent of gastrula stage. 
One and two hours after RA addition, total RNA was isolated and analyzed by RT-PCR. 
Endogenous cyp26a1 is detected one and two hours after RA-addition in the presence and 





3.2.2 Identification of early RA-target genes by RNA-sequencing 
As the known direct RA-target Cyp26a1 was shown to be induced within one hour 
and further increased after two hours, these two time points were chosen for the 
identification of early RA-target genes in the context of pancreas specification. 
Pancreatic organoids were programed by the co-injection of RNAs coding for Vegt, 
Noggin and Cyp26a1. RA and CHX were added at the equivalent of gastrula stage. 
Samples were taken one hour and two hours after RA-addition. For the identification 
of RA-target genes, total RNA was extracted and analyzed by RNA-sequencing for 
two independent experiments (Fig. 3.5 A). About 30.000 transcripts could be 
detected and at least 10 million sequence reads could be mapped to genomic 
sequences indicating a good quality of the RNA-sequencing (Fig. 6.3 B). Since the 
X.laevis genome was not completely sequenced, but is highly similar to that of the 
related species X.tropicalis, sequence reads were initially mapped to the Xenopus 
tropicalis genome and in second instance to the Xenopus laevis genome. Thereby, 
102 genes are found to be differentially expressed in pancreatic organoids treated 
with RA versus untreated. Within one hour, 27 genes and within two hours after RA-
addition 96 genes were recorded with an overlap of 21 genes (Fig. 3.5 B, Tab. 6.3). 
In the presence of the translational inhibitor CHX, 61 genes are differentially 
expressed (Fig. 3.5 B, Tab. 6.4). Most of the detected genes are up-regulated 
higher than two-fold and lower than five-fold. Only a few genes show an up-
regulation higher than five-fold. And even less genes were found to be down-
regulated (Fig. 6.3 C). Comparison of RA-regulated genes in the absence versus 
the presence of CHX was done to detect putative direct RA-targets. Almost half of 
the detected RA-targets are also differentially expressed during a block of 
translation (Fig. 6.3 D, Tab. 6.5). Hence, these 49 genes were referred to as 
candidates for putative direct RA-targets. However, since we want to identify the 
gene-network that leads to pancreas specification, all 102 detected genes were 
further analyzed. Detailed information of RNA-sequencing results are listed in the 








































Fig. 3.5 Identification, verification and expression characteristics of early RA-
responsive genes in the context of pancreas specification 
(A) Vegt (500pg), noggin (500pg) and cyp26a1 (2000pg) RNAs were co-injected into the animal 
pole of a two cell stage embryo. Blastocoel roof tissue was explanted at blastula stage. Explants 
were treated with RA and cycloheximide (CHX) at the equivalent of gastrula stage. One and two 
hours after RA addition samples were taken for RNA-sequencing.  
(B) Venn diagrams show the number of differentially expressed genes within one and two hours 
after RA-addition in the presence or absence of CHX. Genes with less than 50 mapped reads 
were removed.  
(C) Verification of RA-responsive genes. Indicated in red is the number of candidates confirmed for 
RA-inducibility in pancreatic organoids and/or whole embryos and RA-dependency in dorsal parts 
and/or whole embryos. 22 genes were confirmed for RA-responsiveness as they show both RA-
inducibility and -dependency.  
(D) 22 confirmed RA-responsive genes and their expression characteristics obtained by WMISH. 
Indicated with dots are the putative direct RA-target genes. The scheme on the upper right side 
indicates the expression domains of Raldh2 (RA generating enzyme), Cyp26a1 (RA-degrading 
enzyme) and the location of prospective pancreatic progenitors during gastrulation. The schemes 
below indicate the expression domains to which the candidates were assigned. E = endoderm, IIM 






3.2.3 Verification of 22 RA-responsive genes 
Through RNA-sequencing, 102 putative RA-target genes could be identified. 
However, not all candidates could be used for further analysis. For 17 genes no 
sequence for Xenopus laevis was available at this phase of the study. For further 
three genes no Nanostring probe could be designed (Tab. 6.3). Thus, only 82 
candidates were further examined.  
In a first step, we re-examined the RA-responsiveness of these 82 presumptive RA-
target genes. For this issue, RA-inducibility was quantitatively analyzed by 
Nanostring using the ectodermal explant system and whole embryos (Fig. 6.4 A). In 
the explant system, 51 of the 82 candidates were found to be more than 1.5 fold 
induced upon RA-addition. For the majority of these candidate genes, the 
expression is increased between 1.5 and 3 fold one hour after RA-addition 
compared to RA-negative programed explants. After two hours, half of the induced 
genes are increased higher than 3 fold. In whole embryos, 48 of the 82 candidate 
genes were found to be induced more than 1.5 fold upon RA-treatment (Fig. 6.4 A). 
A comparative analysis revealed that 41 candidates could be confirmed for their RA-
inducibility in both, the explant system and whole embryos (Fig. 3.5 C). 
However, RA-inducibility does not necessarily mean that gene expression is 
dependent on RA-signaling activity. We further determined the RA-dependency of 
the 82 candidate genes by the inhibition of RA-signaling in embryos through the 
injection of cyp26a1 RNA or through treatment with the RA-antagonist BMS453 
(Fig. 6.4 B). We examined the gene expression by Nanostring analysis upon the 
inhibition of RA-signaling in whole embryos as well as in isolated dorsal tissue. We 
found the expression of 12 out of 82 candidate genes to be reduced more than 1.5 
fold in RA-negative compared to untreated dorsal tissue. In whole embryos, 23 of 
the 82 candidates were found to be reduced more than 1.5 fold upon BMS453 
treatment (Fig. 6.4 B).  
The comparison of confirmed RA-inducible genes and verified RA-dependent 
candidates revealed a set of 22 candidate genes that are found to be RA-inducible 
as well as RA-dependent expressed (Fig. 3.5 C and D). The observed data are 
summarized in the appendix (Tab. 6.10) and shown in detail in Tab. 6.11 to Tab. 
6.18. 
 




3.2.4 Expression characteristics of 22 verified RA-responsive genes 
Identifying genes that control pancreatic specification in response to RA requires not 
only the determination of RA-responsiveness, but also the exclusion of those 
candidate genes that are not expressed at the right time and the right place during 
embryogenesis. RA-target genes involved in pancreas specification are expected to 
be expressed in the dorsal endoderm and/or the dorsal involuting mesoderm during 
gastrulation (Pan et al., 2007). Therefore, the expression patterns of the 22 RA-
responsive candidate genes were analyzed at gastrula stage by WMISH. Thereby, 
candidates could be grouped according to their expression pattern (Fig. 3.5 D). We 
found that almost half of the candidates are expressed exclusively in the outer 
involuting mesoderm. A second group of five candidates display an additional 
expression domain in the prospective neuroectoderm and a third group of four 
candidates shows an expression in the inner involuting mesoderm (Fig. 3.5 D, Fig. 
6.5). Two candidate genes, Hnf1b and Fzd4, exhibit an endodermal expression 
domain. Hnf1b is expressed in the entire endoderm with an enrichment in the dorsal 
area, whereas Fzd4 expression domain is restricted in the endoderm at the dorsal 
side. Besides its endodermal expression domain, Fzd4 shows a second expression 
domain in the prospective neuro-ectoderm (Fig. 6.5).  
Pancreatic progenitor cells are known to derive from the dorsal endoderm under the 
control of RA that is synthesized in the dorsal involuting mesoderm (Pan et al., 
2007.) Thus, it was important, especially for Hnf1b, to quantify transcript levels in the 
dorsal versus ventral endoderm and/or mesoderm. As by the use of the WMISH 
minor quantitative variations in gene expression cannot be determined, again 
Nanostring analysis was used for further analysis. Four-cell stage embryos were 
injected with RNA encoding GFP into the two dorsal blastomeres to facilitate the 
differentiation between GFP positive dorsal tissue and GFP negative ventral tissue. 
For the preparation of the endoderm, gastrula stage embryos were bisected form 
anterior to posterior along the dorso-ventral axis. From both, ectodermal and 
mesodermal tissue was removed to get pure dorsal and ventral endodermal tissue 
(Fig. 6.6 A). For the preparation of dorsal tissue surrounding the blastoporus lip, 
comprising cells of all three germlayers, also gastrula stage embryos were used. 10 
preparations each were subjected to Nanostring analysis. Apart from the 22 RA-
responsive candidate genes, the expression of marker genes for the three different 
germlayers was analyzed (Fig. 6.6 B). Candidate genes were grouped according to 
their expression characteristics into three groups: dorsally enriched, ventrally 
enriched and equally distributed (Fig. 6.7). Fzd4 shows a clear dorsal enrichment in 




dorsal enrichment (Fig. 6.7 A). Besides Hnf1b and Fzd4, six more candidates show 
a dorsal enrichment while eight candidates were found to be ventrally enriched and 
six candidates are equally distributed (Fig. 6.7 B and C). Data are shown in the 
appendix (Tab. 6.19 to Tab. 6.21). 
As only Hnf1b and Fzd4 exhibit an endodermal expression, these two candidates 
were chosen for further functional analysis. 
  




3.3 The direct RA-target gene Hnf1b is required for pancreas 
specification  
In our screen, the homeodomain transcription factor Hnf1b was found as RA-
responsive gene. We next examined the location of its RA-responsive expression 
domain during gastrulation. Furthermore, in order to determine the requirement of 
Hnf1b for pancreas specification, functional analyses were carried out in vitro and in 
vivo. 
3.3.1 Hnf1b is RA-responsively expressed in the dorsal endoderm during 
gastrulation  
During gastrulation, Hnf1b is expressed in the entire endoderm (Fig. 6.8 A) with a 
slight enrichment in the dorsal endoderm (Fig. 6.8 B). In a late neurula stage 
embryo (stage 18), Hnf1b transcripts are detected in the anterior endoderm that 
gives rise to foregut derivatives like liver and ventral pancreas. Furthermore, Hnf1b 
is expressed in the anterior archenteron roof that gives rise to the dorsal pancreatic 
anlage. An additional Hnf1b expression domain is observed in the neuroectoderm. 
At stage 23, Hnf1b is expressed in an anterior-posterior gradient within the 
endoderm including the ventral foregut that will later differentiate into liver and 
ventral pancreas. Additionally, Hnf1b is detected in the mesoderm derived 
pronephric anlage. At later stages, Hnf1b transcripts are found in the liver 
primordium, pronephros and proctodeum (Fig. 6.8 A). 
The observed pan-endodermal expression of Hnf1b during gastrulation, with a slight 
enrichment in the dorsal endoderm, raises the question if differences in RA-
responsiveness of endodermal Hnf1b expression domains exist. Therefore, Hnf1b 
expression in untreated, RA-treated and dorsally cyp26a1-injected gastrula stage 
embryos was examined by WMISH. We found that an excess of RA leads to a 
strong increase of Hnf1b expression in the dorsal endoderm, whereas the ventral 
endoderm remains unaffected (Fig. 6.8 C). Conversely, the degradation of 
endogenous RA by Cyp26a1 leads to a loss of Hnf1b expression in the dorsal 
endoderm. However, a strong decrease of Hnf1b in the ventral endoderm is 
observed as well (Fig. 6.8 C).  
Additionally, RA-responsiveness of Hnf1b expression was quantified using 
Nanostring analysis. Embryos were either treated with RA or BMS453 at blastula 
stage (Fig. 6.8 D). Compared to untreated embryos, the excess of RA leads to a 




stages 13 and 14. In contrast, the block of RA-signaling by BMS453 results in a two-
fold decrease in Hnf1b expression compared to untreated embryos.  
In summary, Hnf1b is expressed in the dorsal and ventral foregut and we found its 
endodermal expression to be RA-responsive.  
3.3.2 Hnf1b is directly induced by RA in pancreatic organoids 
Several previous studies in mouse identified RA-responsive elements within the 
genomic sequence of the hnf1b gene, including a DR1 element in the Hnf1b 
promotor (Power and Cereghini, 1995) and a second DR5 element within intron 4 
(Pouilhe et al., 2007). These findings suggest that Hnf1b is a direct RA-target. 
However, a direct induction of Hnf1b expression in the endoderm by RA has not 
been shown so far. RNA-sequencing has revealed that Hnf1b is induced by RA 
within one hour and its expression is further increased within two hours after RA-
addition. Hnf1b transcripts are upregulated upon RA-treatment in the absence as 
well as in the presence of the translational inhibitor CHX, indicating that Hnf1b is 
directly induced by RA (Fig. 3.6 A). These data were confirmed by RT-PCR and 
Hnf1b is found to behave in a similar fashion as the known direct RA-target 
Cyp26a1 (Fig. 3.6 B). However, in contrast to Cyp26a1, Hnf1b shows low but 
significant expression levels even in the absence of RA. In summary, Hnf1b is 
indeed a direct RA-target gene in Xenopus, but there must be an additional, RA-















































Fig. 3.6 Hnf1b is directly induced by RA and required for pancreas specification in 
pancreatic organoids 
Direct induction of Hnf1b by RA (A) Two cell stage embryos were co-injected with vegt (500pg), 
noggin (500pg) and cyp26a1 (2000pg) RNA. Blastocoel roof tissue was explanted, cultivated and 
treated with RA and CHX at the equivalent of gastrula stage. Samples for RNA-sequencing were 
taken one and two hours after RA-addition. Hnf1b expression levels are represented by the number 
of mapped reads. (B) RT-PCR analyzing Hnf1b, Cyp26a1 and the housekeeping gene H4 transcripts 
for samples of programed explants before and one/two hours after RA addition.  
Requirement of Hnf1b for pancreatic gene expression in pancreatic organoids  
(C) 55 ng Hnf1b-morpholino (Hnf1b-mo) or 55 ng control-morpholino (ctr-mo) were co-injected with 
vegt (500pg) and noggin (500pg) RNA into two cell stage embryos. 800 pg of RNA for a hormone-
inducible Hnf1b (Hnf1b-GR) was co-injected and explants were treated with dexamethasone (DEX) 
and RA at the equivalent of gastrula stage to rescue the morpholino-mediated phenotype. At the 
equivalent of stages 31 and 39, total RNA was isolated and subjected to RT-PCR. Detection of 
endogenous (endo) and injected Hnf1b (inj.), pancreatic progenitor markers Pdx1 and Ptf1a, early 
endocrine differentiation marker Insulin (Ins) and late differentiation marker Pdia2, direct Hnf1b target 





3.3.3 Hnf1b is required for pancreas specification in vitro 
In order to determine the requirement of Hnf1b for pancreas specification, Hnf1b 
protein expression was downregulated by the injection of a morpholino antisense 
oligonucleotide, targeting the intron1/exon2 boundary of the Hnf1b pre-mRNA (Fig. 
6.9 A). Binding of the morpholino to the pre-mRNA should inhibit conventional 
splicing. In a first step, the functionality of the morpholino was tested in the explant 
system (Fig. 6.9 B). At the equivalent of neurula stage, the Hnf1b amplicon in 
Hnf1b-morpholino injected explants is shifted to a smaller size compared to the 
Hnf1b amplicon of control embryos and control-morpholino injected explants (Fig. 
6.9 C). Sequencing of the amplicon revealed that indeed exon2 is lost in the 
presence of the Hnf1b-morpholino (data not shown). Thus, a frameshift occurs and 
a premature stop codon in exon3 is used that leads to a shortened open reading 
frame of Hnf1b. As a result, a shortened Hnf1b protein is translated that lacks the 
functional DNA-binding domains and the transactivation domain (Fig. 6.9 A).  
First, we wanted to determine if Hnf1b is required for RA-mediated activation of 
pancreatic marker genes in pancreatic organoids. For this purpose, the morpholino 
was used to downregulate Hnf1b protein expression in pancreatic organoids (Fig. 
3.6 C). At the equivalent of stage 31, endogenous Hnf1b is only detected in 
pancreatic organoids and control embryos (Fig. 3.6 C lanes 3 and 4) and is 
completely abolished upon co-injection of the Hnf1b-morpholino (Fig. 3.6 C lanes 5 
and 6) suggesting that the smaller Hnf1b amplicon, observed at late neurula stage, 
is probably degraded at stage 31 due to nonsense-mediated mRNA decay (Chang 
et al., 2007). Pancreatic progenitor markers Pdx1 and Ptf1a as well as the early 
endocrine differentiation marker Insulin and the late exocrine marker Pdia2 are 
detected in control embryos (lane1) and pancreatic organoids (lanes 3 and 4) but 
not in un-programed explants (lane2) (Fig. 3.6 C). Furthermore, the direct Hnf1b 
target gene Hnf4a (Thomas et al., 2001) and endodermal marker genes Darmin and 
Sox17a are expressed in control embryos and pancreatic organoids. Upon co-
injection of the Hnf1b-morpholino, Ptf1a expression is strongly decreased and the 
expression of Pdx1, Insulin, Pdia2 and Hnf4a are completely lost. In addition, the 
expression of Darmin is strongly decreased whereas the expression of the other 
endodermal marker Sox17a is only slightly affected. These effects were not 
observed in the presence of the control-morpholino (lanes 9 and 10) (Fig. 3.6 C). In 
order to demonstrate that the observed effects are specific for the loss of functional 
Hnf1b protein, a rescue experiment was performed. For this purpose, RNA encoding 
a hormone-inducible Hnf1b (Hnf1b-GR) was co-injected. Hnf1b protein function was 
activated at the equivalent of gastrula stage by dexamethasone (DEX) treatment. 




Indeed, the activation of Hnf1b re-establishes the expression of the progenitor 
marker Pdx1, the direct Hnf1b target gene Hnf4a, the endodermal marker Darmin as 
well as the differentiation markers Insulin and Pdia2 (Fig. 3.6 C). However, results 
for Ptf1a expression under rescue conditions are inconsistent. In a few experiments 
Ptf1a expression could be fully rescued (not shown) and in other experiments it 
remained strongly decreased. 
In summary, Hnf1b is required for RA-mediated expression of pancreatic marker 
genes in pancreatic organoids. Moreover, Darmin, which was found to be RA-
























3.3.4 Hnf1b is required for pancreas specification in vivo  
As we could show that Hnf1b is required for pancreatic gene expression in in vitro 
generated pancreatic organoids, we next asked if Hnf1b is required for pancreas 
specification in vivo. 
 
3.3.4.1 Hnf1b-overexpression leads to an expansion of the pancreatic 
progenitor field in vivo 
In order to determine the role of Hnf1b for the development of pancreatic progenitor 
formation in vivo, a gain of function approach was done. RNAs encoding a hormone-
inducible Hnf1b (Hnf1b-GR) and β-galactosidase (glb1) were injected vegetally into 
the two dorsal blastomeres of a four-cell stage embryo. Hnf1b activity was induced 
at gastrula stage through dexamethasone-treatment (DEX) until stage 32 and a 
WMISH was carried out to visualize Pdx1 and Ptf1a expression (Fig. 3.7 A). In 
control embryos, the progenitor marker Pdx1 is not exclusively expressed in the 
pancreas but is also detected in the adjacent duodenum. In Hnf1b-overexpressing 
embryos, the Pdx1 expression domain is expanded along the anterior-posterior axis. 
The second progenitor marker Ptf1a is expressed in the eye, the hindbrain and in 
the endoderm, where it is restricted to the dorsal and ventral pancreatic buds. Upon 
Hnf1b-overexpression, the dorsal as well as the ventral pancreatic Ptf1a expression 
domain is expanded whereas the expression in the eye and the hindbrain is 
unaffected (Fig. 3.7 A). The effects of Hnf1b-overexpression on Pdx1 and Ptf1a 
expression, observed by WMISH, were quantified for two independent experiments 
using ImageJ. At least 20 embryos per experiment were analyzed (Tab. 6.22 and 
Tab. 6.23). In control embryos on average 9 % of the endodermal area is Pdx1-
positive with a variation from 4 % to 17 %. Upon Hnf1b-overexpression, the average 
is significantly increased to 13 % Pdx1 domain in the endoderm with a variation from 
8% to 28 %. Ptf1a is expressed in 3% of the endoderm in control embryos. Hnf1b-
overexpressing embryos show almost 5% of the endodermal area positive for Ptf1a 
with a variation of 2 % to 13 %. When dorsal and ventral pancreatic Ptf1a 
expression is examined individually, we find that the ventral pancreatic domain of 
Ptf1a is affected more dramatically than the dorsal domain (Fig. 3.7 A). In 
conclusion, Hnf1b-overexpression in the endoderm leads to the formation of an 
expanded pancreatic progenitor field.  
 




3.3.4.2 Hnf1b-knockdown causes a decrease in or a complete loss of 
pancreatic progenitors in vivo 
The observation that the morpholino-mediated knockdown of Hnf1b in pancreatic 
organoids results in a loss of Ptf1a and Pdx1 expression suggests that Hnf1b is 
required for pancreas specification. In order to verify this hypothesis, we carried out 
a morpholino-mediated Hnf1b loss-of-function analysis in vivo. Hnf1b-morpholino 
injected embryos were cultivated until stage 32 and the expression of Ptf1a and 
Pdx1 was determined by WMISH. Upon Hnf1b-knockdown, Pdx1 and the 
endodermal Ptf1a expression are completely lost. However, in control-morpholino 
injected embryos, Pdx1 and the endodermal Ptf1a expression are also affected as 
the WMISH signal is decreased (Fig. 3.7 B). Nevertheless, control-morpholino 
injected embryos do not show a phenotype as severe as caused by the injection of 
the Hnf1b-morpholino. In order to compare control- and Hnf1b-morpholino effects in 
more detail, a quantification of pancreatic marker gene expression using real-time 
PCR was done. The expression levels of Pdx1, Ptf1a and Insulin were calculated 
with respect to the levels of the housekeeping gene ornithine decarboxylase (odc). 
In the presence of the Hnf1b-morpholino, the transcript levels of Pdx1, Ptf1a and 
Insulin are almost un-detectable. In contrast, in the presence of the control-
morpholino, Pdx1 and Insulin transcript levels were decreased to 60% and 70 %, 
while Ptf1a levels were unaffected compared to control embryos. Hence, the 
downregulation of Hnf1b in vivo leads to strong decreased expression levels of 
pancreatic progenitor markers. 









































Fig. 3.7 Hnf1b is required for pancreas specification in vivo 
Hnf1b-overexpression leads to expanded pancreatic progenitor field. (A) 200pg β-
calactosidase (glb1) and 800pg Hnf1b-GR RNA were co-injected vegetally into the two 
dorsal blastomeres of a four-cell stage embryo. As control (ctr) served β-calactosidase RNA 
injected embryos.  At gastrula stage, embryos were treated with dexamethasone (DEX) and 
cultivated until stage 32. WMISH against Pdx1 and Ptf1a in control and Hnf1b-
overexpressing embryos is shown. Upper graphs show the percentage of Pdx1 and 
endodermal Ptf1a domains in the whole endoderm. Lower graphs are boxplots displaying the 
range of observed data and indicating outliers.  
P-values in a Student´s t-test **<0.01, ***<0.001. 
Hnf1b-downregulation leads to a strong decrease in pancreatic progenitor expression. 
(B) 200pg β-calactosidase (glb1) RNA and 25ng Hnf1b-morpholino or ctr-morpholino were 
co-injected vegetally into the two dorsal blastomeres of a four-cell stage embryo. Embryos at 
stage 32 were used for WMISH against Pdx1 and Ptf1a and real-time PCR analysis for 
Pdx1, Ptf1a and Insulin. Graph indicated the fold changes of tested markers in ratio to ODC. 
WMISH analysis was performed once and real-time PCR results emerge from two 
independent biological replicates.   




3.3.5 Hnf1b alone cannot substitute for RA-activity during pancreas 
specification 
As we could show that Hnf1b is required for pancreas specification in vitro as well as 
in vivo, we next asked if Hnf1b is the key factor that mediates RA-activity in the 
context of pancreas specification. The explant system was used to answer that 
question. RNA coding for the hormone-inducible Hnf1b-GR was co-injected with 
vegt and noggin RNA. Endogenous RA-signaling was blocked by the co-injection of 
cyp26a1 RNA (Fig. 3.8 A). In control embryos and explants in the presence of RA, 
the pancreatic markers Pdx1, Ptf1a and Insulin, the direct Hnf1b target Hnf4a and 
the endodermal markers Darmin and Sox17a are expressed. If RA-signaling is 
blocked, only the endodermal marker Sox17a is detected. However, upon the 
induction of Hnf1b activity (+DEX), pancreatic marker gene expression is still not 
detectable (Fig. 3.8 B). Interestingly, the endodermal marker Darmin and the direct 
target Hnf4a are induced by Hnf1b, indicating the presence of functional Hnf1b 
protein. Taken together, Hnf1b is not sufficient to substitute for RA-activity in 
pancreas development. Hence, Hnf1b is not the only RA-responsive gene that is 
















































Fig. 3.8 Hnf1b is not sufficient to substitute for RA in pancreas 
specification in ectodermal explants 
(A) Indicated RNAs were co-injected with 800 pg Hnf1b-GR RNA into a two-cell 
stage embryo. Ectodermal explants were prepared and cultivated. Treatments 
with dexamethasone (DEX) and RA were performed at the equivalent of gastrula 
stage. At the equivalent of stage 28, total RNA was isolated and analyzed by RT-
PCR. (B) RT-PCR for pancreatic progenitor markers Pdx1 Ptf1a, differentiation 
marker Insulin (Ins), direct Hnf1b target Hnf4a, endodermal markers Darmin and 
Sox17a and housekeeping gene histone H4. 
 




3.4 The direct target Fzd4/Fzd4s is required for pancreas specification  
The second promising candidate, potentially involved in pancreas specification, is 
the Wnt-receptor Fzd4 as it was found to be induced by RA in the RNA sequencing 
experiment and is expressed in the dorsal endoderm during gastrulation.  
3.4.1 Fzd4 and the alternative splice variant Fzd4s are directly induced by RA 
RNA-sequencing data revealed that Fzd4 is induced by RA even in the presence of 
the translational inhibitor CHX (Fig. 3.9 A). Moreover, we found that Fzd4 is 
expressed in the dorsal endoderm during gastrulation, suggesting Fzd4 as a direct 
RA-target gene potentially involved in pancreas specification. 
The Fzd4 gene includes two exons separated by a large intronic region. Through 
conventional splicing a Fzd4 protein is generated comprising a small extracellular 
cysteine-rich domain (CRD) for Wnt ligand interaction, a seven transmembrane 
domain (TM) and an intracellular domain (ICD) (Fig. 6.10). Additionally, an 
alternative splice variant for Fzd4 that retains the intron was discovered (Yam et al., 
2005; Swain et al., 2005). This splice variant retains the Wnt-binding CRD domain, 
but is missing the transmembrane and the intracellular domain as a premature stop 
codon within the retained intron is used (Fig. 6.10). As this splice variant was 
assumed to be secreted it was named Fzd4s (Fzd4 secreted). Fzd4s can act as an 
activator as well as inhibitor of Wnt-signaling depending on the identidity of the 
corresponding Wnt-ligand (Swain et al., 2005). The question arises if both Fzd4 
variants are induced by RA. The RNA-sequencing data contain sequence reads 
mainly mapped to exon1 and exon2 of the Fzd4 gene locus, but a significant 
number of reads was mapped to intronic sequences as well (data not shown). 
Nanostring analysis, used for the verification process, does not give the information 
which variant is induced by RA as the Nanostring probe against Fzd4 targets the 
exon2 that is contained in both splice variants (Fig. 6.11 C). Therefore, 
oligonucleotides were designed either neighbouring the intronic sequence or 
targeting within the intron to distinguish between the different Fzd4 transcripts. As 
the intronic sequence is larger than 6 kb, amplicons generated by RT-PCR with 
oligonucleotides flanking the intron would give only a signal for Fzd4. With the 
oligonucleotides targeting the intronic region, only Fzd4s transcripts are detected. 
The RT-PCR results reveal that both variants of Fzd4 are directly induced by RA 




3.4.2 Fzd4/Fzd4s is enriched in the dorsal half of a gastrula embryo including 
the dorsal endoderm 
Fzd4/Fzd4s expression was examined during Xenopus development by WMISH in 
order to visualize expression domains (Fig. 6.11 A/B). An antisense probe was 
applied that was already used during the screen for the determination of Fzd4 
expression characteristics. This antisense probe targets the complete open reading 
frame of the Fzd4 transcript. Theoretically, Fzd4s transcripts should also be targeted 
by this antisense probe as the major part of this probe binds to the sequence 
derived from exon2 (Fig. 6.11 A). Fzd4/Fzd4s transcripts are detected in the dorsal 
endoderm and the prospective neuroectoderm at gastrula stage. At neurula stage, 
Fzd4/Fzd4s transcripts are found in the prospective foregut, in the lateral plate 
mesoderm and in the forebrain region (Fig. 6.11 A). Later during development, 
Fzd4/Fzd4s is expressed in the head and the regions of pancreas, liver, duodenum 
and heart primordium. In order to specifically detect transcripts of the alternative 
splice variant Fzd4s, an antisense probe was designed targeting the intronic-derived 
sequence (Fig. 6.11 B). During gastrulation, WMISH signals are detected in the 
dorsal and ventral mesoderm, prospective neuroectoderm and in very low intensity 
in the entire endoderm. However, in contrast to the first antisense-probe, a clear 
dorsal enrichment was not observed. At neurula stage, Fzd4s is expressed in the 
notochord and in the prospective foregut region. Later during development, a 
moderate expression of Fzd4s is detected in the entire embryo with an enrichment 
in the head region (Fig. 6.11 B). As low levels of staining are found in the entire 
embryo for all tested developmental stages it cannot be excluded that the detected 
signals are unspecific. Thus, the expression of Fzd4 and Fzd4s during gastrulation 
was tested by RT-PCR using preparations of dorsal and ventral endoderm as well 
as of dorsal and ventral tissues as described in Fig. 6.6 A. Fzd4 and Fzd4s 
transcripts could not be detected in endodermal preparations (not shown). This 
might be due to the preparation technique by which a lot of endodermal tissue gets 
lost. Nevertheless, for preparations of the tissue surrounding the dorsal and ventral 
blastopore lip, Fzd4 as well as Fzd4s transcripts are found to be enriched in the 
dorsal half (Fig. 6.11 C). In order to quantify the level of dorsal enrichment, a 
Nanostring analysis was carried out, although a distinction between Fzd4 and Fzd4s 
transcripts is not possible as the Nanostring probe targets the region encoded by 
exon2. Fzd4/Fzd4s is 1.5-fold enriched in the dorsal compared to ventral endoderm 
(Fig. 6.7 A) and 4-fold enriched in the dorsal compared to the ventral part around 
the blastopore lip (Fig. 6.11 C).  




However, neither the expression data from WMISH nor from RT-PCR allow a 
conclusion about which Fzd4 variant is expressed in the dorsal endoderm during 
gastrulation. Thus, further following designations concerning Fzd4 are termed as 
Fzd4/Fzd4s. In conclusion, Fzd4/Fzd4s is enriched in the dorsal tissue of a gastrula 
embryo including the dorsal endoderm. Later in development, Fzd4/Fzd4s 
expression is restricted to pancreas, liver, duodenum, heart primordium and head 
structures. 
3.4.3 Fzd4/Fzd4s is RA-responsively expressed during gastrulation 
In our screen, Fzd4/Fzd4s was identified as direct RA-responsive gene in vitro. In 
order to verify the RA-responsiveness of Fzd4/Fzd4s expression in vivo during 
gastrulation, WMISH and Nanostring analyses were performed (Fig. 6.12). 
Untreated, RA-treated and Cyp26a1-injected embryos were cultivated until gastrula 
stage and subjected to WMISH analysis using an antisense probe targeting both, 
Fzd4 and Fzd4s. Upon an excess of RA the expression of Fzd4/Fzd4s in the dorsal 
endoderm as well as that in the prospective neuro-ectoderm is strongly increased. 
Conversely, the degradation of endogenous RA by Cyp26a1 leads to a loss of 
endodermal Fzd4/Fzd4s expression whereas the prospective neuro-ectodermal 
expression is unaffected (Fig. 6.12 A). Thus, endodermal and neuro-ectodermal 
Fzd4/Fzd4s expression domains are RA-inducible but only the endodermal 
expression domain is RA-dependent.  
Moreover, quantitative Nanostring analysis of stage 12 to 14 embryos reveals a 
clear increase of Fzd4/Fzd4s expression from 2 fold up to 2.5 fold in RA-treated 
embryos compared to untreated embryos. In contrast, upon the inhibition of RA-
signaling by BMS453, a reduction in Fzd4/Fzd4s transcript levels up to 2 fold was 
observed (Fig. 6.12 B). In summary, during gastrulation the endodermal expression 









3.4.4 Fzd4/Fzd4s is required for pancreatic marker gene expression in vitro 
In order to determine if Fzd4/Fzd4s is required for pancreas specification, we 
analyzed the function of Fzd4/Fzd4s in pancreatic organoids. For this issue, two 
loss-of-function approaches were done, interfere with the translation or impair the 
gene locus. First, a morpholino was used that targets the start-codon of the fzd4 and 
fzd4s RNA and thereby blocks the translation of both Fzd4 variants (Fig. 3.9 C) 
(Gorny et al., 2013). The morpholino was co-injected with vegt and noggin RNA and 
pancreatic organoids were generated and cultivated until stage 28 and RNA was 
subjected to RT-PCR. Pancreatic progenitor markers Pdx1 and Ptf1a, the early 
differentiation marker Insulin as well as the endodermal marker Sox17a were 
strongly decreased upon Fzd4/Fzd4s-downregulation compared to control embryos 
or mismatch-morpholino-injected explants. In contrast, the endodermal marker 
Darmin was not affected (Fig. 3.9 C). These results indicate a requirement of Fzd4 
for RA-mediated pancreatic marker gene induction. However, injection of various 
concentrations of fzd4 and fzd4s RNA could not rescue the observed knockdown 
phenotype (not shown). We suppose that, for pancreatic gene expression, 
Fzd4/Fzd4s protein activity is required during gastrulation and that an earlier activity, 
caused by RNA injection at early cleavage stage and subsequent translation inhibits 
pancreatic gene expression. A temporally controlled activation of Fzd4/Fzd4s using 
the GR/DEX-system, as used for over-expression of Hnf1b, would not function for 
membrane bound or secreted factors. Due to this reasons, Fzd4 and Fzd4s 
encoding plasmid DNA was injected, which is not transcribed before MBT (mid 
blastula transition). However, the Fzd4/Fzd4s-knockdown phenotype of decreased 
pancreatic marker gene expression could not be restored (not shown). This might be 
due to an inadequate Fzd4/Fzd4s concentration as the appropriate level of active 
Fzd4/Fzd4s protein for proper pancreas specification remains to be determined.  
In order to confirm the phenotype observed upon morpholino-mediated knockdown 
of Fzd4/Fzd4s, we went for a second type of loss-of-function approach. The 
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-
associated) is based on the RNA-guided DNA endonuclease Cas9 that can be 
targeted against a specific genomic region. A guide RNA (Fzd4-gRNA) was 
designed targeting a twenty nucleotide sequence within exon1 of the fzd4 gene 
(Fig. 3.9 D). This guide RNA was co-injected with RNAs encoding for Cas9, Vegt 
and Noggin at one-cell stage. At blastula stage, ectodermal explants were prepared 
and cultivated as previously described. RA was not added as endogenous RA 
levels, indirectly induced by Noggin, are sufficient to induce pancreatic marker gene 




expression (Fig. 3.1). Furthermore, a mosaicism of cells carrying wildtype or 
mutated fzd4 gene in the explants is expected. Therefore, the system was not 
saturated with exogenous RA in order to detect an effect on pancreatic marker 
genes upon Fzd4 gene disruption. RT-PCR analysis and genomic DNA extraction 
for mutation analysis were done using extracts from 50 explants each. Mutation 
analysis revealed a 100% mutation rate in total and 66% effective mutations which 
result in impaired protein function (Fig. 3.9 D; Fig. 6.13). Upon Fzd4-gRNA co-
injection, transcript levels of Ptf1a, Pdx1 and Insulin were strongly reduced as 
compared to Cas9 over-expressing pancreatic organoids. Furthermore, Darmin 
transcript levels are decreased whereas Sox17a levels are not affected (Fig. 3.9 D). 
Since a stretch of twenty nucleotides can be found multiple times in the genome and 
the CRISPR/Cas system can accept mismatches depending on their position, 
potential off-targets were predicted using the online tool CCTop (Stemmer et al., 
2015). In doing so, eight potential off-target sequences within exonic regions of the 
X. laevis genome were predicted (Tab. 6.24). Three of them were analyzed for 
mutations in the presence of Fzd4-gRNA. The potential off-target sequence within 
genomic sequences of Impad1, Kremen2 and Fzd7 contain in total 5 mismatches. 
However, for Kremen2 and Impad1 only one mismatch is located within protospacer 
sequence proximal to the PAM (protospacer adjacent motif). A gRNA/Cas9 
efficiency study in Xenopus tropicalis revealed that single mismatches within the 
protospacer completely abolish targeting activity of this RNA/endonuclease complex 
(Guo et al., 2014).  Indeed, mutation analysis of the three potential off-targets 
revealed that no mutations were introduced into the gene loci. Data for Kremen2 are 
shown in the appendix (Fig. 6.13).  
Taken together, both loss-of-function approaches revealed that Fzd4/Fzd4s is 
indeed required for pancreatic gene induction in pancreatic organoids, suggesting a 







































Fig. 3.9 Fzd4 and Fzd4s are directly induced by RA and required for pancreas 
specification in pancreatic organoids 
Direct induction of Fzd4/Fzd4s by RA  
(A) Two cell stage embryos were co-injected with vegt, noggin and cyp26a1 RNA. Blastocoel roof 
tissue was explanted, cultivated and treated with RA and CHX at the equivalent of gastrula stage. One 
and two hours after RA-addition, total RNA was isolated and subjected to RNA-sequencing. Fzd4 
expression levels are indicated as number of mapped reads. (B) RT-PCR for splice variants Fzd4 and 
Fzd4s, for Cyp26a1 as well as the housekeeping gene H4 in samples of programed explants before 
and one/two hours after RA addition.  
Requirement of Fzd4/Fzd4s for pancreatic gene expression in pancreatic organoids 
(C) Fzd4/Fzd4s-knockdown through translational blocking Fzd4-morpholino (Fzd4-mo). 45 ng Fzd4-mo 
or the corresponding mismatch-morpholino (mmo) were co-injected with vegt and noggin RNA and 
explants for pancreatic organoid formation were prepared. At the equivalent of stage 28, total RNA 
was isolated and subjected to RT-PCR. Amplification of pancreatic progenitor markers Pdx1 and Ptf1a, 
differentiation marker Insulin (Ins), endodermal markers Sox17a and Darmin. (D) Fzd4/Fzd4s 
knockdown through CRISPR/Cas-technique. Fzd4-gRNA was co-injected with RNAs encoding Cas9, 
Vegt and Noggin into one-cell stage embryos. Explants were cultivated until the equivalent of stage 35. 
RT-PCR for pancreatic and endodermal markers was done. Mutation rates are indicated for Cas9 only 
or Cas9 with Fzd4-gRNA. 




3.4.5 Downregulation of Fzd4/Fzd4s leads to an increase in non-canonical 
Wnt-signaling activity in vitro 
Fzd4/Fzd4s loss-of-function experiments in pancreatic organoids showed that the 
direct RA-target gene Fzd4/Fzd4s is required for pancreatic marker gene 
expression. Both variants, Fzd4 and Fzd4s, act as Wnt-interacting molecules (Xu et 
al., 2004; Swain et al., 2005; Mikels and Nusse, 2006). For this reason, we asked if 
the requirement of Fzd4/Fzd4s for pancreas specification is dependent on its 
function in Wnt-signaling. We first tested if Wnt-signaling is active in explants 
programed with Vegt/Noggin and how RA-activity affects this level of Wnt-signaling 
activity. For this purpose, luciferase reporter assays were carried out using reporter 
constructs for both Wnt-signaling pathways, canonical as well as non-canonical 
(Fig. 3.10 A). RNAs coding for Vegt, Noggin and Cyp26a1 were co-injected with 
plasmids coding for either firefly-luciferase reporters under the control of the Siamois 
promotor (canonical Wnt-signaling target) or the Atf2 response element (non-
canonical Wnt-signaling target). In addition, a plasmid coding for reporter Renilla-
luciferase was co-injected in order to normalize the levels of Siamois- and Atf2-
reporter activity. Wnt8a (canonical) and wnt5a (non-canonical) RNA co-injections 
served as positive controls (Fig. 3.10). Both, canonical as well as non-canonical 
Wnt-signaling reporter activity is detected in Vegt/Nog-programed explants in the 
absence of RA-signaling. These activities were set to 100%. Upon RA-treatment, 
the level of canonical reporter is decreased to 70% and the level of the non-
canonical reporter below 60% (Fig. 3.10 B). In conclusion, programed explants 
exhibit a canonical and non-canonical Wnt-signaling activity that is decreased in the 
presence of RA-signaling, in which non-canonical Wnt-signaling is slightly stronger 
affected than canonical Wnt-signaling.  
Next, we asked how a knockdown of Fzd4/Fzd4s in these explants would influence 
the Wnt-signaling activity. For this issue, the Fzd4-morpholino was co-injected. As 
Noggin indirectly activates endogenous RA-signaling, RA was not applied to the 
explants. The levels of luciferase activity in the samples injected with the reporters 
only were set to one (Fig. 3.10 C). Upon Fzd4/Fzd4s-downregulation, the level of 
canonical reporter activity increases from 10-fold in morpholino-un-injected explants 
and mismatch-morpholino-injected explants up to 16-fold. However, the high 
standard deviation between the data of four experiments indicates that the effect on 
canonical Wnt-signaling is not significant. In contrast, non-canonical reporter activity 




upon Fzd4/Fzd4s downregulation (Fig. 3.10 C). Taken together, the downregulation 
of Fzd4/Fzd4s leads to an increase in non-canonical reporter activity.  
 
  


























Fig. 3.10 Wnt-signaling in programed explants 
(A) RNAs coding for Vegt (500pg), Noggin (500pg) were co-injected with RNAs encoding 
Cyp26a1 (2000pg), Wnt8a (400 pg) or Wnt5a (500pg). DNAs coding for the canonical 
reporter Siamois-luciferase (50 pg), non-canonical reporter Atf2-luciferase (100 pg) and 
Renilla-luciferase (10 pg) were also co-injected. Blastocoel-roof tissue was explanted and 
treated with RA or kept untreated. Samples for reporter assay were taken as duplicates two 
hours after RA-addition or at the equivalent of stage 12. (B) Relative luciferase activities of 
canonical and non-canonical Wnt-reporters in programed explants in the absence or 
presence of RA-signaling. (C) Fold changes of luciferase activities from canonical and non-
canonical Wnt-reporters in Vegt/Noggin-programed explants with downregulated 










4.1 Pancreatic organoid formation and the requirement of retinoic acid 
We could demonstrate that pancreatic organoids can be generated in vitro from 
ectodermal explants of blastula stage Xenopus embryos. In a previous study, it was 
already shown that ectodermal explants can be programed by Vegt, β-catenin, 
Noggin and RA-treatment to form pancreatic tissue (Chen et al., 2004). In 
comparison to that study, we found that β-catenin is not essential for the induction of 
pancreatic marker gene expression. Moreover, we provide clear evidences that our 
in vitro generated pancreatic organoids recapitulate the in vivo pancreas 
organogenesis as we detect the same temporal expression profile of pancreatic 
marker genes as described in vivo. 
The co-expression of the two transcription factors Ptf1a and Pdx1 is characteristic 
for pancreatic progenitor cells (Chiang and Melton, 2003; Afelik et al., 2006).  Both 
transcription factors could be detected starting the expression at stage 24 in our 
pancreatic organoids, indicating the presence of a pancreatic progenitor population. 
However, it remains to be evidenced that Ptf1a and Pdx1 are co-expressed in these 
organoids, what would reflect pancreatic progenitors. Single cell analysis through 
RNA-sequencing or Nanostring technique would be applicable to show a co-
expression of Pdx1 and Ptf1a. Nevertheless, we could detect further genes 
described to be expressed in pancreatic progenitors. Gata4, which is not exclusively 
required for pre-pancreatic endoderm formation, but also for the general endoderm 
formation (Holtzinger and Evans, 2005) was detected in pancreatic organoids and 
embryos at all tested stages. We further found Gata4 transcript levels increased in 
pancreatic organoids at the same stage when Ptf1a and Pdx1 were detected. Gata4 
was previously shown to be induced by the key endoderm regulator Vegt (Xanthos 
et al., 2001) what explains the early expression at stage 17. In mouse, Gata4 is 
further known to be expressed in the early pancreatic epithelium (Decker et al., 
2006; Watt et al., 2007) and to be required for early pancreas development 
(Carrasco et al., 2012; Xuan et al., 2012; Rodriguez-Segui et al. 2012). The 
endocrine progenitor marker Ngn3 was only slightly and transiently expressed in 
pancreatic organoids at stages 24 to 32. This observation is consistent with the 
described findings in mouse, where Ngn3 was shown to act upstream of endocrine 
differentiation factors and its expression is turned off prior to final differentiation 




al., 2003). Moreover, in Xenopus, ngn3 transcripts could not been detected in the 
pancreas at later stages (Nieber et al., 2009).  
The earliest endocrine differentiation marker Insulin is detected already at stage 24 
together with Ptf1a and Pdx1 in pancreatic organoids which indicates the first wave 
of Insulin expression during the primary transition phase of pancreas development 
(Kelly and Melton, 2000; Horb and Slack, 2002; Afelik et al., 2004). Insulin 
expression was further increased at stage 39, indicating the formation of β-cells. 
However the detection of Insulin expression does not necessarily mean that 
functional mature ß-cells are formed. In several studies, iPSCs- or hESCs-derived in 
vitro generated β-cells have been frequently observed to express additional 
endocrine hormones together with Insulin. These poly-hormonal Insulin-positive 
cells were shown to be functional immature as they lack the capacity for Glucose-
stimulated Insulin release (D´Amour et al., 2006; Basford et al., 2012; Schiesser et 
al., 2014). So far, we have not tested whether the Insulin-positive cells, found in 
pancreatic organoids, exclusively express Insulin and no additional hormones. A 
single cell analysis should bring clarification. Moreover, it remains to be tested if the 
presence of insulin transcripts reflects the availability of secreted functional Insulin 
peptide.  
Further endocrine and exocrine differentiation markers were detected at later 
stages. The exocrine differentiation marker Pdia2 is detected at stage 39 and 
Amylase is expressed at stage 43 in pancreatic organoids comparable with the 
expression observed in vivo (Horb and Slack 2002; Afelik et al., 2004). The 
endocrine differentiation marker Glucagon is earlier detected in the organoids than 
in the embryos (Horb and Slack, 2002). This might be due to the generally observed 
higher levels of pancreatic marker gene expression in pancreatic organoids 
compared to embryos. An further evidence that the generated pancreatic organoids 
recapitulate the in vivo pancreas organogenesis is the detection of Tm4sf3 at stage 
43. Tm4sf3 is a transmembrane protein which is described as ventral specific 
pancreatic marker in Xenopus with a function in the fusion of the two ventral buds 
with the dorsal bud at stage 40 (Jarikji et al., 2009). 
WMISH against the pancreatic marker genes Ptf1a and Pdx1 further revealed that 
the generated pancreatic organoids exhibit broad expression domains of these 
markers. Moreover, Insulin-positive cells were detected throughout the organoid 
indicating that a large portion of the explant turned into pancreatic tissue. Therefore, 
we used this in vitro system of pancreatic organoids for the identification of RA-
target genes involved in pancreas specification.  




The identification of such RA-dependent regulators of pancreas development could 
bring us one step closer to the major aim of pancreas research which is the in vitro 
generation of functional β-cells for a replacement therapy in order to treat diabetes 
type 1. Several studies used hESCs (Kroon et al., 2008; Rezania et al., 2012; 
Schulz et al., 2012; Pagliuca et al., 2014) or iPSCs (Zhang et al., 2009; Schiesser et 
al., 2014; Shaer et al., 2015) for a successful in vitro generation of β-cells. All 
studies applied stepwise differentiation protocols including the application of Activin 
A, a TGFβ-family member that mimics nodal signaling required for endoderm 
formation (reviewed in Tam and Loebel, 2007), Noggin and RA. Our identified RA-
induced pancreatic regulators could help to optimize these protocols and to increase 
the amount of generated β-cells. Moreover, our findings could help to find strategies 
for the trans-differentiation of patient-derived somatic cells into endocrine pancreatic 
cells. The trans-differentiation of somatic cells into pancreatic cells would be a 
promising alternative for ESC-derived pancreatic cells as the potential tumorigenicity 
of such cells is still a major concern and long-term studies are missing.  
4.2 Identification of 22 RA-responsive genes 
Unlike other signaling molecules, RA enters the cell independent of cell-surface 
receptors and binds directly to nuclear receptors (Rochette-Egly and Germain, 2009; 
Huang et al., 2014b). However, no studies are available dealing with the question in 
which time scale nuclear receptors are activated to induce target gene expression. 
We could show that the known direct RA-target Cyp26a1 (Loudig et al., 2000) is 
induced within one hour after RA-addition. Thus, for the identification of early RA-
targets, the transcriptome of programed explants was analyzed one and two hours 
after RA-addition. 102 genes were found to be differentially expressed in the 
presence of RA-signaling. Almost half of these genes were affected by RA in the 
presence of CHX, indicating them as putative direct RA-targets. Twelve genes were 
found to be differentially expressed upon CHX-treatments but not affected by RA-
signaling. This might be due to the translational inhibition of transcriptional 
repressors. Under these conditions, genes are possibly transcribed that are usually 
repressed. The list of 102 differentially expressed genes arise from the alignment of 
50 nucleotide short sequence reads to the genome of two Xenopus species, 
tropicalis and laevis. The inclusion of the tropicalis genome was necessary as the 
laevis genome is not fully sequenced. Thus, six mismatches were allowed during the 
process of alignment to target also the tropicalis genome. Beside the frequently 




positive candidates (González and Joly, 2013). Thus, several approaches were 
used to validate the RA-responsiveness of the candidates.  
By this, the list of RA-responsive genes was diminished to 22 candidates. This list 
contains nine homeobox transcription factors (Hnf1b, Lhx1, Gbx2.1, Meis3, Nkx6.2, 
Hoxd1, Hoxd4, Hoxa1, Hoxb1), three other transcription factors (Znf703, Foxh1, 
Cebpd), two enzymes (Dhrs3 and Cyp26a1), two signaling components (Fzd4, Igf3), 
an intermediate filament protein (Prph), an autocrine glycoprotein (Fst) and four 
candidates with unknown identity. A review by Balmer and Blomhoff in 2002 
evaluated published data from in total 1,191 papers covering 532 described RA-
target genes and classified them into categories according to the probability of RA-
regulation (Balmer and Blomhoff, 2002). However, most of these data were obtained 
in cell cultures without any developmental aspect. Nevertheless, 13 of the listed 22 
RA-responsive genes in our study were already described as RA-regulated genes in 
the review of Balmer and Blomhoff or in following studies.  
The homeobox-containing transcription factor Hnf1b was initially described as RA-
inducible in a mouse stem cell line (De Simone et al., 1991). Furthermore, Hnf1b 
was found to be RA-induced in the mouse and zebrafish hindbrain (Hernandez et 
al., 2004; Pouilhe et al., 2007). It is described in several studies using zebrafish, 
mouse and Xenopus embryos that an RA-gradient during neural development 
contributes to the anterior-posterior expression pattern of homeobox-containing 
genes in the hindbrain (reviewed in Glover et al., 2006). Thus, the RA-inducibility of 
most of the Hox-genes in our list was previously described including Hoxd4 (Nolte et 
al., 2003), Hoxa1 (Boylan et al., 1993; Frasch et al., 1995), Hoxb1 (Huang et al., 
2002; Ishioka et al., 2012), Hoxd1 (Kolm and Sive, 1994), Gbx2.1 (Bouillet et al., 
1995) and Lhx1 (Strate et al., 2009). Furthermore, Fzd4 and Fst were previously 
shown to be up-regulated by RA in mouse embryonal tumor cells (Hashimoto et al., 
1992; Katoh, 2002). For the RA-metabolic enzymes Cyp26a1 (Abu-Abed et al., 
1998) and Dhrs3 (Kam et al., 2013), the zinc-finger transcription factor Znf-703 
(Mitchell et al., 2015) and the intermediate filament Prph (De Genaro et al., 2013) 
the RA-inducibility was also shown previously. Beside these known RA-regulated 
genes detected in our screen, 9 additional candidates are identified as novel RA-
target genes.  
Based on the CHX-treatment data, we can distinguish between putative direct and 
indirect targets. However, the presence of retinoic acid response elements (RARE), 
as additional indicators for direct RA-regulation, remains to be proven. For Xenopus 
laevis genes this is a challenging venture as intronic and enhancer sequences are 




not fully sequenced. RAREs are characterized by two direct repeats of the 
hexameric motif RGKTSA (R=A/G, K=G/T, S=C/G) separated by either one, two or 
five nucleotide spacers. RAREs were found to be located between 10 kb upstream 
and downstream from the gene locus and were bound by RXR/RAR heterodimers 
that display distinct motif affinities. Both classes of RA-receptors exist as α-, β-, γ-
isoforms and further numerous isoforms by differential promotor usage or alternative 
splicing exist, varying in RARE recognition (reviewed in Germain et al., 2006; 
Lalevee et al., 2011). Several studies in mouse and zebrafish detect RAREs within 
the gene loci of RA-responsive homeodomain-containing transcription factors. 
These include Hnf1b (Pouilhe et al., 2007), Hoxd4 (Nolte et al., 2003), Hoxa1 
(Langston et al., 1997) and Hoxb1 (Huang et al., 2002). 
The expression characteristics of the identified 22 RA-responsive genes during 
gastrulation gave us further indications about their possible function in pancreas 
development. Based on their RA-responsive endodermal expression domains, 
Hnf1b and Fzd4 were selected for functional analysis. Through loss and gain of 
function approaches, the requirement of Hnf1b for pancreas development could be 
confirmed and for Fzd4 a function in pancreatic fate determination is strongly 
suggested. These findings will be discussed in detail in the next sections. However, 
it remains to be urgently examined if the combined activity of Hnf1b and Fzd4 is 
sufficient to substitute for RA in pancreas specification.  
If this is not the case, the list of RA-responsive genes from our screen contains 
some further interesting candidates. The results of a previous study, using different 
combinations of dorsal and ventral endodermal and mesodermal explants, suggests 
that RA-signaling acts simultaneously in both, dorsal endoderm and mesoderm, to 
promote pancreatic fate (Pan et al., 2007). In our list, four genes were found to be 
expressed in the dorsal internal involuting mesoderm which corresponds to the 
Raldh2 expression domain. Cebpd, a transcription factor of the C/EBP family, is 
linked to β-cell survival as it has an anti-apoptotic function in rat and human insulin-
producing cells (Moore et al., 2012). The enzyme Dhrs3 exhibits a retinal reductase 
activity that converts retinal to retinol counteracting against RA-generation 
(Haeseleer et al., 1998). Fst (Follistatin), an autocrine glycoprotein, is an Activin 
inhibitor (Kogawa et al., 1991). In the context of pancreas development the inhibition 
of Activin was shown to expand pancreatic epithelium, but decrease the number of 
differentiated β-cells. Thus, it is suggested that Fst is required to regulate Activin 
activity to acquire the homeostasis of growth and differentiation in this context 
(Zhang et al., 2004). A further candidate, expressed in the dorsal involuting 




development is described. Not expressed in the internal involuting mesoderm but 
linked to pancreas development is Nkx6.2. In mouse, this transcription factor was 
found to be expressed in pancreatic progenitors regulating pancreatic subtype 
specification (Henseleit et al., 2005). Therefore, functional studies for the listed 
candidates appear to be important. 
4.3 The direct RA-target Hnf1b is required for pancreas development 
We identified the transcription factor Hnf1b as direct RA-target gene in the dorsal 
endoderm during gastrulation and could demonstrate that its function is required for 
pancreas development in Xenopus. In mouse, Hnf1b was found to be expressed in 
the endodermal germ layer and in endodermal derived structures including 
pancreas, liver, gallbladder and duodenum (Barbacci et al., 1999; Haumaitre et al., 
2003). We could detect Hnf1b transcripts in the entire endoderm during gastrulation 
with a minor enrichment in the dorsal endoderm. At later stages, Hnf1b expression 
was observed in the foregut endoderm including the anterior archenteron roof that 
gives rise to the dorsal pancreatic anlagen. These observations are consistent with 
findings in mouse where Hnf1b expression was also detected in early proliferating 
pancreatic progenitor epithelium together with Pdx1 and Ptf1a (Haumaitre et al., 
2005). Furthermore, Hnf1b was identified as pancreatic trunk marker in mouse and 
lineage tracing experiments showed that Hnf1b-positive cells of the pancreatic 
epithelium are precursors of acinar, duct and endocrine cells (Solar et al., 2009).  
We could further show that the dorsal endodermal expression of Hnf1b during 
gastrulation is RA-responsive. So far, the induction of Hnf1b by RA was solely 
described for hindbrain tissue (reviewed in Glover et al., 2006) and the only 
evidence for endodermal RA-inducibility was found in gastric organoids derived from 
mouse embryonal stem cells (McCracken et al., 2014). We further identified Hnf1b 
as direct RA-target what is supported by the identification of two RAREs in the 
promotor sequence and within the fourth intron of the mouse Hnf1b gene locus 
(Power and Cereghini, 1995; Pouilhe et al., 2007). The RA-responsive expression in 
the dorsal endoderm strongly indicates a role for Hnf1b in the pre-arrangement of 
conditions promoting pancreatic fate. Indeed, upon the downregulation of functional 
Hnf1b in pancreatic organoids almost a complete loss of pancreatic markers was 
observed. Furthermore, the endodermal marker Darmin was also decreased 
whereas another endodermal marker Sox17a was only slightly affected. Darmin is 
described in Xenopus as an endodermal marker with unknown function (Pera et al., 




2003) and no indications for a regulation of Darmin by Hnf1b are found in the 
literature. Interestingly, Hnf1b and Darmin exhibit a similar expression in the entire 
endoderm in Xenopus blastula embryos and we find both genes to be RA-inducible 
expressed in programed explants. As we found Darmin downstream of Hnf1b, 
Darmin could be identified as novel Hnf1b target genes with a possible role in 
pancreas development. The rescue of most pancreatic markers and Darmin by a 
hormone-inducible Hnf1b indicates that the observed knockdown-phenotype is 
specific due to the downregulation of functional Hnf1b. The data observed for the 
rescue of Ptf1a expression were inconsistent. Some rescue experiments showed a 
Ptf1a expression (not shown) and others not. The failed rescue of Ptf1a does not 
reflect a failed rescue of exocrine differentiation as Pdia2 expression could be 
rescued. We have no convincing explanations for this observation, but we can 
provide some speculations. Hnf1b and Ptf1a are found to be co-expressed in 
pancreatic progenitors and later during the segregation of tip and trunk domains 
Ptf1a is expressed in acinar cells whereas Hnf1b expression is observed in bi-
potential trunk cells where it promotes endocrine differentiation (reviewed in Pan 
and Wright, 2011; De Vas et al., 2015). The Hnf1b-GR fusion protein, used for 
rescue approaches, is probably more stable than endogenous protein and 
continuous DEX-treatment provides high levels of active Hnf1b. It is possible that 
high Hnf1b levels promote endocrine fate at the expense of exocrine fate. This 
would be supported by the low transcript levels of Pdia2 in the rescue. However, we 
cannot provide evidences for this.  
Nevertheless, our data indicate a function of Hnf1b in pancreas development and 
support and confirm previous studies. Mutations within the Hnf1b gene locus in 
humans cause a monogenetic form of diabetes, named MODY 5 (maturity onset 
diabetes of the young) and is further linked to kidney and genital malformations 
(reviewed in Ryffel, 2001; Wang et al., 2004; Haumaitre et al., 2006). Chimeric 
mutant mice with a specific loss of Hnf1b in the visceral endoderm exhibit a lack of 
the ventral pancreas and a hypoblastic dorsal pancreas (Haumaitre et al., 2005). 
Therefore, Hnf1b is considered as putative upstream regulator of pancreatic 
progenitor markers Pdx1 and Ptf1a.  Our findings in pancreatic organoids could be 
confirmed in whole embryos where the downregulation of Hnf1b leads to a 
decreased expression of Pdx1, Ptf1a and Insulin. Moreover, upon Hnf1b over-
expression, endodermal Ptf1a and Pdx1 expression domains were significantly 
expanded. This indicates an early function of Hnf1b in promoting pancreas 
progenitor formation. Further indications for an early function of Hnf1b in pancreas 




where Hnf1b was found to directly induce Hnf6 expression (Poll et al., 2006). Hnf6 
precedes the expression of Pdx1 in the foregut-midgut region and is later restricted 
to the liver and the pancreas (Landry et al., 1997; Rausa et al., 1997). Hnf6 was 
shown to initiate Pdx1 expression in mouse and the inactivation of Hnf6 results in a 
delayed onset of Pdx1 expression leading to pancreatic hypoplasia (Jacquemin et 
al., 2003). Therefore, it is suggested that a sequential transcriptional cascade of 
Hnf1b, Hnf6 and Pdx1 directs endodermal cells into pancreatic progenitors (Poll et 
al., 2006). However, the fact that the Pdx1 expression in Hnf6 mutants is delayed 
and not completely missing indicates the requirement of additional factors, possibly 
further Hnf1b targets.  
Besides the indicated early function of Hnf1b in progenitor formation, De Vas and 
colleagues demonstrated in a mouse system the requirement of Hnf1b for endocrine 
cell specification (De Vas et al., 2015). They inactivated Hnf1b specifically in 
pancreatic progenitors and observed the absence of Ngn3-positive endocrine 
precursor cells throughout embryogenesis. Another direct Hnf1b-target Hnf4a is also 
linked to MODY as β-cells in patients with Hnf4a mutations exhibit an impaired 
insulin secretory response to glucose (Yamagata et al., 1996; Hattersley, 1998; 
Lausen et al., 2000). Pancreatic organoids would be a suitable system for the 
identification of further direct Hnf1b targets that are possibly involved in pancreas 
development. 
In summary, our data confirm several studies that found Hnf1b as direct RA-target 
and its requirement for pancreas development. We could provide further evidences 
for an early endodermal induction of Hnf1b by RA and its early function in pancreatic 
progenitor formation. However, the gene network induced by Hnf1b that is involved 
in pancreas development needs to be further investigated. Moreover, we show that 
Hnf1b is not sufficient to substitute for RA in pancreas development. Hence, Hnf1b 









4.4 The direct RA-target Fzd4 is required for pancreas development 
We identified the transmembrane Wnt-receptor Fzd4 and its secreted splice variant 
Fzd4s as direct RA-target genes required for pancreas development. Fzd4 was 
previously found to be upregulated together with other Wnt-receptors and Wnt-
ligands by RA in human embryonal tumor cells (Katoh, 2002). Furthermore, 
evidences exist for an interplay of RA-signaling and Wnt-signaling in chondrocytes 
to regulate cartilage matrix homeostasis (Yasuhara et al., 2010). However, a 
connection of Fzd4 and RA-signaling in pancreas development is not described so 
far.  
 
Two studies of Fzd4 in Xenopus describe an expression in the prospective neuro-
ectoderm and later in the head region including the forebrain (Shi and Boucaut, 
2000; Zhang et al., 2011). We found an additional Fzd4 RA-responsive expression 
domain in the dorsal endoderm of gastrula stage embryos. We initially observed this 
endodermal Fzd4 expression domain in RA-treated embryos only. A prolonged 
staining of un-treated embryos confirmed a weak endogenous endodermal 
expression of Fzd4 that have been missed by a too short staining. At later stages, 
Fzd4 expression was also detected in the foregut. For human and Xenopus Fzd4, 
an alternative splice variant through intron retention was identified (Sagara et al., 
2001; Swain et al., 2005). This Fzd4 variant, named Fzd4s, encodes a small protein 
missing the transmembrane domain but still containing the Wnt-ligand binding 
cysteine rich domain (Swain et al., 2005). Therefore, the question appeared which 
variant is expressed in the dorsal endoderm. The endodermal expression domain 
was detected by the use of an antisense probe targeting the exonic sequence. This 
should theoretically detect both variants. Therefore, we additionally used an 
antisense probe targeting a part of the intronic region that should specifically detect 
Fzd4s. Steinbeisser and colleagues described an ubiquitous staining of Fzd4s 
transcripts during gastrulation and at tailbud stages in head region, not identical with 
Fzd4 but with overlaps in the eye (Swain et al., 2005). In contrast, beside a certain 
level of staining in the whole embryo, we could detect enriched regions in the 
mesoderm during gastrulation and later in the notochord and head region. The 
expression in the notochord was not observed with the probe that targets the exonic 
regions. Either the probe that targets the exons detects only Fzd4 and not Fzd4s or 
the probe targeting the intronic region results in an unspecific signal. Thus, we 
cannot conclude with certainty which variant exhibits the dorsal endodermal 




RNA-sequencing and RT-PCR data indicate that both variants of Fzd4 were induced 
by RA. However, compared to the other direct RA-target genes Hnf1b and Cyp26a1, 
the Fzd4 variants exhibit only a minor induction by RA. A certain level of Fzd4 and 
Fzd4s transcripts is detected also in the absence of RA. This probably corresponds 
to maternally provided transcripts in the case of Fzd4 (Shi and Boucaut, 2000) and 
for Fzd4s an additional RA-independent expression is conceivable.  
The described loss-of-function studies through morpholino-oligonucleotide and 
CRISPR/Cas-system should affect both Fzd4 variants. Therefore, Fzd4 and Fzd4s 
were designated as Fzd4/Fzd4s in this context. We demonstrated that both, the 
knockdown of Fzd4/Fzd4s by morpholino-oligonucleotide and the knockout by RNA-
guided Cas9 in pancreatic organoids showed a similar decrease of pancreatic 
marker gene expression. For the knockdown approach, several strategies failed to 
rescue the observed phenotype in order to demonstrate the specifity of the used 
morpholino-oligonucleotide. As mentioned in the results section, this might have 
several reasons. On the one hand, we were not able to provide active Fzd4 or 
Fzd4s specifically during gastrulation. On the other hand, we are not aware of the 
variant that is required and the appropriate level of active protein necessary for a 
proper pancreas development.  
Both variants were not described to be involved in pancreas development so far. 
The transmembrane Fzd4 is described as mediator of both, canonical and non-
canonical Wnt-signaling downstream of Wnt5a (Umbhauer et al., 2000; Chen et al., 
2003; Mikels and Nusse, 2006; Xu et al., 2004). The activation of non-
canonical/PCP pathway by Wnt5a/Fzd4-interaction was shown to be required for 
arterial network formation in mouse (Descamps et al., 2012). Furthermore, Fzd4 is 
the only known Wnt-receptor that binds Norrin and thereby activates canonical Wnt-
signaling promoting retinal vascularization in mouse (Xu et al., 2004; reviewed in Ye 
et al.,  2010). Fzd4s shows structural similarities to secreted frizzled-related proteins 
(sfrps) and is therefore considered to be secreted (Rattner et al., 1997). Fzd4s still 
contains the Wnt-ligand binding domain and was described in Xenopus as an 
activator or inhibitor of canonical Wnt-signaling dependent on its ligand. Steinbeisser 
and colleagues showed that dependent on the corresponding Wnt-ligand, the 
Wnt/Fzd4s complex is recognized by the LRP5/6-co-receptor and mediates Wnt-
signaling or it is not recognized (Swain et al., 2005). Following studies revealed that 
the activatory or inhibitory function of Fzd4s is further dependent on its 
concentration. Low Fzd4s concentrations enhance and high concentrations repress 
Wnt-signaling in the presence of low Wnt-ligand levels (Gorny et al., 2013). This 
supports the assumption of the importance of appropriate Fzd4/Fzd4s levels 




required to rescue the morpholino-mediated knockdown phenotype. Findings by the 
Fzd4/Fzd4s-knockout confirm the results of Fzd4/Fzd4s-knockdown in pancreatic 
organoids. We could demonstrate that the observed decrease of pancreatic marker 
gene expression is due to specific mutations within the Fzd4 gene locus as tested 
potential off-targets showed no mutations.  
The next important question that needs to be answered is whether the function of 
Fzd4/Fzd4s in Wnt-signaling is required for pancreas development. For Fzd4 also a 
signaling function outside of the classical Wnt-signaling pathway was described. 
During Wnt-signaling, Fzd4 usually binds intracellular Disheveled via a PDZ-binding 
motif that mediates Wnt-signaling (Wong et al., 2003; reviewed in Niehrs, 2012). In a 
mouse neuronal cell culture, the intracellular PDZ-binding motif of Fzd4 was shown 
to interact with other PDZ-domain containing proteins than Dvl and thereby 
promoting dendrite outgrowth (Bian et al., 2015). Therefore, a function of Fzd4 in 
pancreas development independent from the Wnt-signaling pathway is possible. 
However, results from luciferase reporter assays showed an inhibitory effect of RA-
treatment on canonical as well as non-canonical reporter activity in Vegt/Noggin-
programed explants. The activatory effect of the Fzd4-knockdown on non-canonical 
reporter activity in these explants suggests the involvement of Wnt-signaling in early 
pancreas development. This issue will be discussed in the next section. In summary, 
we identified Fzd4 and its splice variant Fzd4s as direct RA-target genes. Our 
results strongly suggest the requirement of Fzd4 and/or Fzd4s in pancreas 
development. 
4.5 Wnt- and RA-signaling in pancreas development 
We identified the Wnt-receptor Fzd4 and its secreted variant Fzd4s as direct RA-
targets with a possible role in pancreas development. Therefore, we asked about 
the role of Wnt-signaling in pancreas development. Previous studies proposed that 
Wnt-signaling needs to be repressed for foregut maintenance and therefore to allow 
a proper pancreas development. In Xenopus, McLin and colleagues found several 
foregut markers repressed upon Wnt8 over-expression (McLin etal., 2007). 
Furthermore, Li and colleagues identified the secreted Wnt-inhibitor sfrp5 to be 
expressed in the early foregut epithelium of Xenopus embryos. A downregulation of 
functional sfrp5 leads to smaller foregut domains and in contrast the ectopic sfrp5 
expression results in an expanded foregut domain at the expense of the hindgut (Li 




low Wnt-signaling activity for foregut maintenance. It was shown that the depletion 
of Wnt-receptor Fzd7 in the foregut results in pancreas agenesis in Xenopus and 
that a low expression level of this Wnt-receptor is essential for foregut maintenance 
(Zhang et al., 2013a). Moreover, sfrps that were initially thought to be exclusively 
negative Wnt-signaling modulators emerged as biphasic regulators in a 
concentration dependent manner (Mii and Taira, 2009). These findings suggest a 
regulatory mechanism that ensures an appropriate Wnt-signaling activity in the 
foregut.  
Our finding of Wnt-receptors Fzd4 and Fzd4s involved in pancreas development is 
further supported by transcriptome analysis of hepatic and pancreatic progenitors in 
mouse. The transcriptome of bi-potential hepato-pancreatic progenitors was 
compared to the transcriptome of developed dorsal and ventral pancreatic buds and 
the liver bud (Rodríguez-Seguel et al., 2013). They found intracellular Wnt-signaling 
transducers like Disheveled to be expressed equally in all samples whereas Wnt-
ligands, receptors and co-receptors were strongly downregulated in liver 
progenitors. Among these differentially expressed Wnt-components, Fzd4 and its 
ligand Wnt5a were found. It was demonstrated that endodermal explants from 
Xenopus embryos treated with soluble Wnt5a exhibit an enhanced expression of 
Pdx1 and Ptf1a. Furthermore, liver cells treated with Wnt5a strongly induce Pdx1 
expression (Rodríguez-Seguel et al., 2013). They suggest that non-canonical Wnt-
signaling is a potential promotor of pancreatic fate. We found only Fzd4/Fzd4s 
expression regulated by RA and not Wnt5a expression. However, we observed an 
effect of RA-treatment on Wnt-signaling in our explant system. Two hours after RA-
addition the activity of both, canonical and non-canonical Wnt-signaling reporter was 
decreased. Thereby, the non-canonical Wnt-reporter was slightly stronger affected. 
The described effect of RA-treatment on canonical Wnt-signaling is consistent with 
several other studies. Zhang and colleagues identified Ndrg1a as RA-target and 
demonstrated that the inhibitory function of Ndrg1 on canonical Wnt-signaling is 
required for foregut development (Zhang et al., 2013b). However, Ndrg1 was not 
differentially expressed upon RA-treatment in our system. One explanation for this 
could be the late time point of Ndrg1 induction by RA that was observed in stage 16 
embryos earliest, but we searched for RA-targets that were induced within two hours 
after RA-addition. Another study using mouse ESCs also found the negative 
regulatory effect of RA on canonical Wnt-signaling (Osei-sarfo and Gudas, 2014). In 
addition, they found non-canonical Wnt-signaling activated by RA. This activatory 
effect of RA on non-canonical Wnt-signaling was also described by Harada and 
colleagues (Harada et al., 2007). There, RA-inducible G-protein-coupled receptors 




were found to bind Wnt-receptors and thereby activating non-canonical Wnt-
signaling. These findings seem to be contradictory to our observed negative 
regulation of non-canonical Wnt-reporter activity by RA-treatment. However, the 
term “non-canonical Wnt-signaling” comprises two different pathways. The planar 
cell polarity (PCP) pathway that involves Rho GTPase and JNK and on the other 
hand the calcium pathway that involves calcium-sensitive kinases and PKC 
(reviewed in Nusse, 2012). Our non-canonical Wnt-reporter system is based on an 
Atf2-response element that is activated by the PCP-pathway (Ohkawara and Niehrs, 
2010). In contrast, both studies used a reporter that contains a binding site for the 
transcription factor NFAT. This transcription factor is activated by the Wnt/calcium 
pathway (Dejmek et al., 2006). Thus, the effect of RA on the NFAT-reporter needs 
to be tested in our system. It is possible that RA-signaling has a biphasic activity on 
different non-canonical Wnt-signaling pathways.  
We further examined the effect of Fzd4-knockdown on Wnt-signaling reporter 
activity in the explant system. We found canonical Wnt-reporter activity only slightly 
and not significantly increased upon Fzd4-downregulation. In contrast, non-
canonical Atf2-reporter activity was significantly increased. This finding complies 
with the observed decrease in non-canonical Wnt-reporter activity upon RA addition. 
Hence, these data suggest that the negative regulatory effect of RA on non-
canonical Wnt-signaling is mediated by Fzd4 and/or Fzd4s. However, Fzd4 as well 
as Fzd4s were shown to positively regulate non-canonical Wnt/PCP-signaling 
(Descamps et al., 2012; Gorny et al., 2013). Therefore, the effect of Fzd4-
downregulation on non-canonical Wnt-signaling needs to be further investigated. 
Moreover, it remains to be tested whether the downregulation of Wnt-signaling by 
RA is mediated by Fzd4 and if this Fzd4-function is required for pancreas 
specification.  
A connection of Hnf1b and Wnt-signaling was shown in zebrafish. Lancman and 
colleagues demonstrated that Hnf1b and Wnt2b synergistically function in the 
specification of hepato-pancreatic progenitors (Lancman et al., 2013). Thus, it is 
necessary to examine if a combined activity of Hnf1b and Fzd4 and/or Fzd4s is 





4.6 Conclusions  
In this study, a system of in vitro generated pancreatic organoids was used for the 
identification of RA-target genes involved in the early pancreas development. We 
could identify 22 RA-responsive genes, some of which have previously been 
described as RA-targets. For the transcription factor Hnf1b and the Wnt-receptor 
Fzd4, we found RA-responsive expression domains within the dorsal endoderm, the 
origin of pancreatic precursor cells, during gastrulation. Functional analysis for both 
factors revealed their requirement for pancreas development. We provide the 
evidence for an early function of Hnf1b in pancreatic progenitor formation. Moreover, 
we found non-canonical Wnt-signaling activity decreased upon RA-treatment, which 
is probably mediated by Fzd4. Based on our data we suggest the following model. 
During gastrulation, RA is secreted from the dorsal mesoderm and directly induces 
the expression of Hnf1b and Fzd4 in the dorsal endoderm. The overlapping activity 
of these two RA-target genes establishes a pre-pancreatic domain in the dorsal 
endoderm. Fzd4 activity down-regulates non-canonical Wnt-signaling which allows 
the specification of the pancreatic epithelium in the foregut endoderm characterized 
by the co-expression of Ptf1a and Pdx1. Hnf1b induces a transcriptional cascade via 
its direct target Hnf6 that leads to the expression of Pdx1. Finally, pancreatic 
progenitors proliferate and differentiate to endocrine and exocrine tissue constituting 
the pancreas (Fig. 4.1). 
In order to extend and further confirm the suggested model, a few aspects remain to 
be investigated. It would be interesting to uncover which of the two Fzd4 splice 
variants is required for pancreas specification. Moreover, a further evidence is 
needed that the regulatory function of Fzd4 in respect to Wnt-signaling is involved in 
pancreas development. For the function of Hnf1b in pancreas development it would 
be interesting to search for additional direct targets in this context. Most importantly, 
it remains to be proven whether the combined activity of Hnf1b and Fzd4 is sufficient 
































Fig. 4.1 Model of pancreas specification involving direct RA-targets, Fzd4 and 
Hnf1b, in Xenopus embryos. 
During gastrulation, the expression of Fzd4 and Hnf1b is directly induced by RA. The 
overlapping activity of Fzd4 and Hnf1b establishes a pre-pancreatic domain within the dorsal 
endoderm. Fzd4 down-regulates non-canonical Wnt-signaling activity, which allows the 
specification of pancreatic progenitors characterized by the co-expression of Ptf1a and Pdx1. 
In addition, Hnf1b directs endodermal cells into pancreatic progenitors through a sequential 
transcriptional cascade including Hnf6 and Pdx1. Pancreatic progenitors subsequently 










Abu-Abed, S.S., Beckett, B.R., Chiba, H., Chithalen, J.V., Jones, G., Metzger, D., 
Chambon, P. and Petkovich, M. (1998) Mouse P450RAI (CYP26) expression and 
retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic 
acid receptor gamma and retinoid X receptor alpha. J Biol Chem, 273, 2409-2415. 
Afelik, S., Chen, Y. and Pieler, T. (2004) Pancreatic protein disulfide isomerase (XPDIp) is 
an early marker for the exocrine lineage of the developing pancreas in Xenopus 
laevis embryos. Gene Expr Patterns, 4, 71-76. 
Afelik, S., Chen, Y. and Pieler, T. (2006) Combined ectopic expression of Pdx1 and 
Ptf1a/p48 results in the stable conversion of posterior endoderm into endocrine and 
exocrine pancreatic tissue. Genes Dev, 20, 1441-1446. 
Agius, E., Oelgeschlager, M., Wessely, O., Kemp, C. and De Robertis, E.M. (2000) 
Endodermal Nodal-related signals and mesoderm induction in Xenopus. 
Development, 127, 1173-1183. 
Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Hrabe de 
Angelis, M., Lendahl, U. and Edlund, H. (1999) Notch signalling controls 
pancreatic cell differentiation. Nature, 400, 877-881. 
Ariizumi, T. and Asashima, M. (1995) Control of the embryonic body plan by activin during 
amphibian development. Zoolog Sci, 12, 509-521. 
Ariizumi, T., Kinoshita, M., Yokota, C., Takano, K., Fukuda, K., Moriyama, N., 
Malacinski, G.M. and Asashima, M. (2003) Amphibian in vitro heart induction: a 
simple and reliable model for the study of vertebrate cardiac development. Int J Dev 
Biol, 47, 405-410. 
Ariizumi, T., Sawamura, K., Uchiyama, H. and Asashima, M. (1991) Dose and time-
dependent mesoderm induction and outgrowth formation by activin A in Xenopus 
laevis. Int J Dev Biol, 35, 407-414. 
Arnes, L. and Sussel, L. (2015) Epigenetic modifications and long noncoding RNAs 
influence pancreas development and function. Trends Genet, 31, 290-299. 
Asashima, M., Ito, Y., Chan, T., Michiue, T., Nakanishi, M., Suzuki, K., Hitachi, K., 
Okabayashi, K., Kondow, A. and Ariizumi, T. (2009) In vitro organogenesis from 
undifferentiated cells in Xenopus. Dev Dyn, 238, 1309-1320. 
Bae, S., Reid, C.D. and Kessler, D.S. (2011) Siamois and Twin are redundant and essential 
in formation of the Spemann organizer. Dev Biol, 352, 367-381. 
Balmer, J.E. and Blomhoff, R. (2002) Gene expression regulation by retinoic acid. J Lipid 
Res, 43, 1773-1808. 
Barbacci, E., Reber, M., Ott, M.O., Breillat, C., Huetz, F. and Cereghini, S. (1999) Variant 
hepatocyte nuclear factor 1 is required for visceral endoderm specification. 
Development, 126, 4795-4805. 
Barker, N., Huch, M., Kujala, P., van de Wetering, M., Snippert, H.J., van Es, J.H., Sato, 
T., Stange, D.E., Begthel, H., van den Born, M., Danenberg, E., van den Brink, 
S., Korving, J., Abo, A., Peters, P.J., Wright, N., Poulsom, R. and Clevers, H. 
(2010) Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived 
gastric units in vitro. Cell Stem Cell, 6, 25-36. 
Basford, C.L., Prentice, K.J., Hardy, A.B., Sarangi, F., Micallef, S.J., Li, X., Guo, Q., 
Elefanty, A.G., Stanley, E.G., Keller, G., Allister, E.M., Nostro, M.C. and 
Wheeler, M.B. (2012) The functional and molecular characterisation of human 
embryonic stem cell-derived insulin-positive cells compared with adult pancreatic 
beta cells. Diabetologia, 55, 358-371. 
Beres, T.M., Masui, T., Swift, G.H., Shi, L., Henke, R.M. and MacDonald, R.J. (2006) 
PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex 
containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L. 
Mol Cell Biol, 26, 117-130. 
Beucher, A., Gjernes, E., Collin, C., Courtney, M., Meunier, A., Collombat, P. and 
Gradwohl, G. (2012) The homeodomain-containing transcription factors Arx and 
Pax4 control enteroendocrine subtype specification in mice. PLoS One, 7, e36449. 
Bian, W.J., Miao, W.Y., He, S.J., Wan, Z.F., Luo, Z.G. and Yu, X. (2015) A novel Wnt5a-
Frizzled4 signaling pathway mediates activity-independent dendrite morphogenesis 
via the distal PDZ motif of Frizzled 4. Dev Neurobiol, 75, 805-822. 




Xenopus tropicalis embryos using the CRISPR/Cas system. Genesis, 51, 827-834. 
Boj, S.F., Hwang, C.I., Baker, L.A., Chio, II, Engle, D.D., Corbo, V., Jager, M., Ponz-
Sarvise, M., Tiriac, H., Spector, M.S., Gracanin, A., Oni, T., Yu, K.H., van Boxtel, 
R., Huch, M., Rivera, K.D., Wilson, J.P., Feigin, M.E., Ohlund, D., Handly-
Santana, A., Ardito-Abraham, C.M., Ludwig, M., Elyada, E., Alagesan, B., Biffi, 
G., Yordanov, G.N., Delcuze, B., Creighton, B., Wright, K., Park, Y., Morsink, 
F.H., Molenaar, I.Q., Borel Rinkes, I.H., Cuppen, E., Hao, Y., Jin, Y., Nijman, I.J., 
Iacobuzio-Donahue, C., Leach, S.D., Pappin, D.J., Hammell, M., Klimstra, D.S., 
Basturk, O., Hruban, R.H., Offerhaus, G.J., Vries, R.G., Clevers, H. and 
Tuveson, D.A. (2015) Organoid models of human and mouse ductal pancreatic 
cancer. Cell, 160, 324-338. 
Borchers, A. and Pieler, T. (2010) Programing pluripotent precursor cells derived from 
Xenopus embryos to generate specific tissues and organs. Genes (Basel), 1, 413-
426. 
Bort, R., Signore, M., Tremblay, K., Martinez Barbera, J.P. and Zaret, K.S. (2006) Hex 
homeobox gene controls the transition of the endoderm to a pseudostratified, cell 
emergent epithelium for liver bud development. Dev Biol, 290, 44-56. 
Bouillet, P., Chazaud, C., Oulad-Abdelghani, M., Dolle, P. and Chambon, P. (1995) 
Sequence and expression pattern of the Stra7 (Gbx-2) homeobox-containing gene 
induced by retinoic acid in P19 embryonal carcinoma cells. Dev Dyn, 204, 372-382. 
Bourguignon, C., Li, J. and Papalopulu, N. (1998) XBF-1, a winged helix transcription 
factor with dual activity, has a role in positioning neurogenesis in Xenopus 
competent ectoderm. Development, 125, 4889-4900. 
Boylan, J.F., Lohnes, D., Taneja, R., Chambon, P. and Gudas, L.J. (1993) Loss of 
retinoic acid receptor gamma function in F9 cells by gene disruption results in 
aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc 
Natl Acad Sci U S A, 90, 9601-9605. 
Brannon, M., Gomperts, M., Sumoy, L., Moon, R.T. and Kimelman, D. (1997) A beta-
catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis 
specification in Xenopus. Genes Dev, 11, 2359-2370. 
Brannon, M. and Kimelman, D. (1996) Activation of Siamois by the Wnt pathway. Dev Biol, 
180, 344-347. 
Brereton, M.F., Vergari, E., Zhang, Q. and Clark, A. (2015) Alpha-, Delta- and PP-cells: 
Are They the Architectural Cornerstones of Islet Structure and Co-ordination? J 
Histochem Cytochem, 63, 575-591. 
Burlison, J.S., Long, Q., Fujitani, Y., Wright, C.V. and Magnuson, M.A. (2008) Pdx-1 and 
Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor 
cells. Dev Biol, 316, 74-86. 
Carrasco, M., Delgado, I., Soria, B., Martin, F. and Rojas, A. (2012) GATA4 and GATA6 
control mouse pancreas organogenesis. J Clin Invest, 122, 3504-3515. 
Chalmers, A.D. and Slack, J.M. (2000) The Xenopus tadpole gut: fate maps and 
morphogenetic movements. Development, 127, 381-392. 
Chan, T.C., Ariizumi, T. and Asashima, M. (1999) A model system for organ engineering: 
transplantation of in vitro induced embryonic kidney. Naturwissenschaften, 86, 224-
227. 
Chang, Y.F., Imam, J.S. and Wilkinson, M.F. (2007) The nonsense-mediated decay RNA 
surveillance pathway. Annual review of biochemistry, 76, 51-74. 
Chen, J.Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J.E., Reczek, P., 
Chambon, P. and Gronemeyer, H. (1995) RAR-specific agonist/antagonists which 
dissociate transactivation and AP1 transrepression inhibit anchorage-independent 
cell proliferation. Embo j, 14, 1187-1197. 
Chen, W., ten Berge, D., Brown, J., Ahn, S., Hu, L.A., Miller, W.E., Caron, M.G., Barak, 
L.S., Nusse, R. and Lefkowitz, R.J. (2003) Dishevelled 2 recruits beta-arrestin 2 to 
mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science, 301, 1391-1394. 
Chen, Y., Pan, F.C., Brandes, N., Afelik, S., Solter, M. and Pieler, T. (2004) Retinoic acid 
signaling is essential for pancreas development and promotes endocrine at the 
expense of exocrine cell differentiation in Xenopus. Dev Biol, 271, 144-160. 
Chen, Y., Pollet, N., Niehrs, C. and Pieler, T. (2001) Increased XRALDH2 activity has a 
posteriorizing effect on the central nervous system of Xenopus embryos. Mech Dev, 
101, 91-103. 
Chiang, M.K. and Melton, D.A. (2003) Single-cell transcript analysis of pancreas 
development. Dev Cell, 4, 383-393. 




Chitnis, A., Henrique, D., Lewis, J., Ish-Horowicz, D. and Kintner, C. (1995) Primary 
neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila 
neurogenic gene Delta. Nature, 375, 761-766. 
Chung, W.S., Shin, C.H. and Stainier, D.Y. (2008) Bmp2 signaling regulates the hepatic 
versus pancreatic fate decision. Dev Cell, 15, 738-748. 
Clagett-Dame, M. and DeLuca, H.F. (2002) The role of vitamin A in mammalian 
reproduction and embryonic development. Annu Rev Nutr, 22, 347-381. 
Clements, D., Friday, R.V. and Woodland, H.R. (1999) Mode of action of VegT in 
mesoderm and endoderm formation. Development, 126, 4903-4911. 
Cockell, M., Stevenson, B.J., Strubin, M., Hagenbuchle, O. and Wellauer, P.K. (1989) 
Identification of a cell-specific DNA-binding activity that interacts with a 
transcriptional activator of genes expressed in the acinar pancreas. Mol Cell Biol, 9, 
2464-2476. 
Conlon, F.L., Lyons, K.M., Takaesu, N., Barth, K.S., Kispert, A., Herrmann, B. and 
Robertson, E.J. (1994) A primary requirement for nodal in the formation and 
maintenance of the primitive streak in the mouse. Development, 120, 1919-1928. 
Damianitsch, K., Melchert, J. and Pieler, T. (2009) XsFRP5 modulates endodermal 
organogenesis in Xenopus laevis. Dev Biol, 329, 327-337. 
D'Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., 
Moorman, M.A., Kroon, E., Carpenter, M.K. and Baetge, E.E. (2006) Production 
of pancreatic hormone-expressing endocrine cells from human embryonic stem 
cells. Nat Biotechnol, 24, 1392-1401. 
De Genaro, P., Simon, M.V., Rotstein, N.P. and Politi, L.E. (2013) Retinoic acid promotes 
apoptosis and differentiation in photoreceptors by activating the P38 MAP kinase 
pathway. Invest Ophthalmol Vis Sci, 54, 3143-3156. 
De Simone, V., De Magistris, L., Lazzaro, D., Gerstner, J., Monaci, P., Nicosia, A. and 
Cortese, R. (1991) LFB3, a heterodimer-forming homeoprotein of the LFB1 family, 
is expressed in specialized epithelia. Embo j, 10, 1435-1443. 
De Vas, M.G., Kopp, J.L., Heliot, C., Sander, M., Cereghini, S. and Haumaitre, C. (2015) 
Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine 
progenitors. Development, 142, 871-882. 
Decker, K., Goldman, D.C., Grasch, C.L. and Sussel, L. (2006) Gata6 is an important 
regulator of mouse pancreas development. Dev Biol, 298, 415-429. 
Dejmek, J., Safholm, A., Kamp Nielsen, C., Andersson, T. and Leandersson, K. (2006) 
Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein 
kinase 1alpha signaling in human mammary epithelial cells. Molecular and cellular 
biology, 26, 6024-6036. 
Dersch, H. and Zile, M.H. (1993) Induction of normal cardiovascular development in the 
vitamin A-deprived quail embryo by natural retinoids. Dev Biol, 160, 424-433. 
Descamps, B., Sewduth, R., Ferreira Tojais, N., Jaspard, B., Reynaud, A., Sohet, F., 
Lacolley, P., Allieres, C., Lamaziere, J.M., Moreau, C., Dufourcq, P., Couffinhal, 
T. and Duplaa, C. (2012) Frizzled 4 regulates arterial network organization through 
noncanonical Wnt/planar cell polarity signaling. Circ Res, 110, 47-58. 
Dessimoz, J., Bonnard, C., Huelsken, J. and Grapin-Botton, A. (2005) Pancreas-specific 
deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions 
during development. Curr Biol, 15, 1677-1683. 
Dessimoz, J., Opoka, R., Kordich, J.J., Grapin-Botton, A. and Wells, J.M. (2006) FGF 
signaling is necessary for establishing gut tube domains along the anterior-posterior 
axis in vivo. Mech Dev, 123, 42-55. 
Deutsch, G., Jung, J., Zheng, M., Lora, J. and Zaret, K.S. (2001) A bipotential precursor 
population for pancreas and liver within the embryonic endoderm. Development, 
128, 871-881. 
Dichmann, D.S. and Harland, R.M. (2011) Nkx6 genes pattern the frog neural plate and 
Nkx6.1 is necessary for motoneuron axon projection. Dev Biol, 349, 378-386. 
Dickman, E.D., Thaller, C. and Smith, S.M. (1997) Temporally-regulated retinoic acid 
depletion produces specific neural crest, ocular and nervous system defects. 
Development, 124, 3111-3121. 
Djiane, A., Riou, J., Umbhauer, M., Boucaut, J. and Shi, D. (2000) Role of frizzled 7 in the 
regulation of convergent extension movements during gastrulation in Xenopus 
laevis. Development, 127, 3091-3100. 





Edlund, H. (2002) Pancreatic organogenesis--developmental mechanisms and implications 
for therapy. Nat Rev Genet, 3, 524-532. 
Ellis, P., Fagan, B.M., Magness, S.T., Hutton, S., Taranova, O., Hayashi, S., McMahon, 
A., Rao, M. and Pevny, L. (2004) SOX2, a persistent marker for multipotential 
neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev 
Neurosci, 26, 148-165. 
Engleka, M.J., Craig, E.J. and Kessler, D.S. (2001) VegT activation of Sox17 at the 
midblastula transition alters the response to nodal signals in the vegetal endoderm 
domain. Dev Biol, 237, 159-172. 
Fineran, P.C. and Dy, R.L. (2014) Gene regulation by engineered CRISPR-Cas systems. 
Curr Opin Microbiol, 18, 83-89. 
Finkbeiner, S.R., Freeman, J.J., Wieck, M.M., El-Nachef, W., Altheim, C.H., Tsai, Y.H., 
Huang, S., Dyal, R., White, E.S., Grikscheit, T.C., Teitelbaum, D.H. and Spence, 
J.R. (2015) Generation of tissue-engineered small intestine using embryonic stem 
cell-derived human intestinal organoids. Biol Open, 4, 1462-1472. 
Frasch, M., Chen, X. and Lufkin, T. (1995) Evolutionary-conserved enhancers direct 
region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and 
Drosophila. Development, 121, 957-974. 
Fukuda, K. and Kikuchi, Y. (2005) Endoderm development in vertebrates: fate mapping, 
induction and regional specification. Dev Growth Differ, 47, 343-355. 
Fukui, Y., Furue, M., Myoishi, Y., Sato, J.D., Okamoto, T. and Asashima, M. (2003) 
Long-term culture of Xenopus presumptive ectoderm in a nutrient-supplemented 
culture medium. Dev Growth Differ, 45, 499-506. 
Gammill, L.S. and Sive, H. (1997) Identification of otx2 target genes and restrictions in 
ectodermal competence during Xenopus cement gland formation. Development, 
124, 471-481. 
Gao, D., Vela, I., Sboner, A., Iaquinta, P.J., Karthaus, W.R., Gopalan, A., Dowling, C., 
Wanjala, J.N., Undvall, E.A., Arora, V.K., Wongvipat, J., Kossai, M., 
Ramazanoglu, S., Barboza, L.P., Di, W., Cao, Z., Zhang, Q.F., Sirota, I., Ran, L., 
MacDonald, T.Y., Beltran, H., Mosquera, J.M., Touijer, K.A., Scardino, P.T., 
Laudone, V.P., Curtis, K.R., Rathkopf, D.E., Morris, M.J., Danila, D.C., Slovin, 
S.F., Solomon, S.B., Eastham, J.A., Chi, P., Carver, B., Rubin, M.A., Scher, H.I., 
Clevers, H., Sawyers, C.L. and Chen, Y. (2014) Organoid cultures derived from 
patients with advanced prostate cancer. Cell, 159, 176-187. 
Germain, P., Chambon, P., Eichele, G., Evans, R.M., Lazar, M.A., Leid, M., De Lera, 
A.R., Lotan, R., Mangelsdorf, D.J. and Gronemeyer, H. (2006) International Union 
of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev, 58, 712-725. 
Germain, P., Iyer, J., Zechel, C. and Gronemeyer, H. (2002) Co-regulator recruitment and 
the mechanism of retinoic acid receptor synergy. Nature, 415, 187-192. 
Gilchrist, M.J., Zorn, A.M., Voigt, J., Smith, J.C., Papalopulu, N. and Amaya, E. (2004) 
Defining a large set of full-length clones from a Xenopus tropicalis EST project. Dev 
Biol, 271, 498-516. 
Gittes, G.K. (2009) Developmental biology of the pancreas: a comprehensive review. Dev 
Biol, 326, 4-35. 
Glover, J.C., Renaud, J.S. and Rijli, F.M. (2006) Retinoic acid and hindbrain patterning. J 
Neurobiol, 66, 705-725. 
Gonzalez, E. and Joly, S. (2013) Impact of RNA-seq attributes on false positive rates in 
differential expression analysis of de novo assembled transcriptomes. BMC Res 
Notes, 6, 503. 
Gorny, A.K., Kaufmann, L.T., Swain, R.K. and Steinbeisser, H. (2013) A secreted splice 
variant of the Xenopus frizzled-4 receptor is a biphasic modulator of Wnt signalling. 
Cell Commun Signal, 11, 89. 
Gouzi, M., Kim, Y.H., Katsumoto, K., Johansson, K. and Grapin-Botton, A. (2011) 
Neurogenin3 initiates stepwise delamination of differentiating endocrine cells during 
pancreas development. Dev Dyn, 240, 589-604. 
Gradwohl, G., Dierich, A., LeMeur, M. and Guillemot, F. (2000) neurogenin3 is required 
for the development of the four endocrine cell lineages of the pancreas. Proc Natl 
Acad Sci U S A, 97, 1607-1611. 
Grapin-Botton, A. and Constam, D. (2007) Evolution of the mechanisms and molecular 
control of endoderm formation. Mech Dev, 124, 253-278. 
Gu, G., Dubauskaite, J. and Melton, D.A. (2002) Direct evidence for the pancreatic 
lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. 




Development, 129, 2447-2457. 
Guenette, S.A., Giroux, M.C. and Vachon, P. (2013) Pain perception and anaesthesia in 
research frogs. Exp Anim, 62, 87-92. 
Guo, X., Zhang, T., Hu, Z., Zhang, Y., Shi, Z., Wang, Q., Cui, Y., Wang, F., Zhao, H. and 
Chen, Y. (2014) Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis. 
Development, 141, 707-714. 
Haeseleer, F., Huang, J., Lebioda, L., Saari, J.C. and Palczewski, K. (1998) Molecular 
characterization of a novel short-chain dehydrogenase/reductase that reduces all-
trans-retinal. J Biol Chem, 273, 21790-21799. 
Harada, Y., Yokota, C., Habas, R., Slusarski, D.C. and He, X. (2007) Retinoic acid-
inducible G protein-coupled receptors bind to frizzled receptors and may activate 
non-canonical Wnt signaling. Biochemical and biophysical research 
communications, 358, 968-975. 
Harland, R.M. (1991) In situ hybridization: an improved whole-mount method for Xenopus 
embryos. Methods Cell Biol, 36, 685-695. 
Hashimoto, M., Nakamura, T., Inoue, S., Kondo, T., Yamada, R., Eto, Y., Sugino, H. and 
Muramatsu, M. (1992) Follistatin is a developmentally regulated cytokine in neural 
differentiation. J Biol Chem, 267, 7203-7206. 
Hattersley, A.T. (1998) Maturity-onset diabetes of the young: clinical heterogeneity 
explained by genetic heterogeneity. Diabet Med, 15, 15-24. 
Haumaitre, C., Barbacci, E., Jenny, M., Ott, M.O., Gradwohl, G. and Cereghini, S. (2005) 
Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc Natl Acad Sci U S A, 
102, 1490-1495. 
Haumaitre, C., Fabre, M., Cormier, S., Baumann, C., Delezoide, A.L. and Cereghini, S. 
(2006) Severe pancreas hypoplasia and multicystic renal dysplasia in two human 
fetuses carrying novel HNF1beta/MODY5 mutations. Hum Mol Genet, 15, 2363-
2375. 
Haumaitre, C., Reber, M. and Cereghini, S. (2003) Functions of HNF1 family members in 
differentiation of the visceral endoderm cell lineage. J Biol Chem, 278, 40933-40942. 
Heasman, J. (2006) Maternal determinants of embryonic cell fate. Semin Cell Dev Biol, 17, 
93-98. 
Hebrok, M., Kim, S.K. and Melton, D.A. (1998) Notochord repression of endodermal Sonic 
hedgehog permits pancreas development. Genes Dev, 12, 1705-1713. 
Hebrok, M., Kim, S.K., St Jacques, B., McMahon, A.P. and Melton, D.A. (2000) 
Regulation of pancreas development by hedgehog signaling. Development, 127, 
4905-4913. 
Henry, G.L., Brivanlou, I.H., Kessler, D.S., Hemmati-Brivanlou, A. and Melton, D.A. 
(1996) TGF-beta signals and a pattern in Xenopus laevis endodermal development. 
Development, 122, 1007-1015. 
Henseleit, K.D., Nelson, S.B., Kuhlbrodt, K., Hennings, J.C., Ericson, J. and Sander, M. 
(2005) NKX6 transcription factor activity is required for alpha- and beta-cell 
development in the pancreas. Development, 132, 3139-3149. 
Hernandez, R.E., Rikhof, H.A., Bachmann, R. and Moens, C.B. (2004) vhnf1 integrates 
global RA patterning and local FGF signals to direct posterior hindbrain development 
in zebrafish. Development, 131, 4511-4520. 
Hesselson, D., Anderson, R.M. and Stainier, D.Y. (2011) Suppression of Ptf1a activity 
induces acinar-to-endocrine conversion. Curr Biol, 21, 712-717. 
Hollemann, T., Chen, Y., Grunz, H. and Pieler, T. (1998) Regionalized metabolic activity 
establishes boundaries of retinoic acid signalling. Embo j, 17, 7361-7372. 
Hollemann, T. and Pieler, T. (1999) Xpitx-1: a homeobox gene expressed during pituitary 
and cement gland formation of Xenopus embryos. Mech Dev, 88, 249-252. 
Holtzinger, A. and Evans, T. (2005) Gata4 regulates the formation of multiple organs. 
Development, 132, 4005-4014. 
Horb, M.E., Shen, C.N., Tosh, D. and Slack, J.M. (2003) Experimental conversion of liver 
to pancreas. Curr Biol, 13, 105-115. 
Horb, M.E. and Slack, J.M. (2001) Endoderm specification and differentiation in Xenopus 
embryos. Dev Biol, 236, 330-343. 
Horb, M.E. and Slack, J.M. (2002) Expression of amylase and other pancreatic genes in 
Xenopus. Mech Dev, 113, 153-157. 
Hsu, P.D., Lander, E.S. and Zhang, F. (2014) Development and applications of CRISPR-
Cas9 for genome engineering. Cell, 157, 1262-1278. 




Fine, E.J., Wu, X., Shalem, O., Cradick, T.J., Marraffini, L.A., Bao, G. and Zhang, 
F. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 
31, 827-832. 
Huang, D., Chen, S.W. and Gudas, L.J. (2002) Analysis of two distinct retinoic acid 
response elements in the homeobox gene Hoxb1 in transgenic mice. Dev Dyn, 223, 
353-370. 
Huang, H.P., Liu, M., El-Hodiri, H.M., Chu, K., Jamrich, M. and Tsai, M.J. (2000) 
Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. 
Mol Cell Biol, 20, 3292-3307. 
Huang, P., Chandra, V. and Rastinejad, F. (2014b) Retinoic acid actions through 
mammalian nuclear receptors. Chem Rev, 114, 233-254. 
Huang, W., Wang, G., Delaspre, F., Vitery Mdel, C., Beer, R.L. and Parsons, M.J. 
(2014a) Retinoic acid plays an evolutionarily conserved and biphasic role in 
pancreas development. Dev Biol, 394, 83-93. 
Huch, M., Boj, S.F. and Clevers, H. (2013b) Lgr5(+) liver stem cells, hepatic organoids and 
regenerative medicine. Regen Med, 8, 385-387. 
Huch, M., Bonfanti, P., Boj, S.F., Sato, T., Loomans, C.J., van de Wetering, M., Sojoodi, 
M., Li, V.S., Schuijers, J., Gracanin, A., Ringnalda, F., Begthel, H., Hamer, K., 
Mulder, J., van Es, J.H., de Koning, E., Vries, R.G., Heimberg, H. and Clevers, 
H. (2013a) Unlimited in vitro expansion of adult bi-potent pancreas progenitors 
through the Lgr5/R-spondin axis. Embo j, 32, 2708-2721. 
Hufton, A.L., Vinayagam, A., Suhai, S. and Baker, J.C. (2006) Genomic analysis of 
Xenopus organizer function. BMC Dev Biol, 6, 27. 
Hutchison, K.A., Scherrer, L.C., Czar, M.J., Stancato, L.F., Chow, Y.H., Jove, R. and 
Pratt, W.B. (1993) Regulation of glucocorticoid receptor function through assembly 
of a receptor-heat shock protein complex. Ann N Y Acad Sci, 684, 35-48. 
Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Tsai, S.Q., Sander, J.D., Peterson, R.T., 
Yeh, J.R. and Joung, J.K. (2013) Efficient genome editing in zebrafish using a 
CRISPR-Cas system. Nat Biotechnol, 31, 227-229. 
Hyde, C.E. and Old, R.W. (2000) Regulation of the early expression of the Xenopus nodal-
related 1 gene, Xnr1. Development, 127, 1221-1229. 
Ikuzawa, M., Kobayashi, K., Yasumasu, S. and Iuchi, I. (2005) Expression of 
CCAAT/enhancer binding protein delta is closely associated with degeneration of 
surface mucous cells of larval stomach during the metamorphosis of Xenopus laevis. 
Comp Biochem Physiol B Biochem Mol Biol, 140, 505-511. 
Ishioka, A., Jindo, T., Kawanabe, T., Hatta, K., Parvin, M.S., Nikaido, M., Kuroyanagi, 
Y., Takeda, H. and Yamasu, K. (2011) Retinoic acid-dependent establishment of 
positional information in the hindbrain was conserved during vertebrate evolution. 
Dev Biol, 350, 154-168. 
Ismadi, S.D. and Olson, J.A. (1982) Dynamics of the fetal distribution and transfer of 
Vitamin A between rat fetuses and their mother. Int J Vitam Nutr Res, 52, 112-119. 
Jacquemin, P., Lemaigre, F.P. and Rousseau, G.G. (2003) The Onecut transcription factor 
HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream 
of Pdx-1 in the specification cascade. Dev Biol, 258, 105-116. 
Jacquemin, P., Yoshitomi, H., Kashima, Y., Rousseau, G.G., Lemaigre, F.P. and Zaret, 
K.S. (2006) An endothelial-mesenchymal relay pathway regulates early phases of 
pancreas development. Dev Biol, 290, 189-199. 
Jarikji, Z., Horb, L.D., Shariff, F., Mandato, C.A., Cho, K.W. and Horb, M.E. (2009) The 
tetraspanin Tm4sf3 is localized to the ventral pancreas and regulates fusion of the 
dorsal and ventral pancreatic buds. Development, 136, 1791-1800. 
Jarikji, Z.H., Vanamala, S., Beck, C.W., Wright, C.V., Leach, S.D. and Horb, M.E. (2007) 
Differential ability of Ptf1a and Ptf1a-VP16 to convert stomach, duodenum and liver 
to pancreas. Dev Biol, 304, 786-799. 
Jensen, J., Heller, R.S., Funder-Nielsen, T., Pedersen, E.E., Lindsell, C., Weinmaster, 
G., Madsen, O.D. and Serup, P. (2000) Independent development of pancreatic 
alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch 
pathway in repression of premature differentiation. Diabetes, 49, 163-176. 
Johansson, K.A., Dursun, U., Jordan, N., Gu, G., Beermann, F., Gradwohl, G. and 
Grapin-Botton, A. (2007) Temporal control of neurogenin3 activity in pancreas 
progenitors reveals competence windows for the generation of different endocrine 
cell types. Dev Cell, 12, 457-465. 
Jones, E.A. (1985) Epidermal development in Xenopus laevis: the definition of a monoclonal 




antibody to an epidermal marker. J Embryol Exp Morphol, 89 Suppl, 155-166. 
Jorgensen, M.C., Ahnfelt-Ronne, J., Hald, J., Madsen, O.D., Serup, P. and Hecksher-
Sorensen, J. (2007) An illustrated review of early pancreas development in the 
mouse. Endocr Rev, 28, 685-705. 
Jung, J., Zheng, M., Goldfarb, M. and Zaret, K.S. (1999) Initiation of mammalian liver 
development from endoderm by fibroblast growth factors. Science, 284, 1998-2003. 
Kam, R.K., Chen, Y., Chan, S.O., Chan, W.Y., Dawid, I.B. and Zhao, H. (2010) 
Developmental expression of Xenopus short-chain dehydrogenase/reductase 3. Int J 
Dev Biol, 54, 1355-1360. 
Kam, R.K., Shi, W., Chan, S.O., Chen, Y., Xu, G., Lau, C.B., Fung, K.P., Chan, W.Y. and 
Zhao, H. (2013) Dhrs3 protein attenuates retinoic acid signaling and is required for 
early embryonic patterning. J Biol Chem, 288, 31477-31487. 
Karthaus, W.R., Iaquinta, P.J., Drost, J., Gracanin, A., van Boxtel, R., Wongvipat, J., 
Dowling, C.M., Gao, D., Begthel, H., Sachs, N., Vries, R.G., Cuppen, E., Chen, 
Y., Sawyers, C.L. and Clevers, H.C. (2014) Identification of multipotent luminal 
progenitor cells in human prostate organoid cultures. Cell, 159, 163-175. 
Katoh, M. (2002) Regulation of WNT signaling molecules by retinoic acid during neuronal 
differentiation in NT2 cells: threshold model of WNT action (review). Int J Mol Med, 
10, 683-687. 
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D. and 
Sun, H. (2007) A membrane receptor for retinol binding protein mediates cellular 
uptake of vitamin A. Science, 315, 820-825. 
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R.J. and Wright, C.V. 
(2002) The role of the transcriptional regulator Ptf1a in converting intestinal to 
pancreatic progenitors. Nat Genet, 32, 128-134.  
Keller, R. (1991) Early embryonic development of Xenopus laevis. Methods Cell Biol, 61-
113. 
Kelly, O.G. and Melton, D.A. (2000) Development of the pancreas in Xenopus laevis. Dev 
Dyn, 218, 615-627. 
Kim, S.K., Hebrok, M. and Melton, D.A. (1997) Notochord to endoderm signaling is 
required for pancreas development. Development, 124, 4243-4252. 
Kirchgessner, A.L. and Gershon, M.D. (1990) Innervation of the pancreas by neurons in 
the gut. J Neurosci, 10, 1626-1642. 
Klein, S.L., Strausberg, R.L., Wagner, L., Pontius, J., Clifton, S.W. and Richardson, P. 
(2002) Genetic and genomic tools for Xenopus research: The NIH Xenopus 
initiative. Dev Dyn, 225, 384-391. 
Klisch, T. (2006) Transcriptional control in the context of primary neurogenesis PhD thesis. 
Kofron, M., Puck, H., Standley, H., Wylie, C., Old, R., Whitman, M. and Heasman, J. 
(2004) New roles for FoxH1 in patterning the early embryo. Development, 131, 
5065-5078. 
Kogawa, K., Nakamura, T., Sugino, K., Takio, K., Titani, K. and Sugino, H. (1991) 
Activin-binding protein is present in pituitary. Endocrinology, 128, 1434-1440. 
Kolm, P.J. and Sive, H.L. (1994) Complex regulation of Xenopus HoxAI and HoxDI. 
Biochem Soc Trans, 22, 579-584. 
Kopp, J.L., Dubois, C.L., Hao, E., Thorel, F., Herrera, P.L. and Sander, M. (2011a) 
Progenitor cell domains in the developing and adult pancreas. Cell Cycle, 10, 1921-
1927. 
Kopp, J.L., Dubois, C.L., Schaffer, A.E., Hao, E., Shih, H.P., Seymour, P.A., Ma, J. and 
Sander, M. (2011b) Sox9+ ductal cells are multipotent progenitors throughout 
development but do not produce new endocrine cells in the normal or injured adult 
pancreas. Development, 138, 653-665. 
Krapp, A., Knofler, M., Ledermann, B., Burki, K., Berney, C., Zoerkler, N., Hagenbuchle, 
O. and Wellauer, P.K. (1998) The bHLH protein PTF1-p48 is essential for the 
formation of the exocrine and the correct spatial organization of the endocrine 
pancreas. Genes Dev, 12, 3752-3763. 
Kroon, E., Martinson, L.A., Kadoya, K., Bang, A.G., Kelly, O.G., Eliazer, S., Young, H., 
Richardson, M., Smart, N.G., Cunningham, J., Agulnick, A.D., D'Amour, K.A., 
Carpenter, M.K. and Baetge, E.E. (2008) Pancreatic endoderm derived from 
human embryonic stem cells generates glucose-responsive insulin-secreting cells in 
vivo. Nat Biotechnol, 26, 443-452. 
Kubo, A., Shinozaki, K., Shannon, J.M., Kouskoff, V., Kennedy, M., Woo, S., Fehling, 




stem cells in culture. Development, 131, 1651-1662. 
Kurisaki, A., Ito, Y., Onuma, Y., Intoh, A. and Asashima, M. (2010) In vitro organogenesis 
using multipotent cells. Hum Cell, 23, 1-14. 
Lalevee, S., Anno, Y.N., Chatagnon, A., Samarut, E., Poch, O., Laudet, V., Benoit, G., 
Lecompte, O. and Rochette-Egly, C. (2011) Genome-wide in silico identification of 
new conserved and functional retinoic acid receptor response elements (direct 
repeats separated by 5 bp). J Biol Chem, 286, 33322-33334. 
Lammert, E., Cleaver, O. and Melton, D. (2001) Induction of pancreatic differentiation by 
signals from blood vessels. Science, 294, 564-567. 
Lancaster, M.A. and Knoblich, J.A. (2014) Organogenesis in a dish: modeling 
development and disease using organoid technologies. Science, 345, 1247125. 
Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., 
Homfray, T., Penninger, J.M., Jackson, A.P. and Knoblich, J.A. (2013) Cerebral 
organoids model human brain development and microcephaly. Nature, 501, 373-
379. 
Lancman, J.J., Zvenigorodsky, N., Gates, K.P., Zhang, D., Solomon, K., Humphrey, 
R.K., Kuo, T., Setiawan, L., Verkade, H., Chi, Y.I., Jhala, U.S., Wright, C.V., 
Stainier, D.Y. and Dong, P.D. (2013) Specification of hepatopancreas progenitors 
in zebrafish by hnf1ba and wnt2bb. Development, 140, 2669-2679. 
Landry, C., Clotman, F., Hioki, T., Oda, H., Picard, J.J., Lemaigre, F.P. and Rousseau, 
G.G. (1997) HNF-6 is expressed in endoderm derivatives and nervous system of the 
mouse embryo and participates to the cross-regulatory network of liver-enriched 
transcription factors. Dev Biol, 192, 247-257. 
Langmead, B. and Salzberg, S.L. (2012) Fast gapped-read alignment with Bowtie 2. Nat 
Methods, 9, 357-359. 
Langston, A.W., Thompson, J.R. and Gudas, L.J. (1997) Retinoic acid-responsive 
enhancers located 3' of the Hox A and Hox B homeobox gene clusters. Functional 
analysis. J Biol Chem, 272, 2167-2175. 
Lausen, J., Thomas, H., Lemm, I., Bulman, M., Borgschulze, M., Lingott, A., Hattersley, 
A.T. and Ryffel, G.U. (2000) Naturally occurring mutations in the human HNF4alpha 
gene impair the function of the transcription factor to a varying degree. Nucleic Acids 
Res, 28, 430-437. 
Lee, J.C., Smith, S.B., Watada, H., Lin, J., Scheel, D., Wang, J., Mirmira, R.G. and 
German, M.S. (2001) Regulation of the pancreatic pro-endocrine gene neurogenin3. 
Diabetes, 50, 928-936. 
Lee, Y.H. and Saint-Jeannet, J.P. (2003) Sox9, a novel pancreatic marker in Xenopus. Int J 
Dev Biol, 47, 459-462. 
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., 
Abecasis, G. and Durbin, R. (2009) The Sequence Alignment/Map format and 
SAMtools. Bioinformatics, 25, 2078-2079. 
Li, M.L., Aggeler, J., Farson, D.A., Hatier, C., Hassell, J. and Bissell, M.J. (1987) 
Influence of a reconstituted basement membrane and its components on casein 
gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad 
Sci U S A, 84, 136-140. 
Li, Y., Rankin, S.A., Sinner, D., Kenny, A.P., Krieg, P.A. and Zorn, A.M. (2008) Sfrp5 
coordinates foregut specification and morphogenesis by antagonizing both canonical 
and noncanonical Wnt11 signaling. Genes Dev, 22, 3050-3063. 
Lioubinski, O., Muller, M., Wegner, M. and Sander, M. (2003) Expression of Sox 
transcription factors in the developing mouse pancreas. Dev Dyn, 227, 402-408. 
Logan, C.Y. and Nusse, R. (2004) The Wnt signaling pathway in development and disease. 
Annu Rev Cell Dev Biol, 20, 781-810. 
Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., Gansmuller, A. 
and Chambon, P. (1994) Function of the retinoic acid receptors (RARs) during 
development (I). Craniofacial and skeletal abnormalities in RAR double mutants. 
Development, 120, 2723-2748. 
Loudig, O., Babichuk, C., White, J., Abu-Abed, S., Mueller, C. and Petkovich, M. (2000) 
Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response 
element underlies the complex regulation of retinoic acid metabolism. Molecular 
endocrinology (Baltimore, Md.), 14, 1483-1497. 
Loudig, O., Maclean, G.A., Dore, N.L., Luu, L. and Petkovich, M. (2005) Transcriptional 
co-operativity between distant retinoic acid response elements in regulation of 
Cyp26A1 inducibility. Biochem J, 392, 241-248. 




Lynn, F.C., Smith, S.B., Wilson, M.E., Yang, K.Y., Nekrep, N. and German, M.S. (2007) 
Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl 
Acad Sci U S A, 104, 10500-10505. 
 
Maake, C., Hanke, W. and Reinecke, M. (1998) An immunohistochemical and 
morphometric analysis of insulin, insulin-like growth factor I, glucagon, somatostatin, 
and PP in the development of the gastro-entero-pancreatic system of Xenopus 
laevis. Gen Comp Endocrinol, 110, 182-195. 
Maczkowiak, F., Mateos, S., Wang, E., Roche, D., Harland, R. and Monsoro-Burq, A.H. 
(2010) The Pax3 and Pax7 paralogs cooperate in neural and neural crest patterning 
using distinct molecular mechanisms, in Xenopus laevis embryos. Dev Biol, 340, 
381-396. 
Maestro, M.A., Boj, S.F., Luco, R.F., Pierreux, C.E., Cabedo, J., Servitja, J.M., German, 
M.S., Rousseau, G.G., Lemaigre, F.P. and Ferrer, J. (2003) Hnf6 and Tcf2 
(MODY5) are linked in a gene network operating in a precursor cell domain of the 
embryonic pancreas. Hum Mol Genet, 12, 3307-3314. 
Magenheim, J., Klein, A.M., Stanger, B.Z., Ashery-Padan, R., Sosa-Pineda, B., Gu, G. 
and Dor, Y. (2011) Ngn3(+) endocrine progenitor cells control the fate and 
morphogenesis of pancreatic ductal epithelium. Dev Biol, 359, 26-36. 
Mark, M., Ghyselinck, N.B. and Chambon, P. (2006) Function of retinoid nuclear 
receptors: lessons from genetic and pharmacological dissections of the retinoic acid 
signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol, 46, 
451-480. 
Martin, M., Gallego-Llamas, J., Ribes, V., Kedinger, M., Niederreither, K., Chambon, P., 
Dolle, P. and Gradwohl, G. (2005) Dorsal pancreas agenesis in retinoic acid-
deficient Raldh2 mutant mice. Dev Biol, 284, 399-411. 
Masui, T., Long, Q., Beres, T.M., Magnuson, M.A. and MacDonald, R.J. (2007) Early 
pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in 
the PTF1 bHLH complex. Genes Dev, 21, 2629-2643. 
Masui, T., Swift, G.H., Deering, T., Shen, C., Coats, W.S., Long, Q., Elsasser, H.P., 
Magnuson, M.A. and MacDonald, R.J. (2010) Replacement of Rbpj with Rbpjl in 
the PTF1 complex controls the final maturation of pancreatic acinar cells. 
Gastroenterology, 139, 270-280. 
Masui, T., Swift, G.H., Hale, M.A., Meredith, D.M., Johnson, J.E. and Macdonald, R.J. 
(2008) Transcriptional autoregulation controls pancreatic Ptf1a expression during 
development and adulthood. Mol Cell Biol, 28, 5458-5468. 
McCracken, K.W., Cata, E.M., Crawford, C.M., Sinagoga, K.L., Schumacher, M., 
Rockich, B.E., Tsai, Y.H., Mayhew, C.N., Spence, J.R., Zavros, Y. and Wells, 
J.M. (2014) Modelling human development and disease in pluripotent stem-cell-
derived gastric organoids. Nature, 516, 400-404. 
McCracken, K.W. and Wells, J.M. (2012) Molecular pathways controlling pancreas 
induction. Semin Cell Dev Biol, 23, 656-662. 
McLin, V.A., Rankin, S.A. and Zorn, A.M. (2007) Repression of Wnt/beta-catenin signaling 
in the anterior endoderm is essential for liver and pancreas development. 
Development, 134, 2207-2217. 
Medina, A., Reintsch, W. and Steinbeisser, H. (2000) Xenopus frizzled 7 can act in 
canonical and non-canonical Wnt signaling pathways: implications on early 
patterning and morphogenesis. Mech Dev, 92, 227-237. 
Mellitzer, G., Bonne, S., Luco, R.F., Van De Casteele, M., Lenne-Samuel, N., Collombat, 
P., Mansouri, A., Lee, J., Lan, M., Pipeleers, D., Nielsen, F.C., Ferrer, J., 
Gradwohl, G. and Heimberg, H. (2006) IA1 is NGN3-dependent and essential for 
differentiation of the endocrine pancreas. Embo j, 25, 1344-1352. 
Mendelsohn, C., Lohnes, D., Decimo, D., Lufkin, T., LeMeur, M., Chambon, P. and 
Mark, M. (1994) Function of the retinoic acid receptors (RARs) during development 
(II). Multiple abnormalities at various stages of organogenesis in RAR double 
mutants. Development, 120, 2749-2771. 
Mii, Y. and Taira, M. (2009) Secreted Frizzled-related proteins enhance the diffusion of Wnt 
ligands and expand their signalling range. Development, 136, 4083-4088. 
Mikels, A.J. and Nusse, R. (2006) Purified Wnt5a protein activates or inhibits beta-catenin-
TCF signaling depending on receptor context. PLoS Biol, 4, e115. 
Mitchell, D.M., Stevens, C.B., Frey, R.A., Hunter, S.S., Ashino, R., Kawamura, S. and 




the Tandemly-Duplicated Long Wavelength-Sensitive Cone Opsin Genes in 
Zebrafish. PLoS Genet, 11, e1005483. 
Miyatsuka, T., Matsuoka, T.A., Shiraiwa, T., Yamamoto, T., Kojima, I. and Kaneto, H. 
(2007) Ptf1a and RBP-J cooperate in activating Pdx1 gene expression through 
binding to Area III. Biochem Biophys Res Commun, 362, 905-909. 
Molotkov, A., Molotkova, N. and Duester, G. (2005) Retinoic acid generated by Raldh2 in 
mesoderm is required for mouse dorsal endodermal pancreas development. Dev 
Dyn, 232, 950-957. 
Moon, R.T. and Kimelman, D. (1998) From cortical rotation to organizer gene expression: 
toward a molecular explanation of axis specification in Xenopus. Bioessays, 20, 536-
545. 
Moore, F., Santin, I., Nogueira, T.C., Gurzov, E.N., Marselli, L., Marchetti, P. and Eizirik, 
D.L. (2012) The transcription factor C/EBP delta has anti-apoptotic and anti-
inflammatory roles in pancreatic beta cells. PLoS One, 7, e31062. 
Moriya, N., Komazaki, S. and Asashima, M. (2000a) In vitro organogenesis of pancreas in 
Xenopus laevis dorsal lips treated with retinoic acid. Dev Growth Differ, 42, 175-185. 
Moriya, N., Komazaki, S., Takahashi, S., Yokota, C. and Asashima, M. (2000b) In vitro 
pancreas formation from Xenopus ectoderm treated with activin and retinoic acid. 
Dev Growth Differ, 42, 593-602. 
Mukhi, S., Mao, J. and Brown, D.D. (2008) Remodeling the exocrine pancreas at 
metamorphosis in Xenopus laevis. Proc Natl Acad Sci U S A, 105, 8962-8967. 
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. (1986) Specific 
enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring 
Harb Symp Quant Biol, 51 Pt 1, 263-273. 
Murtaugh, L.C., Law, A.C., Dor, Y. and Melton, D.A. (2005) Beta-catenin is essential for 
pancreatic acinar but not islet development. Development, 132, 4663-4674. 
Nakayama, T., Fish, M.B., Fisher, M., Oomen-Hajagos, J., Thomsen, G.H. and Grainger, 
R.M. (2013) Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in 
Xenopus tropicalis. Genesis, 51, 835-843. 
Napolitano, T., Avolio, F., Courtney, M., Vieira, A., Druelle, N., Ben-Othman, N., Hadzic, 
B., Navarro, S. and Collombat, P. (2015) Pax4 acts as a key player in pancreas 
development and plasticity. Semin Cell Dev Biol, 44, 107-114. 
Nieber, F., Pieler, T. and Henningfeld, K.A. (2009) Comparative expression analysis of the 
neurogenins in Xenopus tropicalis and Xenopus laevis. Dev Dyn, 238, 451-458. 
Niederreither, K., McCaffery, P., Drager, U.C., Chambon, P. and Dolle, P. (1997) 
Restricted expression and retinoic acid-induced downregulation of the retinaldehyde 
dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech Dev, 62, 
67-78. 
Niehrs, C. (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol, 13, 
767-779. 
Nieto, M.A., Bradley, L.C., Hunt, P., Das Gupta, R., Krumlauf, R. and Wilkinson, D.G. 
(1992) Molecular mechanisms of pattern formation in the vertebrate hindbrain. Ciba 
Found Symp, 165, 92-102; discussion 102-107. 
Nieuwkoop, P.D. (1963) Pattern formation in artificially activated ectoderm (Rana pipiens 
and Ambystoma punctatum). Dev Biol, 6, 255-279. 
Nieuwkoop, P.D. and Faber, J. (1967) Normal table of Xenopus laevis. (Daudin) North 
Holland Publishing Co. Amsterdam, 2nd ed. 
Nolte, C., Amores, A., Nagy Kovacs, E., Postlethwait, J. and Featherstone, M. (2003) 
The role of a retinoic acid response element in establishing the anterior neural 
expression border of Hoxd4 transgenes. Mech Dev, 120, 325-335. 
Nusse, R. (2012) Wnt signaling. Cold Spring Harbor perspectives in biology, 4. 
Obata, J., Yano, M., Mimura, H., Goto, T., Nakayama, R., Mibu, Y., Oka, C. and 
Kawaichi, M. (2001) p48 subunit of mouse PTF1 binds to RBP-Jkappa/CBF-1, the 
intracellular mediator of Notch signalling, and is expressed in the neural tube of early 
stage embryos. Genes Cells, 6, 345-360. 
Ohkawara, B. and Niehrs, C. (2011) An ATF2-based luciferase reporter to monitor non-
canonical Wnt signaling in Xenopus embryos. Dev Dyn, 240, 188-194. 
Okabayashi, K. and Asashima, M. (2006) In Vitro organogenesis using amphibian 
pluripotent cells. Proc Jpn Acad Ser B Phys Biol Sci, 82, 197-207. 
Osei-Sarfo, K. and Gudas, L.J. (2014) Retinoic acid suppresses the canonical Wnt 
signaling pathway in embryonic stem cells and activates the noncanonical Wnt 
signaling pathway. Stem cells (Dayton, Ohio), 32, 2061-2071. 




Oster, A., Jensen, J., Serup, P., Galante, P., Madsen, O.D. and Larsson, L.I. (1998) Rat 
endocrine pancreatic development in relation to two homeobox gene products (Pdx-
1 and Nkx 6.1). J Histochem Cytochem, 46, 707-715. 
Pagliuca, F.W., Millman, J.R., Gurtler, M., Segel, M., Van Dervort, A., Ryu, J.H., 
Peterson, Q.P., Greiner, D. and Melton, D.A. (2014) Generation of functional 
human pancreatic beta cells in vitro. Cell, 159, 428-439. 
Pan, F.C., Bankaitis, E.D., Boyer, D., Xu, X., Van de Casteele, M., Magnuson, M.A., 
Heimberg, H. and Wright, C.V. (2013) Spatiotemporal patterns of multipotentiality 
in Ptf1a-expressing cells during pancreas organogenesis and injury-induced 
facultative restoration. Development, 140, 751-764. 
Pan, F.C., Chen, Y., Bayha, E. and Pieler, T. (2007) Retinoic acid-mediated patterning of 
the pre-pancreatic endoderm in Xenopus operates via direct and indirect 
mechanisms. Mech Dev, 124, 518-531. 
Pan, F.C. and Wright, C. (2011) Pancreas organogenesis: from bud to plexus to gland. Dev 
Dyn, 240, 530-565. 
Pearl, E.J., Bilogan, C.K., Mukhi, S., Brown, D.D. and Horb, M.E. (2009) Xenopus 
pancreas development. Dev Dyn, 238, 1271-1286. 
Pera, E.M., Martinez, S.L., Flanagan, J.J., Brechner, M., Wessely, O. and De Robertis, 
E.M. (2003) Darmin is a novel secreted protein expressed during endoderm 
development in Xenopus. Gene Expr Patterns, 3, 147-152. 
Perron, M., Opdecamp, K., Butler, K., Harris, W.A. and Bellefroid, E.J. (1999) X-ngnr-1 
and Xath3 promote ectopic expression of sensory neuron markers in the neurula 
ectoderm and have distinct inducing properties in the retina. Proc Natl Acad Sci U S 
A, 96, 14996-15001. 
Piccolo, S., Sasai, Y., Lu, B. and De Robertis, E.M. (1996) Dorsoventral patterning in 
Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell, 86, 
589-598. 
Pictet, R.L., Clark, W.R., Williams, R.H. and Rutter, W.J. (1972) An ultrastructural analysis 
of the developing embryonic pancreas. Dev Biol, 29, 436-467. 
Pieler, T. and Chen, Y. (2006) Forgotten and novel aspects in pancreas development. Biol 
Cell, 98, 79-88. 
Poll, A.V., Pierreux, C.E., Lokmane, L., Haumaitre, C., Achouri, Y., Jacquemin, P., 
Rousseau, G.G., Cereghini, S. and Lemaigre, F.P. (2006) A vHNF1/TCF2-HNF6 
cascade regulates the transcription factor network that controls generation of 
pancreatic precursor cells. Diabetes, 55, 61-69. 
Pouilhe, M., Gilardi-Hebenstreit, P., Desmarquet-Trin Dinh, C. and Charnay, P. (2007) 
Direct regulation of vHnf1 by retinoic acid signaling and MAF-related factors in the 
neural tube. Dev Biol, 309, 344-357. 
Power, S.C. and Cereghini, S. (1996) Positive regulation of the vHNF1 promoter by the 
orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. Mol Cell Biol, 16, 778-791. 
Quadro, L., Blaner, W.S., Salchow, D.J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, 
S., Cosma, M.P., Colantuoni, V. and Gottesman, M.E. (1999) Impaired retinal 
function and vitamin A availability in mice lacking retinol-binding protein. Embo j, 18, 
4633-4644. 
Rankin, S.A., Kormish, J., Kofron, M., Jegga, A. and Zorn, A.M. (2011) A gene regulatory 
network controlling hhex transcription in the anterior endoderm of the organizer. Dev 
Biol, 351, 297-310. 
Rattner, A., Hsieh, J.C., Smallwood, P.M., Gilbert, D.J., Copeland, N.G., Jenkins, N.A. 
and Nathans, J. (1997) A family of secreted proteins contains homology to the 
cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A, 
94, 2859-2863. 
Rausa, F., Samadani, U., Ye, H., Lim, L., Fletcher, C.F., Jenkins, N.A., Copeland, N.G. 
and Costa, R.H. (1997) The cut-homeodomain transcriptional activator HNF-6 is 
coexpressed with its target gene HNF-3 beta in the developing murine liver and 
pancreas. Dev Biol, 192, 228-246. 
Ray, W.J., Bain, G., Yao, M. and Gottlieb, D.I. (1997) CYP26, a novel mammalian 
cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem, 
272, 18702-18708. 
Rehorn, K.P., Thelen, H., Michelson, A.M. and Reuter, R. (1996) A molecular aspect of 
hematopoiesis and endoderm development common to vertebrates and Drosophila. 
Development, 122, 4023-4031. 




Narayan, K., Karanu, F., O'Neil, J.J., Ao, Z., Warnock, G.L. and Kieffer, T.J. 
(2012) Maturation of human embryonic stem cell-derived pancreatic progenitors into 
functional islets capable of treating pre-existing diabetes in mice. Diabetes, 61, 
2016-2029. 
Rhinn, M. and Dolle, P. (2012) Retinoic acid signalling during development. Development, 
139, 843-858. 
Richard-Parpaillon, L., Heligon, C., Chesnel, F., Boujard, D. and Philpott, A. (2002) The 
IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus. Dev 
Biol, 244, 407-417. 
Rindi, G., Torsello, A., Locatelli, V. and Solcia, E. (2004) Ghrelin expression and actions: 
a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med 
(Maywood), 229, 1007-1016. 
Robinson, M.D., McCarthy, D.J. and Smyth, G.K. (2010) edgeR: a Bioconductor package 
for differential expression analysis of digital gene expression data. Bioinformatics, 
26, 139-140. 
Rochette-Egly, C. and Germain, P. (2009) Dynamic and combinatorial control of gene 
expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal, 7, e005. 
Rock, J.R., Onaitis, M.W., Rawlins, E.L., Lu, Y., Clark, C.P., Xue, Y., Randell, S.H. and 
Hogan, B.L. (2009) Basal cells as stem cells of the mouse trachea and human 
airway epithelium. Proc Natl Acad Sci U S A, 106, 12771-12775. 
Rodriguez-Seguel, E., Mah, N., Naumann, H., Pongrac, I.M., Cerda-Esteban, N., 
Fontaine, J.F., Wang, Y., Chen, W., Andrade-Navarro, M.A. and Spagnoli, F.M. 
(2013) Mutually exclusive signaling signatures define the hepatic and pancreatic 
progenitor cell lineage divergence. Genes Dev, 27, 1932-1946. 
Rodriguez-Segui, S., Akerman, I. and Ferrer, J. (2012) GATA believe it: new essential 
regulators of pancreas development. J Clin Invest, 122, 3469-3471. 
Rookmaaker, M.B., Schutgens, F., Verhaar, M.C. and Clevers, H. (2015) Development 
and application of human adult stem or progenitor cell organoids. Nat Rev Nephrol, 
11, 546-554. 
Rose, S.D., Swift, G.H., Peyton, M.J., Hammer, R.E. and MacDonald, R.J. (2001) The 
role of PTF1-P48 in pancreatic acinar gene expression. J Biol Chem, 276, 44018-
44026. 
Rossi, J.M., Dunn, N.R., Hogan, B.L. and Zaret, K.S. (2001) Distinct mesodermal signals, 
including BMPs from the septum transversum mesenchyme, are required in 
combination for hepatogenesis from the endoderm. Genes Dev, 15, 1998-2009. 
Rubenstein, A., Merriam, J. and Klymkowsky, M.W. (1997) Localizing the adhesive and 
signaling functions of plakoglobin. Dev Genet, 20, 91-102. 
Rukstalis, J.M. and Habener, J.F. (2007) Snail2, a mediator of epithelial-mesenchymal 
transitions, expressed in progenitor cells of the developing endocrine pancreas. 
Gene Expr Patterns, 7, 471-479. 
Rupp, R.A., Snider, L. and Weintraub, H. (1994) Xenopus embryos regulate the nuclear 
localization of XMyoD. Genes Dev, 8, 1311-1323. 
Ryffel, G.U. (2001) Mutations in the human genes encoding the transcription factors of the 
hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological 
consequences. J Mol Endocrinol, 27, 11-29. 
Sagara, N., Kirikoshi, H., Terasaki, H., Yasuhiko, Y., Toda, G., Shiokawa, K. and Katoh, 
M. (2001) FZD4S, a splicing variant of frizzled-4, encodes a soluble-type positive 
regulator of the WNT signaling pathway. Biochem Biophys Res Commun, 282, 750-
756. 
Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A. and Arnheim, N. 
(1985) Enzymatic amplification of beta-globin genomic sequences and restriction 
site analysis for diagnosis of sickle cell anemia. Science, 230, 1350-1354. 
Salzberg, A., Elias, S., Nachaliel, N., Bonstein, L., Henig, C. and Frank, D. (1999) A Meis 
family protein caudalizes neural cell fates in Xenopus. Mech Dev, 80, 3-13. 
Sambrook, J. and Russel, D.W. (2001) Molecular Cloning: a laboratory manual. Cold  
Spring  Harbour  Laboratory  Press,  Cold  Spring Harbour, New York., 3rd edition. 
Sander, J.D. and Joung, J.K. (2014) CRISPR-Cas systems for editing, regulating and 
targeting genomes. Nat Biotechnol, 32, 347-355. 
Sander, J.D., Maeder, M.L., Reyon, D., Voytas, D.F., Joung, J.K. and Dobbs, D. (2010) 
ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids 
Res, 38, W462-468. 
Sander, J.D., Zaback, P., Joung, J.K., Voytas, D.F. and Dobbs, D. (2007) Zinc Finger 




Targeter (ZiFiT): an engineered zinc finger/target site design tool. Nucleic Acids Res, 
35, W599-605. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating 
inhibitors. Proc Natl Acad Sci U S A, 74, 5463-5467. 
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born, M., 
Barker, N., Shroyer, N.F., van de Wetering, M. and Clevers, H. (2011) Paneth 
cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature, 469, 415-
418. 
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van 
Es, J.H., Abo, A., Kujala, P., Peters, P.J. and Clevers, H. (2009) Single Lgr5 stem 
cells build crypt-villus structures in vitro without a mesenchymal niche. Nature, 459, 
262-265. 
Schaffer, A.E., Freude, K.K., Nelson, S.B. and Sander, M. (2010) Nkx6 transcription 
factors and Ptf1a function as antagonistic lineage determinants in multipotent 
pancreatic progenitors. Dev Cell, 18, 1022-1029. 
Schier, A.F. and Talbot, W.S. (2005) Molecular genetics of axis formation in zebrafish. 
Annu Rev Genet, 39, 561-613. 
Schiesser, J.V., Micallef, S.J., Hawes, S., Elefanty, A.G. and Stanley, E.G. (2014) 
Derivation of insulin-producing beta-cells from human pluripotent stem cells. Rev 
Diabet Stud, 11, 6-18. 
Schneider-Poetsch, T., Ju, J., Eyler, D.E., Dang, Y., Bhat, S., Merrick, W.C., Green, R., 
Shen, B. and Liu, J.O. (2010) Inhibition of eukaryotic translation elongation by 
cycloheximide and lactimidomycin. Nature chemical biology, 6, 209-217. 
Schulz, T.C., Young, H.Y., Agulnick, A.D., Babin, M.J., Baetge, E.E., Bang, A.G., 
Bhoumik, A., Cepa, I., Cesario, R.M., Haakmeester, C., Kadoya, K., Kelly, J.R., 
Kerr, J., Martinson, L.A., McLean, A.B., Moorman, M.A., Payne, J.K., 
Richardson, M., Ross, K.G., Sherrer, E.S., Song, X., Wilson, A.Z., Brandon, 
E.P., Green, C.E., Kroon, E.J., Kelly, O.G., D'Amour, K.A. and Robins, A.J. 
(2012) A scalable system for production of functional pancreatic progenitors from 
human embryonic stem cells. PLoS One, 7, e37004. 
Schwank, G., Koo, B.K., Sasselli, V., Dekkers, J.F., Heo, I., Demircan, T., Sasaki, N., 
Boymans, S., Cuppen, E., van der Ent, C.K., Nieuwenhuis, E.E., Beekman, J.M. 
and Clevers, H. (2013) Functional repair of CFTR by CRISPR/Cas9 in intestinal 
stem cell organoids of cystic fibrosis patients. Cell Stem Cell, 13, 653-658. 
Schwitzgebel, V.M., Scheel, D.W., Conners, J.R., Kalamaras, J., Lee, J.E., Anderson, 
D.J., Sussel, L., Johnson, J.D. and German, M.S. (2000) Expression of 
neurogenin3 reveals an islet cell precursor population in the pancreas. 
Development, 127, 3533-3542. 
Seymour, P.A. (2014) Sox9: a master regulator of the pancreatic program. Rev Diabet Stud, 
11, 51-83. 
Seymour, P.A., Freude, K.K., Tran, M.N., Mayes, E.E., Jensen, J., Kist, R., Scherer, G. 
and Sander, M. (2007) SOX9 is required for maintenance of the pancreatic 
progenitor cell pool. Proc Natl Acad Sci U S A, 104, 1865-1870. 
Shaer, A., Azarpira, N., Vahdati, A., Karimi, M.H. and Shariati, M. (2015) Differentiation of 
human-induced pluripotent stem cells into insulin-producing clusters. Exp Clin 
Transplant, 13, 68-75. 
Sharp, P.A., Sugden, B. and Sambrook, J. (1973) Detection of two restriction 
endonuclease activities in Haemophilus parainfluenzae using analytical agarose--
ethidium bromide electrophoresis. Biochemistry, 12, 3055-3063. 
Sharpe, C.R., Pluck, A. and Gurdon, J.B. (1989) XIF3, a Xenopus peripherin gene, 
requires an inductive signal for enhanced expression in anterior neural tissue. 
Development, 107, 701-714. 
Shen, M.M. (2007) Nodal signaling: developmental roles and regulation. Development, 134, 
1023-1034. 
Sherwood, R.I., Maehr, R., Mazzoni, E.O. and Melton, D.A. (2011) Wnt signaling specifies 
and patterns intestinal endoderm. Mech Dev, 128, 387-400. 
Shi, D.L. and Boucaut, J.C. (2000) Xenopus frizzled 4 is a maternal mRNA and its zygotic 
expression is localized to the neuroectoderm and trunk lateral plate mesoderm. 
Mech Dev, 94, 243-245. 
Shih, H.P., Kopp, J.L., Sandhu, M., Dubois, C.L., Seymour, P.A., Grapin-Botton, A. and 
Sander, M. (2012) A Notch-dependent molecular circuitry initiates pancreatic 




Shih, H.P., Seymour, P.A., Patel, N.A., Xie, R., Wang, A., Liu, P.P., Yeo, G.W., 
Magnuson, M.A. and Sander, M. (2015) A Gene Regulatory Network Cooperatively 
Controlled by Pdx1 and Sox9 Governs Lineage Allocation of Foregut Progenitor 
Cells. Cell Rep, 13, 326-336. 
Shih, H.P., Wang, A. and Sander, M. (2013) Pancreas organogenesis: from lineage 
determination to morphogenesis. Annu Rev Cell Dev Biol, 29, 81-105. 
Shuldiner, A.R., Phillips, S., Roberts, C.T., Jr., LeRoith, D. and Roth, J. (1989) Xenopus 
laevis contains two nonallelic preproinsulin genes. cDNA cloning and evolutionary 
perspective. J Biol Chem, 264, 9428-9432. 
Singer, G.a. (2006) Developmental Biology. Sinauer Associates Inc., 8th edition. 
Sive, H.L. and Cheng, P.F. (1991) Retinoic acid perturbs the expression of Xhox.lab genes 
and alters mesodermal determination in Xenopus laevis. Genes Dev, 5, 1321-1332. 
Skirkanich, J., Luxardi, G., Yang, J., Kodjabachian, L. and Klein, P.S. (2011) An 
essential role for transcription before the MBT in Xenopus laevis. Dev Biol, 357, 478-
491. 
Slack, J.M. (1995) Developmental biology of the pancreas. Development, 121, 1569-1580. 
Smith, W.C. and Harland, R.M. (1991) Injected Xwnt-8 RNA acts early in Xenopus embryos 
to promote formation of a vegetal dorsalizing center. Cell, 67, 753-765. 
Smith, W.C., Knecht, A.K., Wu, M. and Harland, R.M. (1993) Secreted noggin protein 
mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature, 361, 547-
549. 
Sogame, A., Hayata, T. and Asashima, M. (2003) Screening for novel pancreatic genes 
from in vitro-induced pancreas in Xenopus. Dev Growth Differ, 45, 143-152. 
Solar, M., Cardalda, C., Houbracken, I., Martin, M., Maestro, M.A., De Medts, N., Xu, X., 
Grau, V., Heimberg, H., Bouwens, L. and Ferrer, J. (2009) Pancreatic exocrine 
duct cells give rise to insulin-producing beta cells during embryogenesis but not after 
birth. Dev Cell, 17, 849-860. 
Soyer, J., Flasse, L., Raffelsberger, W., Beucher, A., Orvain, C., Peers, B., Ravassard, 
P., Vermot, J., Voz, M.L., Mellitzer, G. and Gradwohl, G. (2010) Rfx6 is an Ngn3-
dependent winged helix transcription factor required for pancreatic islet cell 
development. Development, 137, 203-212. 
Spagnoli, F.M. and Brivanlou, A.H. (2008) The Gata5 target, TGIF2, defines the pancreatic 
region by modulating BMP signals within the endoderm. Development, 135, 451-
461. 
Stafford, D., Hornbruch, A., Mueller, P.R. and Prince, V.E. (2004) A conserved role for 
retinoid signaling in vertebrate pancreas development. Dev Genes Evol, 214, 432-
441. 
Stafford, D. and Prince, V.E. (2002) Retinoic acid signaling is required for a critical early 
step in zebrafish pancreatic development. Curr Biol, 12, 1215-1220. 
Stemmer, M., Thumberger, T., Del Sol Keyer, M., Wittbrodt, J. and Mateo, J.L. (2015) 
CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool. 
PLoS One, 10, e0124633. 
Strate, I., Min, T.H., Iliev, D. and Pera, E.M. (2009) Retinol dehydrogenase 10 is a 
feedback regulator of retinoic acid signalling during axis formation and patterning of 
the central nervous system. Development, 136, 461-472. 
Swain, R.K., Katoh, M., Medina, A. and Steinbeisser, H. (2005) Xenopus frizzled-4S, a 
splicing variant of Xfz4 is a context-dependent activator and inhibitor of Wnt/beta-
catenin signaling. Cell Commun Signal, 3, 12. 
Taira, M., Otani, H., Jamrich, M. and Dawid, I.B. (1994) Expression of the LIM class 
homeobox gene Xlim-1 in pronephros and CNS cell lineages of Xenopus embryos is 
affected by retinoic acid and exogastrulation. Development, 120, 1525-1536. 
Takahashi, S., Yokota, C., Takano, K., Tanegashima, K., Onuma, Y., Goto, J. and 
Asashima, M. (2000) Two novel nodal-related genes initiate early inductive events 
in Xenopus Nieuwkoop center. Development, 127, 5319-5329. 
Takasato, M., Er, P.X., Chiu, H.S., Maier, B., Baillie, G.J., Ferguson, C., Parton, R.G., 
Wolvetang, E.J., Roost, M.S., Chuva de Sousa Lopes, S.M. and Little, M.H. 
(2015) Kidney organoids from human iPS cells contain multiple lineages and model 
human nephrogenesis. Nature, 526, 564-568. 
Tam, P.P. and Loebel, D.A. (2007) Gene function in mouse embryogenesis: get set for 
gastrulation. Nat Rev Genet, 8, 368-381. 
Tamai, K., Yokota, C., Ariizumi, T. and Asashima, M. (1999) Cytochalasin B inhibits 
morphogenetic movement and muscle differentiation of activin-treated ectoderm in 




Xenopus. Dev Growth Differ, 41, 41-49. 
Tashiro, K., Yamada, R., Asano, M., Hashimoto, M., Muramatsu, M. and Shiokawa, K. 
(1991) Expression of mRNA for activin-binding protein (follistatin) during early 
embryonic development of Xenopus laevis. Biochem Biophys Res Commun, 174, 
1022-1027. 
Terns, R.M. and Terns, M.P. (2014) CRISPR-based technologies: prokaryotic defense 
weapons repurposed. Trends Genet, 30, 111-118. 
Thomas, H., Jaschkowitz, K., Bulman, M., Frayling, T.M., Mitchell, S.M., Roosen, S., 
Lingott-Frieg, A., Tack, C.J., Ellard, S., Ryffel, G.U. and Hattersley, A.T. (2001) A 
distant upstream promoter of the HNF-4alpha gene connects the transcription 
factors involved in maturity-onset diabetes of the young. Hum Mol Genet, 10, 2089-
2097. 
Tsai, M.J. and O'Malley, B.W. (1994) Molecular mechanisms of action of steroid/thyroid 
receptor superfamily members. Annual review of biochemistry, 63, 451-486. 
Turner, D.L. and Weintraub, H. (1994) Expression of achaete-scute homolog 3 in Xenopus 
embryos converts ectodermal cells to a neural fate. Genes Dev, 8, 1434-1447. 
Umbhauer, M., Djiane, A., Goisset, C., Penzo-Mendez, A., Riou, J.F., Boucaut, J.C. and 
Shi, D.L. (2000) The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled 
receptors mediates Wnt/beta-catenin signalling. Embo j, 19, 4944-4954. 
van der Sanden, M.H., Meems, H., Houweling, M., Helms, J.B. and Vaandrager, A.B. 
(2004) Induction of CCAAT/enhancer-binding protein (C/EBP)-homologous 
protein/growth arrest and DNA damage-inducible protein 153 expression during 
inhibition of phosphatidylcholine synthesis is mediated via activation of a C/EBP-
activating transcription factor-responsive element. J Biol Chem, 279, 52007-52015. 
Vignali, R., Poggi, L., Madeddu, F. and Barsacchi, G. (2000) HNF1(beta) is required for 
mesoderm induction in the Xenopus embryo. Development, 127, 1455-1465. 
Villasenor, A., Chong, D.C., Henkemeyer, M. and Cleaver, O. (2010) Epithelial dynamics 
of pancreatic branching morphogenesis. Development, 137, 4295-4305. 
Wang, F., Shi, Z., Cui, Y., Guo, X., Shi, Y.B. and Chen, Y. (2015) Targeted gene disruption 
in Xenopus laevis using CRISPR/Cas9. Cell Biosci, 5, 15. 
Wang, L., Coffinier, C., Thomas, M.K., Gresh, L., Eddu, G., Manor, T., Levitsky, L.L., 
Yaniv, M. and Rhoads, D.B. (2004) Selective deletion of the Hnf1beta (MODY5) 
gene in beta-cells leads to altered gene expression and defective insulin release. 
Endocrinology, 145, 3941-3949. 
Waters, C.A., Strande, N.T., Wyatt, D.W., Pryor, J.M. and Ramsden, D.A. (2014) 
Nonhomologous end joining: a good solution for bad ends. DNA Repair (Amst), 17, 
39-51. 
Watt, A.J., Zhao, R., Li, J. and Duncan, S.A. (2007) Development of the mammalian liver 
and ventral pancreas is dependent on GATA4. BMC Dev Biol, 7, 37. 
Wells, J.M. and Melton, D.A. (2000) Early mouse endoderm is patterned by soluble factors 
from adjacent germ layers. Development, 127, 1563-1572. 
Wheeler, G.N. and Hoppler, S. (1999) Two novel Xenopus frizzled genes expressed in 
developing heart and brain. Mech Dev, 86, 203-207. 
White, J.A., Guo, Y.D., Baetz, K., Beckett-Jones, B., Bonasoro, J., Hsu, K.E., Dilworth, 
F.J., Jones, G. and Petkovich, M. (1996) Identification of the retinoic acid-inducible 
all-trans-retinoic acid 4-hydroxylase. J Biol Chem, 271, 29922-29927. 
Wierup, N., Sundler, F. and Heller, R.S. (2014) The islet ghrelin cell. J Mol Endocrinol, 52, 
R35-49. 
Willyard, C. (2015) The boom in mini stomachs, brains, breasts, kidneys and more. Nature, 
523, 520-522. 
Wong, H.C., Bourdelas, A., Krauss, A., Lee, H.J., Shao, Y., Wu, D., Mlodzik, M., Shi, 
D.L. and Zheng, J. (2003) Direct binding of the PDZ domain of Dishevelled to a 
conserved internal sequence in the C-terminal region of Frizzled. Mol Cell, 12, 1251-
1260. 
Wright, C.V., Schnegelsberg, P. and De Robertis, E.M. (1989) XlHbox 8: a novel Xenopus 
homeo protein restricted to a narrow band of endoderm. Development, 105, 787-
794. 
Xanthos, J.B., Kofron, M., Wylie, C. and Heasman, J. (2001) Maternal VegT is the initiator 
of a molecular network specifying endoderm in Xenopus laevis. Development, 128, 
167-180. 
Xu, C.R., Cole, P.A., Meyers, D.J., Kormish, J., Dent, S. and Zaret, K.S. (2011) Chromatin 





Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P.M., Williams, J., Woods, C., Kelley, M.W., 
Jiang, L., Tasman, W., Zhang, K. and Nathans, J. (2004) Vascular development in 
the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-
receptor pair. Cell, 116, 883-895. 
Xuan, S., Borok, M.J., Decker, K.J., Battle, M.A., Duncan, S.A., Hale, M.A., Macdonald, 
R.J. and Sussel, L. (2012) Pancreas-specific deletion of mouse Gata4 and Gata6 
causes pancreatic agenesis. J Clin Invest, 122, 3516-3528. 
Yam, J.W., Chan, K.W., Ngan, E.S. and Hsiao, W.L. (2005) Genomic structure, alternative 
splicing and tissue expression of rFrp/sFRP-4, the rat frizzled related protein gene. 
Gene, 357, 55-62. 
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P.J., Menzel, S., Cox, N.J., Fajans, S.S., 
Signorini, S., Stoffel, M. and Bell, G.I. (1996) Mutations in the hepatocyte nuclear 
factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature, 384, 
458-460. 
Yasuhara, R., Yuasa, T., Williams, J.A., Byers, S.W., Shah, S., Pacifici, M., Iwamoto, M. 
and Enomoto-Iwamoto, M. (2010) Wnt/beta-catenin and retinoic acid receptor 
signaling pathways interact to regulate chondrocyte function and matrix turnover. J 
Biol Chem, 285, 317-327. 
Yasuo, H. and Lemaire, P. (1999) A two-step model for the fate determination of 
presumptive endodermal blastomeres in Xenopus embryos. Curr Biol, 9, 869-879. 
Ye, X., Wang, Y. and Nathans, J. (2010) The Norrin/Frizzled4 signaling pathway in retinal 
vascular development and disease. Trends Mol Med, 16, 417-425. 
Yoshitomi, H. and Zaret, K.S. (2004) Endothelial cell interactions initiate dorsal pancreas 
development by selectively inducing the transcription factor Ptf1a. Development, 
131, 807-817. 
Zaret, K.S. and Grompe, M. (2008) Generation and regeneration of cells of the liver and 
pancreas. Science, 322, 1490-1494. 
Zeynali, B., Kalionis, B. and Dixon, K.E. (2000) Determination of anterior endoderm in 
Xenopus embryos. Dev Dyn, 218, 531-536. 
Zhang, C., Basta, T., Fawcett, S.R. and Klymkowsky, M.W. (2005) SOX7 is an immediate-
early target of VegT and regulates Nodal-related gene expression in Xenopus. Dev 
Biol, 278, 526-541. 
Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y. and Deng, H. (2009) 
Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic 
insulin-producing cells. Cell Res, 19, 429-438. 
Zhang, J., Houston, D.W., King, M.L., Payne, C., Wylie, C. and Heasman, J. (1998) The 
role of maternal VegT in establishing the primary germ layers in Xenopus embryos. 
Cell, 94, 515-524. 
Zhang, J. and King, M.L. (1996) Xenopus VegT RNA is localized to the vegetal cortex 
during oogenesis and encodes a novel T-box transcription factor involved in 
mesodermal patterning. Development, 122, 4119-4129. 
Zhang, K., Harada, Y., Wei, X., Shukla, D., Rajendran, A., Tawansy, K., Bedell, M., Lim, 
S., Shaw, P.X., He, X. and Yang, Z. (2011) An essential role of the cysteine-rich 
domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy. J 
Biol Chem, 286, 10210-10215. 
Zhang, T., Guo, X. and Chen, Y. (2013b) Retinoic acid-activated Ndrg1a represses 
Wnt/beta-catenin signaling to allow Xenopus pancreas, oesophagus, stomach, and 
duodenum specification. PLoS One, 8, e65058. 
Zhang, Y.Q., Cleary, M.M., Si, Y., Liu, G., Eto, Y., Kritzik, M., Dabernat, S., Kayali, A.G. 
and Sarvetnick, N. (2004) Inhibition of activin signaling induces pancreatic epithelial 
cell expansion and diminishes terminal differentiation of pancreatic beta-cells. 
Diabetes, 53, 2024-2033. 
Zhang, Z., Rankin, S.A. and Zorn, A.M. (2013a) Different thresholds of Wnt-Frizzled 7 
signaling coordinate proliferation, morphogenesis and fate of endoderm progenitor 
cells. Dev Biol, 378, 1-12. 
Zhou, Q., Law, A.C., Rajagopal, J., Anderson, W.J., Gray, P.A. and Melton, D.A. (2007) 
A multipotent progenitor domain guides pancreatic organogenesis. Dev Cell, 13, 
103-114. 
Zimmerman, L.B., De Jesus-Escobar, J.M. and Harland, R.M. (1996) The Spemann 
organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell, 
86, 599-606. 




Zorn, A.M., Butler, K. and Gurdon, J.B. (1999) Anterior endomesoderm specification in 
Xenopus by Wnt/beta-catenin and TGF-beta signalling pathways. Dev Biol, 209, 
282-297. 
Zorn, A.M. and Wells, J.M. (2009) Vertebrate endoderm development and organ formation. 













6.1 Formation of pancreatic organoids that recapitulate the in vivo 




























Fig. 6.1 Detection of endodermal, mesodermal and neuro-ectodermal marker 
genes 
Nanostring analysis and RT-PCR results for whole embryos (embryo, E), Vegt/Noggin/RA-
programed explants (pancreatic organoids, PO), Vegt/Noggin/Cyp26a1-programed 
explants (ØRA) and un-programed explants (C) are shown. Diagrams indicate the mean of 
normalized Nanostring counts from two independent experiments. Figures on the right 































Fig. 6.2 Detection of marker genes for pancreatic structures 
Nanostring analysis and RT-PCR results for whole embryos (embryo, E), Vegt/Noggin/RA-
programed explants (pancreatic organoids, PO), Vegt/Noggin/Cyp26a1-programed explants 
(ØRA) and un-programed explants (C) are shown. Diagrams indicate the mean of 
normalized Nanostring counts from two independent experiments. Figures on the right and at 
the bottom show RT-PCR results for indicated marker genes.  
 
 
Fig. 6.2 Detection of marker genes for pancreatic structures 
Nanostring analysis and RT-PCR results for whole embryos (embryo, E), Vegt/Noggin/RA-
programed exp ants (pancreatic organoids, PO), Vegt/N ggin/Cyp26a1-pro ramed explants 
(ØRA) and un-programed explants (C) are shown. Diagrams indicate the mean of 
normalize  Nanostring counts from two independent experiments. Figur s on the right and at 
the bottom show RT-PCR re ults for indicated marker genes.
 





































Fig. 6.3 Detection of early direct and indirect RA-target genes by RNA-
sequencing 
(A) Vegt (500pg), noggin (500pg) and cyp26a1 (2000pg) RNAs were co-injected into the 
animal pole of a two-cell stage embryo. Blastocoel roof tissue was explanted at blastula 
stage. Explants were treated with 5µM RA and cycloheximide (CHX) at the equivalent of 
gastrula stage. One and two hours after RA addition, total RNA was isolated and analyzed 
by RNA-sequencing. (B) Number of detected genes and mapped reads for each sample (a 
and b indicate two independent experiments) are shown. (C) Fold changes are shown for 
differentially expressed genes in RA-treated versus untreated pancreatic organoids. Tables 
are shown indicating all targets (absence of CHX) and putative direct targets (presence of 
CHX). (D) Comparison of differentially expressed genes in the presence versus absence of 






































Fig. 6.4  Confirmation of RA-responsiveness 
(A) RA-inducibility was analyzed using two different experimental approaches. Ectodermal 
explants from vegt/nog/cyp26a1-injected embryos or whole embryos were treated with RA for 
one hour or left untreated. Candidate gene expression was analyzed by the use of 
quantitative Nanostring analysis for the time points indicated in red.  
(B) RA-dependency was determined by the use of two different concepts. Embryos were 
injected with RNAs encoding Cyp26a1 (2000 pg) and GFP (200 pg) into the two dorsal 
blastomers of a four-cell stage embryo. At stage 10, dorsal GFP-positive embryos were 
selected. At stage 11 the tissue sourrounding the dorsal blastopore lip (red dotted line = 
dorsal part) was resected and again verified for a GFP signal. In total, 10 dorsal tissues from 
injected and un-injected embryos were analyzed. Additionally, embryos were treated with the 
RA-antagonist BMS453 at stage 9. Five embryos of stages 12 to 14 were analyzed. Numbers 
in front of the tables indicate confirmed candidates. The tables show number of genes and 
their level of induction or reduction for the individual approaches analyzed by Nanostring. 
 





































Fig. 6.5  Expression of RA-responsive genes at gastrula stage by WMISH  
Expression pattern of the 22 confirmed RA-responsive genes at gastrula stage 11 by WMISH. On 
the left side, whole embryos (dorsal side up) and on right side bisected embryos (dorsal side right) 
are shown. Candidates were grouped according to their expression domains in four groups. Hnf1b 
and Fzd4 exhibit an endodermal expression. Cebpd, Dhrs3, Fst and Lhx1 are expressed in the 
dorsal internal involuting mesoderm. Znf703, Foxh1, Meis3, Hoxb1, Prph, Igf3, Nkx6.2, Xl.45046, 
Xl.51509, Xl.47239 and Xl.57926 are expressed in the outer involuting mesoderm. Cyp26a1, 
Hoxd4, Gbx2.1, Hoxa1-b and Hoxd1 are expressed in both, prospective neuro-ectoderm and 






































Fig. 6.6  Expression characteristics of endodermal, mesodermal and ectodermal 
markers at gastrula stage by Nanostring analysis  
(A) Four-cell stage embryos were injected with RNA coding for GFP into the two dorsal 
blastomeres. At stage 10, embryos with a GFP signal at the dorsal site were selected for further 
cultivation. At stage 11, either dorsal and ventral endoderm was isolated or the whole tissue 
surrounding the dorsal blastoporus lip and the corresponding ventral tissue were isolated. (B) 
Graphs show Nanostring counts for endodermal, mesodermal and ectodermal marker genes for 
the different preparations of two independent experiments. CE = control embryo, DE = dorsal 
endoderm, VE = ventral endoderm, D = dorsal part, V = ventral part 
 

































Fig. 6.7 Expression characteristics of RA-responsive genes at gastrula stage 
by Nanostring analysis 
Samples were prepared like described in Fig. 6.6. The 22 RA-responsive genes were 
grouped according to a dorsal (A) or ventral enrichment (B) in the different preparations or 
for their equal distribution (C). Graphs indicate Nanostring counts for two independent 
experiments. Error bars indicate the SEM. DE=dorsal endoderm; VE= ventral endoderm; 




































Fig. 6.8 RA-responsive expression of Hnf1b in the dorsal endoderm 
(A) Expression pattern of Hnf1b during embryogenesis. WMISH against Hnf1b in embryos at 
gastrula stage (stage 11), neurula stage (stage 18) and at stages 23 to 39 are shown. (B) Enrichment 
of Hnf1b in the dorsal part. The tissue surrounding the dorsal blastopore lip and the corresponding 
ventral half were isolated from 10 gastrula stage embryos. Hnf1b transcripts were detected by RT-
PCR and Nanostring analysis and were compared to the levels in whole embryos. Cerberus (Cer1) 
was used as dorsal anterior marker and bmp4 as ventral marker. E = whole embryo, D = dorsal tissue, 
V = ventral tissue (C) The expression domain of Hnf1b in the dorsal endoderm during 
gastrulation is RA-responsive. WMISH of untreated, RA-treated and cyp26a1(2000pg)/glb1(200pg)-
injected gastrula stage embryos stained with X-Gal. (D) Quantitative analysis of Hnf1b RA-
responsiveness in whole embryos at stages 11, 12 and 13 (five embryos each)  treated with RA or 
BMS453.  dorsal blastopore lip = dbl, neuroectoderm = ne, archenteron roof = ar, prospective foregut 
= fg, pronephros = pn, liver primordium = lp, proctodeum = pd 
 




































Fig. 6.9 Knockdown of Hnf1b through loss of exon 2 
(A) Hnf1b-morpholino (Hnf1b-mo) targets the intron1/exon2 boundary (E1/E2) in Hnf1b pre-
mRNA. Conventional splicing is prevented and exon 2 is retained. This leads to a shortened 
open reading frame (ORF) in the Hnf1b mRNA. A shortened Hnf1b protein is translated that 
lacks functional DNA-binding domains (POUs and POUh) and the transactivation domain. 
(B) Functionality of the Hnf1b-morpholino was tested. The Hnf1b-morpholino (55ng) or the 
control-morpholino (55ng) (ctr-mo) were co-injected with vegt and noggin RNA into two-cell 
stage embryos. At blastula stage, blastocoel roof tissue was explanted, cultivated and 
treated with RA at the equivalent of gastrula stage. At the equivalent of stage 18, total RNA 
was isolated and subjected to RT-PCR. (C) RT-PCR result with amplified Hnf1b cDNA using 
the oligonucleotides that bind to exon 1 and exon3 (indicated as arrows in (A)). Hnf1b 
amplicon is shifted to smaller size in the presence of the Hnf1b-morpholino, indicating the 


























Fig. 6.10 Fzd4 has an alternative splice variant Fzd4s 
The Fzd4 gene consists of two exons and one large intronic region. Conventional splicing 
results in the loss of the intron and a protein is generated containing a small extracellular 
cysteine-rich domain (CRD), a seven transmembrane domain (TM) and an intracellular 
domain (ICD) (Shi and Boucaut, 2000). Through alternative splicing, the intron sequence is 
retained. Thereby, a premature stop codon in the intron is used resulting in a shortened 
open reading frame. The alternative splice variant Fzd4s gives rise to a secreted protein 
containing the Wnt-ligand binding cysteine-rich domain (Swain et al., 2005).  
 





































Fig. 6.11 Fzd4/Fzd4s expression analysis 
(A) WMISH using an antisense probe that targets transcripts of both splice variants, Fzd4 and Fzd4s. 
(B) WMISH with an antisense probe that specifically targets the alternative splice variant Fzd4s. 
Embryos at indicated developmental stages were used. (C) Gastrula stage embryos were used for 
preparations of the tissue surrounding the dorsal blastopore lip and the corresponding ventral part. 
RT-PCR for Fzd4 and Fzd4s using the indicated oligonucleotides is shown. Cerberus (Cer1) was used 
as dorsal anterior marker and bmp4 as ventral marker. Nanostring analysis was done to quantify the 
dorsal enrichment of Fzd4/Fzd4s.  
E = whole embryo, D = dorsal tissue, V = ventral tissue, dorsal blastopore lip = dbl, lateral plate 






































Fig. 6.12 RA-responsive expression of Fzd4/Fzd4s 
(A) WMISH against Fzd4/Fzd4s during gastrulation in untreated, RA-treated and cyp26a1-
injected embryos. Upper images show whole embryos (dorsal side up) and lower images 
show bisected embryos (dorsal side right). (B) Nanostring analysis of untreated, RA- and 
BMS-treated embryos. Indicated is the number of counts for Fzd4/Fzd4s transcripts in 
embryos at stages 12, 13 and 14.  

































Fig. 6.13 Mutation analysis of CRISPR/Cas-treated pancreatic organoids by 
DNA sequencing  
The Fzd4-gRNA target sequence is yellow highlighted and number of deleted nucleotides is 
indicated. 
(A) Cloned Fzd4 amplicons from Cas9 only or Cas9 with Fzd4-gRNA treated pancreatic 
organoids aligned to genomic Fzd4 X.leavis sequence. (B) Cloned Kremen2 amplicons from 
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nkx2-1 188 1 27 54 238 1 23 32 328 1 1 50 242 1 1 260 248 13 1 20 243 1 1 51 256 1 1 1 284 2 1 7 539 1 19 1 336 1 1 1
nkx2-2 57 1 26 8 105 1 164 1 104 1 3 13 72 1 1 97 93 1 22 39 74 3 23 1 119 1 44 1 99 3 26 32 124 7 33 1 68 1 1 27
nkx6-1 31 20 95 57 100 90 47 37 105 179 69 100 73 107 1 138 173 121 41 112 50 30 18 109 56 184 21 18 68 258 64 50 206 121 81 61 99 100 30 82
nog 336 124 17428 19057 847 544 14286 18473 729 461 12818 10726 632 49 13341 10565 1065 104 7962 7707 2834 661 18990 20059 3461 5413 9138 6861 2865 3558 8739 8636 5200 773 8824 12187 3998 1325 4149 9596
odc1 27375 27368 27383 27380 27377 27369 27372 27369 27369 27342 27359 27373 27364 27347 27328 27348 27370 27376 27360 27374 27368 27385 27368 27375 27353 27385 27369 27370 27338 27387 27363 27382 27363 27382 27371 27344 27313 27366 27372 27358
onecut 213 4 254 73 405 1 117 69 339 1 388 423 354 1 7 539 277 1 58 144 290 78 1 2 472 14 174 31 518 19 236 157 439 8 443 192 222 9 118 164
pax6-b 733 1 651 264 952 1 241 132 866 1 474 727 702 1 279 375 740 3 233 281 934 39 802 196 616 1 266 143 894 13 607 138 1337 14 516 93 744 22 110 72
pdia 1 1 4 1 1 1 1 1 1 1 119 1 1 1 1934 1 1485 50 29570 1 128 387 130 283 333 1298 271 194 301 2018 427 253 541 1506 6101 239 2779 1464 14034 258
pdx1 1 1 2 1 1 1 208 1 88 1 2156 1 138 1 2789 1 168 7 1336 1 1 1 1 1 1 1 1202 1 43 16 2943 9 96 1 1872 1 58 1 585 1
ptf1a-a/b 4 32 16 7 35 87 94 11 168 177 1856 57 196 90 3730 1 289 168 2628 21 34 33 12 22 16 47 585 1 212 77 2658 16 381 31 3432 1 270 51 1791 1
sftpc 1 51 72 34 33 192 22 13 21 171 23 18 23 129 1 1 5789 198 46 66 1 21 1 1 1 51 1 1 1 30 1 1 176 46 7 1 6734 55 1 1
sox1 105 1 45 39 274 1 69 44 233 1 53 284 138 1 1 347 130 17 1 94 62 79 1 30 80 237 26 10 94 387 56 36 133 191 57 12 82 163 31 28
sox17a-a 866 1 353 282 831 1 15 174 169 1 117 47 88 1 138 58 148 1 204 83 566 1 372 1569 227 15 40 108 6 10 90 52 70 1 178 15 1 0 136 9
sox17b 437 1 26 27 170 1 1 1 5 1 1 1 1 1 1 1 1 1 1 1 312 1 15 212 60 1 1 1 1 1 1 1 1 1 5 1 1 1 1 1
sox2 1699 92 2898 2475 3151 123 1258 1766 2544 37 2474 4705 2108 33 1613 5218 2606 640 1616 4368 2172 247 979 3198 2536 364 1087 2309 2047 354 1576 2672 3197 312 3210 5233 3164 640 2296 3841
sox3 2216 363 1571 1171 2608 114 308 944 1254 141 467 1561 862 151 67 1130 710 161 80 633 2947 1067 380 2628 1986 241 188 595 1253 197 439 411 1399 141 301 494 974 484 54 344
sst 347 1 1037 737 1865 51 3549 4943 1282 627 2832 4214 1352 450 2090 2512 2174 111 1041 1587 447 43 363 283 1542 222 3538 4417 1189 1383 3602 6386 1600 467 1221 833 2762 568 1187 748
t-a/b 895 9 632 1489 360 33 330 289 106 8 150 190 82 1 62 101 47 57 87 143 1521 34 403 840 424 143 189 311 131 163 163 195 17 66 158 95 1 88 72 60
tm4sf3 1 4 20 13 31 69 6 2 26 141 1 1 2 26 1 1 2461 74 2577 6 1 8 1 1 1 1 1 1 1 2 1 1 41 1 162 1 1153 1 4233 1
ventx2.1-b 832 6859 225 862 1243 2046 122 162 248 258 1 40 89 1 1 1 1 1 3 20 1939 4827 190 2189 848 1352 23 312 333 391 9 219 9 8 13 110 1 21 1 188
A B
43393224174339322417
Tab. 6.1 Normalized data of two independent experiments  
(Indicated are the Nanostring counts from two independent experiments (A and B) which were normalized to the internal positive controls and Odc and with 
substracted mean of the negative controls as described in the “Materials and Methods” section). 

























gene CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC
actb 4145 1092 2005 10259 4421 74603 35942 17524 9494 56603 12285 7195 38532 7352 21222 16536 30278 16029 27121 29109
aldh1a2 184 5 11 826 136 11 1 33 121 26 94 12 214 15 503 139 913 16 193 97
amy2a/b 43 139 37 120 72 401 87 54 70 534 76 80 91 259 105 68 155 246 2708 63
chrd 645 24 4468 5189 17 20 366 433 42 32 102 459 65 34 57 201 10 20 23 10
crabp1 15 2 0 0 27 5 6 0 60 13 5 0 42 11 158 6 250 6 12 1
crabp1 1421 2 2128 1054 81 55 72 119 333 24 582 482 241 30 292 1593 315 123 665 484
cyp26a1 76 10 1233 295 131 62 289 237 194 133 293 75 226 21 50 80 179 114 18 57
darmin 553 0 3634 0 2149 0 9756 283 973 1 3962 1488 7808 0 5864 133 2911 1 236 86
dkk1 6 29 54 16 77 58 14 12 90 121 140 59 16 49 282 54 97 368 69 160
foxe1 0 13 0 0 29 6 0 27 26 2 0 101 75 69 1 117 72 54 137 45
foxe3/4 0 6 0 0 29 1 0 106 48 7 0 3 11 9 3 2 7 0 0 90
g6pd 54 43 37 138 16 2 13 25 66 6 31 11 210 227 164 22 275 55 398 299
gapdh 1 54 1472 407 719 135 2899 1350 2295 1234 1430 1807 1816 4383 10004 5905 3000 14631 2091 3931
gata2 329 418 189 25 245 1284 62 49 21 41 31 20 79 131 57 41 14 70 33 14
gata4-a/b 5 0 3 43 83 9 147 14 63 8 164 0 26 4 132 0 118 0 253 0
hes1-a 304 145 170 58 572 192 141 60 280 287 318 19 98 52 448 36 163 82 154 118
hhex 8 82 0 20 96 24 33 37 66 86 61 13 2 45 38 0 83 29 34 11
hoxa1-b 223 368 1 11 6 402 156 9 57 113 161 134 16 54 102 6 21 169 19 51
ins-a 0 1 0 0 1 1 100 0 29 3 669 2 123 0 8426 0 450 0 9593 0
ins-b 0 11 0 3 5 10 197 0 7 19 397 4 89 8 6740 0 499 17 6920 0
isl-1 13 131 30 0 46 78 21 99 84 180 16 29 63 107 36 13 34 79 4 18
neurog3 19 10 3 1 8 43 33 1 17 18 46 2 27 21 16 0 10 40 3 10
nkx2-1 28 0 13 2 9 0 11 15 22 1 0 22 148 0 9 129 44 6 0 9
nkx2-2 9 1 1 3 7 0 60 0 2 1 11 10 26 3 16 48 13 0 11 6
nkx6-1 10 5 39 26 22 47 13 9 18 39 3 25 66 7 40 38 37 11 5 15
nog 1249 268 781 501 1307 2435 2574 5806 1068 1548 2040 1045 2284 362 2258 811 1467 610 1907 945
odc1 3 9 7 2 12 8 1 1 15 22 2 4 0 17 21 2 29 5 6 8
onecut 39 37 127 36 33 7 29 19 89 9 76 133 43 3 218 173 27 4 30 10
pax6-b 100 19 75 34 168 0 13 5 14 6 66 295 317 7 118 141 2 9 62 104
pdia 64 193 63 141 166 648 135 97 150 1009 154 126 270 752 2084 119 647 707 7768 129
pdx1 0 0 1 0 0 0 497 0 23 7 394 4 21 0 458 0 55 3 376 0
ptf1a-a/b 15 0 2 8 10 20 245 5 22 50 401 20 92 29 149 0 10 58 419 10
sftpc 0 15 35 17 16 70 11 6 10 71 11 9 77 41 3 0 472 71 22 33
sox1 22 39 22 5 97 118 22 17 70 193 2 124 3 95 28 168 24 73 15 33
sox17a-a 150 0 10 644 302 7 12 33 82 5 13 3 9 0 20 22 74 0 34 37
sox17b 63 0 5 93 55 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0
sox2 237 78 960 361 308 121 85 271 248 158 449 1016 544 140 799 7 279 0 340 263
sox3 366 352 596 728 311 64 60 174 0 28 14 575 269 5 117 318 132 162 13 144
sst 50 21 337 227 162 86 5 263 47 378 385 1086 124 8 435 839 294 229 73 420
t-a/b 313 12 114 325 32 55 71 11 13 78 7 2 33 33 48 3 23 15 8 41
tm4sf3 0 2 9 6 15 34 3 1 12 70 0 0 19 13 81 0 654 36 828 3
ventx2.1-b 554 1016 17 663 198 347 50 75 42 67 4 90 40 3 6 54 0 10 1 84
17 24 32 39 43
SEM
stage
gene CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC CE ctr VNRA VNC
actb 78108 232034 87323 102341 153310 693579 184311 133190 187636 1057729 190286 142505 235459 667936 146791 130380 226347 649147 161404 184067
aldh1a2 2088 13 270 1161 769 12 63 131 482 40 454 108 982 39 719 265 2103 131 1028 1124
amy2a/b 45 153 98 140 95 496 111 76 84 650 80 92 93 309 106 69 381 370 4300 99
chrd 3489 25 9326 22713 1251 21 1629 2483 260 33 627 1007 161 35 249 363 57 21 47 123
crabp1 16 3 1 1 33 6 14 1 79 14 7 1 278 12 159 7 680 36 13 2
crabp1 5599 36 5065 13005 3273 128 2968 7701 2154 136 2988 4389 2264 65 3064 5215 1452 307 2038 5064
cyp26a1 985 159 3038 633 852 311 832 742 955 337 889 604 799 57 207 169 694 151 58 101
darmin 4785 1 6032 1 20699 1 17162 459 32301 2 14519 1747 21567 1 8050 265 4205 2 307 230
dkk1 316 33 205 119 375 316 1129 176 329 417 1418 190 346 391 1417 217 421 1380 794 449
foxe1 1 25 1 1 38 7 1 28 48 3 1 132 165 70 2 412 365 2179 177 843
foxe3/4 9 7 1 1 92 2 1 107 77 8 1 19 36 10 4 3 8 1 1 91
g6pd 266 360 190 305 405 408 341 248 535 803 385 307 867 943 515 369 1551 3238 1194 977
gapdh 485 169 5928 3112 2568 514 14505 8464 5916 4905 26893 17797 10729 22256 40000 26378 10120 41337 24386 22134
gata2 1668 12246 255 1216 759 3850 206 106 208 1546 158 111 247 485 120 86 151 134 65 73
gata4-a/b 178 1 83 46 243 23 347 15 123 27 661 1 175 5 786 1 212 1 810 1
hes1-a 1227 756 616 1012 1490 958 636 612 744 1524 896 695 824 840 1169 679 678 601 1041 918
hhex 41 425 1 21 185 107 57 50 75 87 157 14 106 46 96 1 99 30 100 20
hoxa1-b 711 2149 1030 141 508 2107 764 233 190 491 630 366 121 342 308 199 40 1309 198 206
ins-a 1 2 1 1 2 2 1886 1 51 4 14459 3 238 1 36320 1 895 1 29702 1
ins-b 1 12 1 4 6 11 1028 1 52 20 10442 5 185 9 29422 1 918 18 22248 1
isl-1 139 529 50 164 222 709 76 202 182 660 110 208 241 317 84 128 235 331 69 128
neurog3 22 35 9 13 48 44 53 12 44 64 69 10 31 22 17 1 11 41 4 11
nkx2-1 215 1 14 53 247 1 12 16 306 2 1 29 390 1 10 130 292 7 1 10
nkx2-2 66 2 24 4 112 1 104 1 101 2 15 23 98 4 17 49 81 1 12 33
nkx6-1 40 25 57 83 78 137 34 27 86 219 66 75 139 114 41 100 136 110 35 97
nog 1585 392 18209 19558 2154 2978 11712 12667 1797 2010 10778 9681 2916 411 11083 11376 2532 714 6056 8651
odc1 27372 27377 27375 27377 27365 27377 27371 27370 27353 27365 27361 27378 27364 27365 27350 27346 27342 27371 27366 27366
onecut 252 41 128 38 438 8 145 50 429 10 312 290 396 4 225 366 250 5 88 154
pax6-b 833 20 727 230 784 1 254 137 880 7 541 432 1019 8 398 234 742 13 171 177
pdia 65 194 67 142 167 649 136 98 151 1010 273 127 271 753 4018 120 2132 757 21802 130
pdx1 1 1 2 1 1 1 705 1 65 8 2549 5 117 1 2331 1 113 4 960 1
ptf1a-a/b 19 32 14 14 25 67 340 6 190 127 2257 37 288 60 3581 1 279 109 2210 11
sftpc 1 36 36 18 17 122 12 7 11 100 12 9 99 88 4 1 6262 126 23 34
sox1 84 40 23 35 177 119 48 27 163 194 54 160 135 96 29 180 106 90 16 61
sox17a-a 716 1 362 925 529 8 28 141 88 6 104 50 79 1 158 37 75 1 170 46
sox17b 375 1 20 119 115 1 1 1 3 1 1 1 1 1 3 1 1 1 1 1
sox2 1935 169 1939 2836 2843 243 1172 2038 2296 196 2025 3688 2652 173 2411 5225 2885 640 1956 4104
sox3 2582 715 976 1899 2297 178 248 770 1254 169 453 986 1130 146 184 812 842 322 67 488
sst 397 22 700 510 1704 137 3543 4680 1236 1005 3217 5300 1476 458 1656 1672 2468 339 1114 1167
t-a/b 1208 22 517 1164 392 88 260 300 118 85 157 193 49 34 110 98 24 72 80 101
tm4sf3 1 6 10 7 16 35 4 2 13 71 1 1 21 14 82 1 1807 37 3405 4
ventx2.1-b 1386 5843 208 1526 1045 1699 72 237 290 325 5 129 49 4 7 55 1 11 2 104
17 24 32 39 43
mean
Tab. 6.2 Calculated mean and standard error of mean (SEM)  
(Mean and SEM were calculated from the normalized Nanostring counts of two independent experiments) 
CE = control embryo; ctr = control explants; VNRA = Vegt/Noggin/RA-programed explants (pancreatic organoids); VNC = Vegt/Noggin/cyp26a1-programed 
explants 





































gene FC gene FC gene FC gene FC
hoxb1 6.79 hoxa1 16.62 / 26.39 mesp2* 27.90 Xl.80298* 2.60
Xl.32109 2.32 hoxa2 15.43 /21.88 Xl.8753 16.22 Xetrov72036339* 2.57
olig4* 2.20 dusp6 5.75 / 8.51 mespa 15.57 Xetrov72039973* 2.55
Xl.59256 2.19 Xl.9874 5.04 / 7.31 hoxa3 13.07 gadd45a† 2.52
Xl.9822 -2.16 Xl.67202 4.85 / 5.63 cebpd 7.04 stox1 2.50
sp9* -3.14 dhrs3 4.36 / 7.23 s1pr5* 6.74 fzd4 2.50
znf703 3.94 / 7.73 hoxb4 6.51 hoxa4* 2.50
hoxa5 3.85 / 7.26 cyp26a1 6.27 Xl.68408 2.48
bhlhe40 3.77 / 4.97 nodal1 5.84 dusp5 2.40
hoxd1 3.75 / 5.36 sox9 5.12 Xl.80297 2.40
neurog2 3.46 / 4.13 Xl.82687* 5.11 tril* 2.39
cxcr7 2.81 / 3.57 prph 4.70 Xl.57926 2.36
rgs2 2.81 / 4.33 nkx6-2 4.39 erf 2.32
cdx4 2.72 / 2.62 Xl.45046 4.38 Xl.70850 2.31
Xl.15091 2.68 / 12.58 mespb 4.23 lhx1 2.27
Xl.71159 2.42 / 2.72 nr2f5 4.20 hoxd4 2.25
hnf1b 2.37 / 5.55 trib1 4.08 fhdc1* 2.25
Xl.58101 2.35 / 3.69 Xl.84363* 3.84 rgs14 2.22
fgf16 † 2.32 / 2.68 fst 3.83 kirrel2 2.16
txnip 2.22 / 2.83 c10orf140 3.59 pim1 2.16
Xl.4906 2.21 / 3.09 Xetrov72011149† 3.55 dact1 2.15
Xl.51509 3.53 Xl.47239 2.14
Xl.6091 3.47 rara 2.12
hunk 3.06 pkdcc.1 2.10
tmem72 3.00 mxi1 2.07
Xl.16263 2.85 cass4 2.06
nodal2 2.81 Xl.79790 2.06
foxh1 2.78 Xl.82247* 2.04
kiaa0182 2.76 fgfr4 2.03
meis3 2.74 slc38a8* 2.03
znf503* 2.72 hey1 2.02
myc 2.70 hoxb3 2.02
igf3 2.70 mn1* 2.02
Xl.74263 2.68 spry2 2.02
tdgf1p2 2.66 Xl.85251 -2.08
gbx2.1 2.65 Xl.13572* -2.09
Xl.57027 2.60 twist1 -2.26
pdgfb -3.02
1h (6) 1 and 2h (21) 2h (75)
Tab. 6.3 Summary of 102 differentially expressed genes in the absence of CHX. 
Fold changes of indicated genes in explants 1h and 2h after RA addition (-RA versus + RA; Ø 
CHX) 
* no sequence known for X.laevis  






































gene FC symbol FC symbol FC
hoxa1 11.94 / 28.34 hoxa3 24.89 Xl.29118 3.26
hoxa2 6.47 / 14.11 hoxb4 12.79 foxh1 3.07
Xl.9874 4.62 / 4.61 foxi4.2 10.73 Xl.58101 3.02
Xl.15091 3.98 / 3.93 hoxb1 9.61 Xl.6091 2.93
dusp6 3.82 / 4.92 Xl.78389 9.49 klb 2.86
nkx6-2 3.20 / 3.26 Xl.67202 6.59 hoxd4 2.81
dhrs3 2.91 / 4.74 cyp26c1 6.58 olig4 2.75
hoxa5 2.89 / 8.13 znf703 6.53 hoxb8 2.68
rgs2 2.18 / 3.23 cyp26a1 5.64 Xl.84363 2.58
bhlhe40 2.05 / 4.24 s1pr5 5.59 hoxb3 2.55
Xl.82687 5.54 hoxa4 2.45
sox9 5.06 Xl.13431 2.43
Xl.45046 4.76 rara 2.31
trib1 4.69 myc 2.30
hoxd1 4.66 igf3 2.30
cebpd 4.48 nr2f5 2.28
hnf1b 4.21 edn1 2.24
gbx2.2 4.06 hunk 2.22
hoxc4 3.93 Xl.79790 2.20
Xl.51509 3.93 Xl.41047 2.15
tmem72 3.90 meis3 2.14
gata3 3.87 kiaa0182 2.12
neurog2 3.56 tril 2.07
c10orf140 3.52 Xl.74263 2.05
gbx2.1 3.46 fzd4 1.90
twist1 -2.14
1 and 2h (10) 2h (51)
Tab. 6.4 Summary of differentially expressed genes in the presence of CHX 
Fold changes of indicated genes in explants 1h and 2h after RA addition (-RA versus + RA; 
+ CHX) 





































 - CHX only            
(53)
 + CHX only            
(12)
 - CHX and + CHX                  























































Tab. 6.5 Comparison of differentially expressed genes absence versus 









































homeodomain transcription factor Xl.23512,Xl.283 4.05 0.00% 38 31 699 499
2 hoxa2 CU025162 homeodomain transcription factor Xl.12098,Xl.751 3.95 0.00% 8 7 157 103







2.52 0.00% 669 562 4471 2737
5 Xl.9874 Xl.9874 2.33 0.00% 10 28 69 123





















basic helix-loop-helix (bHLH) 
transcription factor, circadian regulator







1.91 0.40% 813 398 2970 1553
12 neurog2 XM_002934243


















homeodomain transcription factor Xl.26888 1.44 0.05% 1728 866 5059 2168
16 Xl.15091 Xl.15091 1.42 0.53% 26 29 80 69




homeodomain transcription factor Xl.65135,Xl.12667 1.25 0.01% 454 490 1010 1230
19 Xl.58101 Xl.58101 1.23 0.13% 117 127 210 381
20 Xl.32109 Xl.32109 1.21 0.11% 86 74 200 174






1.15 2.96% 155 102 388 194




transcription factor Xl.72230 1.14 0.84% 33 42 73 95
25 Xl.59256 Xl.59256 1.13 1.45% 51 46 107 108




-1.65 0.14% 64 58 28 10
no.
- RA + RA
symbol accession number gene function UnigeneID_XL log2FC +RA/-RA FDR
Tab. 6.6 RNA-sequencing of explants 1h after RA addition in the absence of CHX. 
Normalized data (1h Ø CHX).   
Genes with > 60 mapped reads in samples with RA. 
 
























A B A B










Xl.12098,Xl.751 4.45 0.00% 18 9 334 276










Xl.9439 3.71 0.00% 18 6 153 173















2.95 0.00% 1013 263 4168 4062





























zerknullt and related 
Xl.54392,Xl.49715,
Xl.72333











factor beta and bone 
Xl.1037,Xl.85704 2.55 0.04% 21 35 240 75






















2.36 0.00% 51 29 157 270
















Xl.55860,Xl.49827 2.13 0.00% 111 203 419 1028










transcription factor Xl.51050,Xl.81675 2.08 4.27% 583 240 4138 453
29 nr2f5 XM_002938463 hormone receptor
Xl.1157,Xl.13423,Xl
.81917,Xl.83500






2.05 0.04% 35 8 102 62
31 trib1 XM_002938661 Xl.75411,Xl.81850 2.03 0.88% 13 16 46 83
no.
- RA + RA
FDRsymbol accession gene function UnigeneID_XL log2FC +RA/-RA
Tab. 6.7 RNA-sequencing of explants 2h after RA addition in the absence of CHX. 
Normalized data (2h Ø CHX).   




A B A B








1.94 3.02% 131 974 1323 1718














1.83 0.00% 28 29 94 111
38 Xl.51509 Xl.51509 1.82 0.11% 35 17 90 87
39 Xl.6091 Xl.6091 1.80 0.00% 32 21 109 81










Xl.17444 1.59 0.10% 38 24 97 87






1.50 0.00% 123 111 470 224
45 nodal2 XM_002932721
transforming growth 
factor beta and bone 




















1.46 0.00% 2458 1457 5909 4590
















1.42 0.00% 289 322 893 746
54 Xl.74263 Xl.74263 1.42 0.01% 153 82 262 339












Xl.26888 1.39 0.03% 2515 1094 6302 3014
58 Xl.57027 Xl.57027 1.38 0.10% 29 34 78 88
















1.33 0.22% 1216 1180 4394 1907
+ RA
no. symbol accession gene function UnigeneID_XL log2FC +RA/-RA FDR
- RA








,Xl.15086 1.32 0.02% 1164 668 1955 2459
64 fzd4 XM_002936543
transmembrane 
receptor in the wnt 




1.32 0.72% 163 85 318 286






Xl.79939,Xl.15374 1.26 0.11% 799 620 1677 1690
68 Xl.80297 Xl.80297 1.26 0.45% 213 316 813 440
69 tril XM_002933390 Xl.73400,Xl.78580 1.26 0.00% 821 401 1596 1160







1.22 2.07% 691 307 961 1174


















1.17 0.07% 897 632 1490 1885



















catenin and c-jun N-
Xl.7602,Xl.19185 1.11 0.05% 3586 2838 8553 5424




















Xl.22909 1.04 0.51% 258 324 507 700
85 Xl.79790 Xl.79790 1.04 2.54% 29 38 41 103



































regulation of signal 
transduction
Xl.11964,Xl.11965 1.01 0.99% 1781 1675 3743 3226
93 Xl.85251 Xl.85251 -1.06 0.75% 85 80 43 35







-1.17 1.23% 217 260 101 108
96 pdgfb XM_002933750 growth factor Xl.14185,Xl.13630 -1.59 0.00% 218 252 102 61
no. FDR
- RA + RA











































































transcription factor Xl.23512,Xl.283 3.58 0.00% 65 17 307 602
2 hoxa2 CU025162
homeodomain 
transcription factor Xl.12098,Xl.751 2.69 0.00% 21 6 70 108
3 Xl.9874 Xl.9874 2.21 0.00% 24 29 98 159
































helix (bHLH) Xl.19778,Xl.26256 1.04 4.91% 114 47 191 131
- RA +CHX + RA +CHX 
FDRno. symbol accession gene function UnigeneID_XL log2FC +RA/-RA
Tab. 6.8 RNA-sequencing of explants 1h after RA addition in the presence of CHX. 
Normalized data (1h + CHX). 
Genes with > 60 mapped reads in samples with RA. 


























































zerknullt and related 
Xl.54392,Xl.4971
5,Xl.72333










Xl.85422 3.27 0.00% 11 12 130 102
7 Xl.78389 Xl.78389 3.25 4.90% 61 10 271 245






Xl.58357 3.02 0.00% 29 43 209 403
10 Xl.67202 Xl.67202 2.72 0.01% 26 58 220 338
11 cyp26c1 XM_002939091 electron transport
Xl.82105,Xl.1946
,Xl.41946

















Xl.75787,Xl.9971 2.48 0.25% 83 129 532 657
















2.30 0.00% 1363 1003 5859 5629


















2.22 0.01% 744 614 3612 2775


































Xl.69442 1.97 0.25% 29 21 89 110








zinc finger transcription 
factor
Xl.28002 1.95 4.90% 186 73 389 471
FDR
-RA +CHX +RA +CHX
no. symbol accession gene function UnigeneID_XL log2FC +RA/-RA
Tab. 6.9 RNA-sequencing of explants 2h after RA addition in the presence of 
CHX. Normalized data (2h + CHX) 































1.71 0.00% 249 281 580 1333












Xl.381 1.62 0.17% 85 80 201 316
38 Xl.58101 Xl.58101 1.59 0.00% 101 109 283 358
39 Xl.6091 Xl.6091 1.55 0.01% 35 26 90 91
















Xl.79158,Xl.9701 1.42 0.13% 39 17 105 49












1.29 1.70% 156 97 232 360
















1.20 0.18% 54 32 108 91
51 nr2f5 XM_002938463 hormone receptor
Xl.1157,Xl.13423
,Xl.81917,Xl.835














1.15 0.03% 649 566 1215 1468
54 Xl.79790 Xl.79790 1.14 0.80% 22 49 55 102


















1.05 0.16% 895 413 1695 941
59 Xl.74263 Xl.74263 1.04 4.90% 136 89 242 216
61 fzd4 XM_002936543
transmembrane 
receptor in the wnt 







-1.10 4.50% 261 222 82 155
-RA +CHX +RA +CHXlog2FC 




































6.7 Nanostring analysis data for the verification of RA-responsiveness 


































1h 2h st.12 st.13 st.14 st.11 st.12 st.13 st.14
1 • bhlhe40 2.05 4.01 4.72 3.24 3.78 / / / /
2 • c10orf140 / / / / / 1.00 / / /
3 cass4 0.64 1.49 1.17 1.54 1.61 0.91 1.19 1.09 1.09
4 cdx4 1.45 2.09 1.26 1.24 1.00 1.15 1.14 1.25 1.19
5 • cebpd 1.44 18.71 3.35 7.92 7.14 2.05 0.96 0.82 1.33
6 cxcr7 1.54 1.69 / / / 1.23 0.96 1.04 0.95
7 • cyp26a1 4.39 14.23 6.70 13.96 14.19 2.29 1.81 1.44 1.53
8 dact1-a/b 0.89 1.51 1.82 1.89 1.74 1.07 1.08 1.01 1.28
9 • dhrs3 5.87 8.86 4.13 7.43 7.80 2.76 1.78 1.56 2.05
10 dusp5 0.91 2.28 1.96 2.42 2.29 1.20 1.49 1.31 1.31
11 • dusp6 2.86 5.39 3.55 4.47 4.43 1.31 1.05 1.27 0.99
12 erf 0.62 1.50 1.23 1.90 1.71 0.97 1.09 1.06 1.30
13 fgfr4-a/b 1.03 1.40 1.09 1.00 0.89 0.99 0.94 0.99 1.05
14 • foxh1 0.65 2.49 1.42 1.56 1.49 1.02 1.32 1.72 1.41
15 fst 1.59 1.73 1.75 2.57 2.91 2.44 1.91 1.13 1.52
16 • fzd4 1.27 2.26 1.92 2.87 2.51 0.90 1.43 1.61 1.90
17 • gbx2.1 2.21 4.56 2.07 2.92 2.99 1.45 1.76 1.74 1.64
18 hey1 1.06 1.57 0.92 1.30 1.41 1.48 1.11 1.20 1.25
19 • hnf1b 1.95 3.00 2.47 4.09 3.21 1.08 1.71 2.51 3.11
20 • hoxa1-b 9.53 44.33 3.27 4.21 4.33 4.24 2.66 3.42 7.32
21 • hoxa2 / / 0.98 1.82 1.26 / / / /
22 • hoxa3 / / 108.71 9.31 10.49 / / / /
23 • hoxa5 / / / / / / / / /
24 • hoxb1 9.81 21.42 2.56 2.69 2.31 / 1.81 2.31 1.62
25 • hoxb3 / / 25.56 5.85 5.01 / / / /
26 • hoxb4 0.85 2.23 2.46 2.64 3.43 0.83 0.93 1.37 1.37
27 • hoxd1 2.54 6.94 1.75 1.97 2.09 1.17 1.39 1.54 1.70
28 • hoxd4 2.33 41.83 6.07 4.26 4.46 1.43 1.22 1.66 0.81
29 • hunk 0.77 2.64 2.02 2.25 2.11 1.00 1.26 1.31 1.31
30 • igf3 3.45 3.38 1.92 2.29 2.61 1.69 1.53 1.41 0.88
31 • kiaa0182 0.47 2.04 1.07 1.56 1.85 1.01 1.30 1.31 1.12
32 kirrel2 0.66 1.87 1.41 1.22 1.21 1.39 1.09 1.17 1.23
33 lhx1 0.98 2.42 4.00 3.96 4.43 1.34 1.16 1.51 1.53
34 • meis-a 1.35 2.59 1.96 2.58 2.72 1.39 1.74 1.56 1.41
35 mespa 2.86 7.19 1.73 2.19 1.35 1.39 / / /
36 mespb 3.53 2.51 1.02 1.26 1.05 1.04 0.96 0.81 1.09
37 mxi1 0.91 3.05 2.08 2.05 1.97 1.18 1.54 1.19 1.45
38 • myc-a/b 0.60 1.99 1.19 1.30 1.26 / 1.14 1.56 1.22
39 • neurog2 / / 1.02 0.88 0.99 1.65 1.21 0.93 1.11
40 • nkx6-2 1.52 4.32 2.49 2.38 3.48 2.09 1.84 1.37 1.07
41 nodal1 1.21 1.75 / / / 1.39 / / /
whole embryo
RA-inducibility                                                                                                      
fold induction +RA/-RA
RA-dependency                                                                          
fold reduction +RA/-RA
no. direct gene
 pancreatic organoids  whole embryo
Tab. 6.10 Overview of Nanostring analysis results. 
Indicated is the fold induction upon activation of RA-signaling and fold reduction upon 





1h 2h st.12 st.13 st.14 st.11 st.12 st.13 st.14
42 nodal2 1.07 1.36 / / / 0.86 / / /
43 • nr2f5 / / / 4.38 3.97 0.93 / / /
44 pdgfb 0.71 1.24 3.87 1.23 1.76 1.22 / / /
45 pim1 1.23 1.76 1.33 1.96 1.59 1.33 1.14 1.31 1.20
46 pkdcc.1 1.02 1.05 1.32 1.16 1.23 1.07 0.97 1.05 1.44
47 prph / 31.75 4.68 5.07 3.60 / 2.85 2.39 1.63
48 • rara / / 1.89 2.05 2.02 1.06 1.60 1.18 1.40
49 rgs14 2.40 4.24 / / / / / / /
50 • rgs2 1.93 4.71 2.43 1.73 1.68 1.40 1.07 1.11 1.08
51 • sox9 1.60 6.45 2.96 2.21 2.40 0.84 1.15 1.44 0.87
52 spry2 1.31 1.61 1.34 1.48 1.55 0.90 0.96 0.95 1.03
53 stox1 0.81 1.04 0.92 1.13 0.95 0.87 1.18 0.93 1.15
54 tdgf1p2-a/b / / / / / / / / /
55 • tmem72 2.74 5.25 1.77 2.50 1.69 1.46 1.15 1.33 1.49
56 • trib1 0.52 4.58 0.73 1.27 1.00 / 1.10 0.90 1.04
57 • twist1 0.55 0.71 0.77 0.30 0.34 1.52 0.99 0.91 0.75
58 txnip 2.72 7.40 1.37 2.10 1.36 1.14 0.91 1.06 1.25
59 • Xl.15091 / / / / / / / / /
60 Xl.16263 / / / / / / / / /
61 Xl.32109 / / / / / / / / /
62 • Xl.45046 1.27 7.03 1.84 2.27 2.50 1.53 2.02 1.97 1.39
63 Xl.47239 0.91 3.34 1.70 1.71 1.62 1.00 1.41 1.77 0.96
64 Xl.4906 1.11 3.14 1.15 0.99 0.78 0.84 0.97 1.04 1.18
65 • Xl.51509 1.63 30.14 3.88 4.96 4.33 2.23 1.74 1.78 1.90
66 Xl.57027 0.64 14.12 2.72 1.49 1.44 0.76 / / /
67 Xl.57926 0.84 1.99 2.37 2.99 2.91 1.27 1.43 1.53 1.56
68 • Xl.58101 / / / / / / / / /
69 Xl.59256 / / / / / / / / /
70 • Xl.6091 / / / / / 0.75 / / /
71 • Xl.67202 / / / / / / / / /
72 Xl.68408 / / / / / / / / /
73 Xl.70850 / / / / / / / / /
74 Xl.71159 0.70 0.66 0.68 0.51 0.48 0.95 0.79 0.86 0.88
75 • Xl.74263 / / / / / / / / /
76 • Xl.79790 0.97 2.24 2.18 2.07 1.40 / / / /
77 Xl.80297 1.64 1.90 2.08 1.94 1.99 1.23 1.19 1.01 1.00
78 Xl.8753 / / / / / 1.00 / / /
79 Xl.85251 / / / / / 1.00 / / /
80 Xl.9822 0.54 2.23 / / / 2.29 / / /
81 • Xl.9874 / / / / / / / / /
82 • znf703 1.41 8.98 1.94 2.52 2.54 1.37 1.64 1.76 1.55
no. direct gene
RA-inducibility                                                                                                      
fold induction +RA/-RA
RA-dependency                                                                          
fold reduction +RA/-RA







































































/ RA CHX RA / CHX / RA CHX RA / CHX
bhlhe40 23 72 2 81 53 94 48 123
c10orf140 2 7 1 6 6 6 5 9
cass4 251 266 5 345 310 261 386 492
cdx4 429 988 12 1212 780 808 1150 1422
cebpd 40 91 1 51 24 122 28 154
cxcr7 197 487 4 637 339 309 539 677
cyp26a1 460 3225 6 2458 572 4387 599 5018
dact1-a 334 349 5 321 327 247 378 516
dact1-b 1509 2175 41 2537 1822 1511 2206 3092
dhrs3 184 1779 5 1419 317 1496 413 2206
dusp5 796 1165 31 1166 876 1089 1091 1753
dusp6 342 1411 10 1632 463 1342 679 2460
e_Cerberus 8391 14195 241 13089 14634 6226 11690 11101
e_darmin 4 12 1 5 10 10 4 6
e_Sox17alph 2721 3750 91 4838 3950 2018 5675 5995
e_Sox17beta 1512 2351 72 2890 1840 974 3285 3269
e_TGIF2 1048 1219 8 1276 1388 607 1479 1514
e_vpp1 40 46 1 36 55 32 38 36
ec_Sox2 284 463 3 509 195 538 564 882
ec_tubb2b 18 27 1 33 41 23 28 25
ec_xk81a1 468 308 8 110 105 290 104 351
em_BMP2-a/ 426 631 6 519 689 337 471 541
em_BMP4-a/ 1432 2078 37 2404 2363 1291 2235 3053
erf 369 376 14 394 394 319 396 494
fgfr4-a 735 1226 26 1043 917 700 898 1050
fgfr4-b 471 833 18 810 614 487 652 964
foxh1 291 313 5 350 234 308 285 447
fst 240 614 8 958 525 493 482 1494
fzd4 362 741 13 783 444 542 579 1102
gbx2.1 28 91 1 108 39 71 43 190
hey1 92 176 3 146 117 87 122 174
hk_g6pd 261 392 10 385 404 226 337 298
hk_gapdh 177 328 5 243 307 188 263 244
hk_H4 81031 121843 2423 146020 130802 67733 157329 153353
hk_ODC 6783 10937 313 10021 12306 6377 9821 9213
hnf1b 194 603 8 445 413 665 300 905
hoxa1-a 1 25 1 35 1 40 6 66
hoxa1-b 14 127 3 164 14 193 22 407
hoxa2-a 14 33 1 31 22 15 21 29
hoxa3 5 30 1 30 8 52 7 130
hoxa5 2 21 1 20 1 22 3 59
hoxb1 7 32 1 26 12 21 12 44
hoxb3 6 15 1 21 11 26 15 27
hoxb4 35 52 2 65 47 47 49 101
hoxd1 265 1114 12 1386 393 1459 704 2098
hoxd4 2 15 1 18 4 38 7 66
hunk 351 438 6 562 367 520 451 972
igf3 17 75 1 86 42 62 35 119
kiaa0182 311 244 1 212 236 256 247 435
kirrel2 98 119 2 158 109 104 128 221
lhx1 223 356 6 550 241 309 355 879
m_Chordin 14236 20467 597 20254 21964 11183 18640 20494
m_Xbra-a/b 1938 2480 56 3743 3593 1911 4577 3849
m_Xwnt8 1109 1508 33 1488 1577 739 1655 1494
me_ventx2.1 612 1298 40 2482 752 428 3005 4569
meis3-a 333 725 3 729 457 658 489 1127
mespa-a 14 50 1 187 21 38 87 280
gene 1h 2h




/ RA CHX RA / CHX / RA CHX RA / CHX
mespb 76 412 11 1044 236 313 475 1368
mxi1 164 244 1 221 174 276 169 373
myc-a 46 51 1 57 54 50 45 105
myc-b 217 458 6 435 315 537 306 587
ndrg1-a 1 2 1 3 1 1 2 4
ndrg1-b 2 3 1 2 1 1 3 1
neurog2 18 29 1 30 18 45 26 50
nkx6-2 251 613 1 522 254 579 224 945
nodal1 89 160 6 311 107 88 219 500
nodal2 454 788 20 887 510 376 944 968
nr2f5 15 28 1 29 18 21 13 32
pdgfb 32 43 1 41 32 18 44 35
pim1 140 277 6 408 237 222 330 614
pkdcc.1 648 1072 42 1181 930 534 1009 1140
prph 12 14 1 9 7 30 7 18
rara 26 23 1 20 31 36 24 39
rgs14 29 102 1 47 41 71 32 45
rgs2 42 125 1 69 37 68 41 135
sox9-a/b 26 64 1 78 30 67 34 118
spry2 769 1627 27 1854 1316 1172 1807 2027
stox2 318 420 6 398 485 274 366 468
tdgf1p2-a 9 33 1 40 10 18 18 63
tdgf1p2-b 6 10 1 6 7 7 12 23
tmem72 29 115 1 58 39 81 26 75
trib1 30 32 1 40 25 36 32 93
twist1-a 185 163 5 199 241 94 211 146
txnip 27 105 2 133 36 92 116 297
Xl.15091 1 1 1 2 1 1 1 2
Xl.16263 3 2 1 1 2 1 2 2
Xl.32109 4 12 1 10 9 3 12 19
Xl.45046 88 180 4 206 77 246 96 460
Xl.47239 52 80 1 67 48 69 50 93
Xl.4906 306 547 9 700 310 544 690 1161
Xl.51509 18 44 1 50 18 94 23 111
Xl.57027 29 36 1 31 16 31 34 61
Xl.57926 331 451 2 428 372 398 426 783
Xl.58101 4 1 1 1 2 1 1 5
Xl.59256 1 2 1 2 3 1 1 2
Xl.6091 14 21 1 31 22 7 29 22
Xl.67202 2 7 1 3 5 5 1 3
Xl.68408 1 1 1 2 1 1 1 3
Xl.70850 3 5 1 2 4 6 5 12
Xl.71159 567 644 20 1114 829 303 1403 1191
Xl.74263 5 6 1 6 3 1 5 6
Xl.79790 20 34 1 30 25 20 23 48
Xl.80297 233 610 11 816 488 501 695 1084
Xl.85251 1 3 1 2 3 1 6 3
Xl.8753 2 8 1 3 5 5 3 5
Xl.9822 36 38 1 24 33 29 27 41
Xl.9874 5 13 1 10 5 13 8 13
znf703 538 1221 8 1628 430 2069 817 3756
NEG_A 3 1 1 4 3 3 1 1
NEG_B 3 1 1 4 5 3 6 3
NEG_C 3 1 1 1 1 1 1 1
NEG_D 4 4 1 2 4 3 1 1
NEG_E 4 4 1 3 3 3 3 3
NEG_F 7 9 1 16 9 6 11 11
NEG_G 2 1 1 1 1 1 1 1
NEG_H 3 2 1 1 3 1 4 3
POS_A 5323 5854 114 5160 6512 4601 5552 6190
POS_B 1789 2124 32 1839 2227 1663 1784 2095
POS_C 519 637 12 580 713 507 577 700
POS_D 127 151 3 106 126 94 134 162
POS_E 18 21 1 24 27 17 31 26
POS_F 10 14 1 13 14 7 14 17






































































/ RA CHX RA / CHX / RA CHX RA / CHX
bhlhe40 20 43 65 48 28 112 26 91
c10orf140 1 1 32 1 1 2 1 1
cass4 285 183 165 249 206 322 283 393
cdx4 491 703 397 909 532 1011 865 1153
cebpd 40 57 32 25 8 148 11 116
cxcr7 222 342 132 471 226 383 400 544
cyp26a1 527 2313 198 1857 388 5514 445 4095
dact1-a 381 243 165 230 218 305 277 412
dact1-b 1744 1557 1360 1918 1254 1895 1669 2520
dhrs3 207 1272 165 1066 211 1876 304 1795
dusp5 917 830 1028 874 598 1364 820 1424
dusp6 390 1007 331 1229 312 1683 506 2003
e_Cerberus 9728 10209 7997 9952 10130 7828 8889 9071
e_darmin 1 0 32 1 1 7 1 1
e_Sox17alpha 3150 2691 3019 3669 2728 2533 4310 4894
e_Sox17beta 1748 1684 2389 2186 1266 1220 2490 2664
e_TGIF2 1209 869 265 957 953 758 1115 1229
e_vpp1 40 25 32 13 29 34 18 20
ec_Sox2 323 325 99 374 126 671 419 712
ec_tubb2b 14 11 32 11 20 23 11 11
ec_xk81a1 536 213 265 70 64 359 69 277
em_BMP2-a/b 488 446 198 381 469 418 348 433
em_BMP4-a/b 1655 1487 1227 1816 1628 1618 1691 2488
erf 421 262 464 286 264 395 291 394
fgfr4-a 846 874 862 780 627 875 673 849
fgfr4-b 540 591 596 603 417 607 486 779
foxh1 331 217 165 252 153 382 206 356
fst 272 433 265 715 355 614 356 1212
fzd4 413 525 430 582 299 676 430 892
gbx2.1 26 57 32 68 18 83 22 146
hey1 100 118 99 97 72 103 82 133
hk_g6pd 296 274 331 279 271 278 246 234
hk_gapdh 199 228 165 171 204 231 190 190
hk_H4 94003 87697 80412 111161 90615 85220 119763 125437
hk_ODC 7863 7864 10387 7616 8517 8018 7466 7527
hnf1b 218 426 265 325 277 831 218 731
hoxa1-a 1 10 32 13 1 44 1 44
hoxa1-b 10 83 99 111 1 237 6 323
hoxa2-a 10 15 32 10 6 13 5 14
hoxa3 1 13 32 9 1 59 1 97
hoxa5 1 7 32 1 1 22 1 38
hoxb1 1 15 32 6 1 20 1 26
hoxb3 0 2 32 2 1 27 1 12
hoxb4 34 29 65 35 24 53 27 73
hoxd1 301 793 397 1041 264 1830 525 1706
hoxd4 1 2 32 1 1 42 1 44
hunk 401 307 198 414 246 648 333 785
igf3 13 46 32 51 20 72 16 88
kiaa0182 354 167 32 147 155 316 177 346
kirrel2 107 77 65 106 67 125 87 171
lhx1 252 248 198 405 158 383 260 709
gene
1h 2h
Tab. 6.12 Normalized data of RA-inducibility in explants 
Indicated are the Nanostring counts which were normalized to the internal positive controls 
and Odc and with substracted mean of the negative controls as described in the “Materials 




/ RA CHX RA / CHX / RA CHX RA / CHX
m_Chordin 16509 14724 19812 15407 15209 14065 14180 16755
m_Xbra-a/b 2242 1777 1858 2836 2481 2399 3474 3139
m_Xwnt8 1280 1077 1094 1119 1084 924 1249 1212
me_ventx2.1-b 703 926 1327 1876 512 533 2277 3728
meis3-a 380 513 99 541 308 822 362 912
mespa-a 10 28 32 128 6 42 56 219
mespb 82 288 364 781 155 388 351 1109
mxi1 184 167 32 154 112 341 118 295
myc-a 47 28 32 29 29 57 24 76
myc-b 245 321 198 317 209 670 222 470
ndrg1-a 1 1 32 1 1 1 1 1
ndrg1-b 1 1 32 1 1 1 1 1
neurog2 14 12 32 9 4 51 9 31
nkx6-2 285 433 32 383 167 723 160 763
nodal1 97 107 198 223 65 105 156 399
nodal2 520 559 663 661 345 467 708 782
nr2f5 11 12 32 8 4 20 1 16
pdgfb 30 22 32 17 13 17 23 19
pim1 156 191 198 297 155 273 241 493
pkdcc.1 745 763 1393 885 636 666 758 923
prph 7 2 32 1 1 32 1 5
rara 24 8 32 1 13 39 8 22
rgs14 27 65 32 22 20 83 14 27
rgs2 42 82 32 39 17 80 21 101
sox9-a/b 24 38 32 45 12 78 15 87
spry2 886 1163 895 1398 903 1469 1365 1648
stox2 362 294 198 289 327 339 268 373
tdgf1p2-a 4 15 32 16 1 17 3 42
tdgf1p2-b 0 1 32 1 1 3 1 9
tmem72 27 74 32 30 18 96 9 52
trib1 28 15 32 16 9 39 14 66
twist1-a 208 109 165 137 158 112 150 110
txnip 25 67 65 87 16 110 78 233
Xl.15091 1 1 32.19 1 1 1 1 1
Xl.16263 1 1 32 1 1 1 1 1
Xl.32109 1 0 32 1 1 1 1 6
Xl.45046 95 121 132 143 45 304 62 367
Xl.47239 54 49 32 37 25 81 27 66
Xl.4906 348 385 298 519 206 678 515 940
Xl.51509 14 23 32 24 4 112 7 81
Xl.57027 27 17 32 10 2 33 15 40
Xl.57926 377 316 65 312 249 495 314 631
Xl.58101 1 1 32 1 1 1 1 1
Xl.59256 1 1 32 1 1 1 1 1
Xl.6091 10 7 32 10 6 3 11 8
Xl.67202 1 1 32 1 1 0 1 1
Xl.68408 1 1 32 1 1 1 1 1
Xl.70850 1 1 32 1 1 2 1 0
Xl.71159 651 455 663 834 566 375 1058 965
Xl.74263 1 1 32 1 1 1 1 1
Xl.79790 17 16 32 9 9 19 7 30
Xl.80297 264 431 364 607 329 624 519 877
Xl.85251 1 1 32 1 1 1 1 1
Xl.8753 1 1 32 1 1 0 1 1
Xl.9822 35 19 32 4 14 30 10 24
Xl.9874 1 1 32 1 1 10 1 1








































































CE RA CE RA CE RA CE RA CE RA CE RA
bhlhe40 21 30 29 77 22 119 19 20 32 68 49 84
c10orf140 5 2 4 6 5 8 6 3 3 3 1 3
cass4 189 147 241 303 151 356 207 173 172 328 273 362
cdx4 1484 1521 1873 2325 1313 2015 1863 1425 1615 2082 2163 1852
cebpd 42 74 28 169 63 215 82 192 47 229 38 259
cxcr7 148 111 114 162 96 161 201 166 128 148 131 161
cyp26a1 814 2337 884 11847 612 12983 1491 8338 740 11128 951 11009
dact1-a 99 82 75 104 67 99 121 139 91 129 147 99
dact1-b 655 759 630 1099 493 1217 974 1272 613 1204 794 1227
dhrs3 378 730 432 2631 308 3191 630 2268 359 3272 429 2960
dusp5 308 319 308 694 245 841 390 631 339 884 433 839
dusp6 349 506 491 1709 322 2063 314 1002 304 1732 481 1842
e_Cerberus 254 457 89 118 80 66 1461 943 491 695 556 313
e_darmin 693 873 480 1189 911 1490 959 519 530 1094 1209 1108
e_Sox17alph 525 531 623 478 516 455 807 420 565 576 725 459
e_Sox17beta 563 509 570 521 426 444 736 409 577 487 684 438
e_TGIF2 192 190 310 234 186 243 460 293 299 281 243 141
e_vpp1 70 78 35 52 71 35 162 81 93 95 123 52
ec_Sox2 890 659 1139 841 812 1039 1430 1068 1001 1412 1067 1340
ec_tubb2b 43 37 70 77 52 119 39 21 43 43 55 60
ec_xk81a1 3456 2400 6564 6466 5765 8264 4112 2638 6402 8453 10511 8033
em_BMP2-a/ 457 458 324 399 368 494 661 238 443 308 668 416
em_BMP4-a/ 1624 1501 1377 1240 1026 1058 2915 1512 1660 1298 1863 1000
erf 221 151 193 299 174 422 304 302 219 508 308 454
fgfr4-a 1100 927 1113 971 894 905 1742 972 1357 1228 1511 1133
fgfr4-b 469 429 526 498 396 510 781 521 468 520 608 485
foxh1 236 197 282 445 165 402 290 321 257 406 338 403
fst 169 183 241 373 183 606 407 559 215 814 276 828
fzd4 450 537 311 1006 328 999 641 871 383 938 448 1037
gbx2.1 384 330 351 910 253 1058 379 710 330 1003 466 1220
hey1 118 117 156 213 101 192 165 68 165 190 163 207
hk_g6pd 186 147 192 161 124 147 296 147 137 165 207 152
hk_gapdh 125 101 165 156 125 245 123 102 120 158 120 186
hk_H4 66093 54788 86152 78237 62183 66486 146073 84833 93587 84235 112190 93322
hk_ODC 7511 6970 8871 9650 6875 9427 9779 6085 6549 7328 8264 6815
hnf1b 416 402 398 1562 425 1928 432 983 388 1678 630 1769
hoxa1-a 18 31 27 140 35 149 40 150 36 208 51 225
hoxa1-b 153 247 251 897 196 994 264 711 236 1060 280 1209
hoxa2-a 17 15 31 38 19 32 30 16 17 32 35 34
hoxa3 61 48 79 345 47 498 12 183 33 401 57 491
hoxa5 4 8 11 61 12 70 5 114 12 200 12 143
hoxb1 132 129 199 507 158 519 98 208 151 422 203 390
hoxb3 18 19 24 73 24 99 16 49 20 102 34 123
hoxb4 39 35 60 129 40 160 57 96 52 141 62 169
hoxd1 1309 1648 1378 2785 931 2703 2262 2791 1570 3129 1451 2769
hoxd4 100 106 193 400 106 650 49 230 107 708 228 892
hunk 623 582 684 1197 468 1414 846 1517 531 1550 801 1468
igf3 73 74 116 236 93 291 94 134 127 315 123 327
kiaa0182 274 215 361 519 215 631 578 435 376 645 498 700
kirrel2 180 174 212 287 195 359 361 363 360 388 403 398
lhx1 83 126 120 327 81 347 90 287 87 468 99 447
st.14gene
s23 (B)s22 (A)
st.12 st.13 st.14 st.12 st.13
Tab. 6.13 Raw data of RA-inducibility in whole embryos 




CE RA CE RA CE RA CE RA CE RA CE RA
m_Chordin 1302 1330 1451 849 1085 1034 2672 1872 1554 1423 1495 1220
m_Xbra-a/b 955 912 961 439 533 233 2013 1001 829 440 888 310
m_Xwnt8 396 297 491 240 233 191 859 585 383 514 337 366
me_ventx2.1 1328 748 992 1118 179 921 2356 1431 1200 2000 1507 848
meis3-a 703 649 706 1715 505 2034 794 1393 633 1803 934 2026
mespa-a 28 45 27 45 32 61 43 30 37 68 46 47
mespb 196 146 180 199 94 151 348 246 164 243 193 164
mxi1 359 397 330 514 278 657 434 735 309 816 384 769
myc-a 88 101 130 156 101 181 103 60 91 130 144 156
myc-b 1067 1042 1490 1579 907 1505 1378 841 1299 1057 1730 1082
ndrg1-a 1 1 2 1 3 1 1 2 1 1 1 2
ndrg1-b 1 2 2 1 2 6 1 2 2 3 6 2
neurog2 93 73 83 68 49 74 174 115 119 110 86 69
nkx6-2 94 126 112 224 73 352 159 305 124 334 138 378
nodal1 12 6 18 11 10 11 10 13 3 8 3 9
nodal2 13 6 13 4 1 4 14 6 6 5 8 7
nr2f5 19 16 90 347 103 590 18 41 72 311 144 437
pdgfb 15 12 21 22 19 28 17 16 16 19 23 29
pim1 174 179 166 354 133 371 328 284 210 357 317 319
pkdcc.1 213 233 265 266 229 343 512 399 338 470 387 484
prph 50 39 82 312 56 237 49 179 89 493 114 368
rara 54 41 88 97 54 146 52 72 58 175 115 190
rgs14 1 1 1 1 1 1 1 3 1 3 1 4
rgs2 66 144 180 273 119 346 112 131 93 202 124 142
sox9-a/b 107 176 222 483 164 474 147 358 184 431 271 667
spry2 290 339 347 465 239 539 509 395 344 579 389 520
stox2 211 147 169 206 153 204 274 169 171 178 254 219
tdgf1p2-a 25 33 42 72 38 92 37 64 28 97 46 110
tdgf1p2-b 9 6 3 9 9 18 3 10 4 11 11 14
tmem72 104 98 142 314 169 342 154 233 202 541 293 499
trib1 52 40 51 75 37 60 53 21 51 45 63 48
twist1-a 215 188 287 92 244 129 261 83 267 96 374 110
txnip 231 280 207 465 233 488 110 83 115 207 209 212
Xl.15091 1 2 6 2 2 2 2 1 1 3 4 4
Xl.16263 2 2 1 1 1 3 3 1 2 1 5 2
Xl.32109 11 5 8 14 3 8 11 7 10 7 5 19
Xl.45046 324 316 497 919 311 1116 508 773 478 1342 694 1333
Xl.47239 65 54 82 130 72 160 50 58 76 131 101 137
Xl.4906 603 455 578 568 489 626 1131 880 744 773 1062 614
Xl.51509 66 79 94 339 74 447 58 166 72 420 133 446
Xl.57027 35 33 44 60 35 75 42 76 38 52 70 74
Xl.57926 232 350 276 693 160 862 430 757 309 1003 511 823
Xl.58101 2 1 2 1 1 5 3 3 2 3 2 1
Xl.59256 1 1 1 2 1 2 1 1 1 1 2 5
Xl.6091 10 9 16 11 7 14 17 8 14 19 17 18
Xl.67202 2 2 4 2 3 1 7 4 3 7 5 1
Xl.68408 1 2 3 3 1 3 1 1 1 3 1 1
Xl.70850 3 6 5 6 4 11 17 8 7 12 10 13
Xl.71159 608 431 775 413 494 382 929 306 629 316 652 258
Xl.74263 6 1 1 5 2 3 2 3 1 7 2 4
Xl.79790 29 23 60 82 50 75 49 77 47 113 86 114
Xl.80297 63 77 72 134 61 135 110 161 77 139 69 127
Xl.85251 1 1 5 1 2 4 6 3 3 2 4 2
Xl.8753 1 1 1 2 1 5 2 3 2 5 5 4
Xl.9822 13 12 23 8 11 10 23 18 16 23 32 9
Xl.9874 4 4 8 3 5 7 5 3 2 3 2 3
znf703 2494 2707 2278 5979 1642 6561 2789 4455 2505 6285 3439 6863
NEG_A 2 2 6 4 2 4 5 3 2 4 5 7
NEG_B 2 4 3 3 1 2 5 3 3 7 5 9
NEG_C 1 1 1 1 1 1 1 1 1 1 1 1
NEG_D 1 1 2 1 2 1 1 3 2 5 4 3
NEG_E 2 1 6 2 2 7 4 4 3 2 4 5
NEG_F 8 5 12 10 9 8 14 13 9 9 16 8
NEG_G 1 1 1 1 1 2 1 1 1 1 1 1
NEG_H 1 3 1 1 1 5 1 3 1 1 2 2
POS_A 4427 5014 6295 5330 5094 4745 6726 4348 5441 6022 7964 7603
POS_B 1739 1975 2557 2088 2053 1910 2829 1780 2058 2343 2986 2844
POS_C 511 607 814 686 616 580 787 555 592 718 938 788
POS_D 124 135 160 131 144 121 158 105 133 135 176 184
POS_E 15 21 31 30 18 18 22 35 16 23 38 36
POS_F 4 13 13 6 13 7 13 10 17 10 20 21
gene
s22 (A) s23 (B)






































































CE RA CE RA CE RA CE RA CE RA CE RA
bhlhe40 17 35 15 68 22 114 2 13 29 62 32 74
c11orf140 1 1 1 1 1 1 1 1 1 1 1 1
cass4 216 193 214 293 188 331 147 214 193 331 245 354
cdx4 1666 2143 1743 2316 1693 1912 1429 1764 1876 2151 2138 1858
cebpd 41 94 15 159 74 196 52 228 47 228 22 251
cxcr7 160 144 95 152 117 144 143 195 141 144 120 152
cyp26a1 912 3142 816 11789 785 12369 1142 11377 855 11536 888 11199
dact1-a 115 115 59 95 79 85 82 162 98 124 125 89
dact1-b 731 1117 579 1185 632 1151 742 1573 717 1239 739 1227
dhrs3 419 978 393 2611 391 3133 475 2814 412 3385 393 2976
dusp5 341 424 277 682 320 793 289 775 387 917 396 836
dusp6 386 676 448 1693 419 1958 231 1237 347 1787 442 1848
e_Cerberus 279 611 72 118 96 54 1118 1163 565 711 513 315
e_darmin 774 1171 438 1175 1172 1411 729 635 611 1125 1133 1117
e_Sox17alpha 585 720 572 467 662 425 612 512 652 588 673 452
e_Sox17beta 628 681 522 520 544 414 557 498 665 495 634 431
e_TGIF2 219 251 279 224 233 223 343 354 342 282 216 131
e_vpp1 72 100 21 43 84 24 112 89 111 89 112 42
ec_Sox2 996 882 1155 828 1144 981 1194 1319 1160 1455 998 1341
ec_tubb2b 41 44 54 68 60 114 17 15 42 35 38 50
ec_xk81a1 3890 3227 6138 6431 7459 7870 3169 3275 7459 8762 9957 8196
em_BMP2-a/b 518 611 292 388 469 462 499 285 519 320 619 419
em_BMP4-a/b 1824 2116 1278 1226 1321 1000 2243 1872 1928 1337 1753 998
erf 242 198 169 289 218 393 222 365 247 517 278 447
fgfr4-a 1233 1243 1131 958 1151 854 1335 1200 1575 1264 1419 1133
fgfr4-b 522 572 481 487 515 477 592 638 538 530 562 479
foxh1 259 260 252 434 216 374 212 388 292 411 316 396
fst 184 241 214 362 229 569 312 685 243 835 247 825
fzd4 511 718 280 993 417 943 483 1174 439 963 412 1136
gbx2.1 426 439 317 897 320 1000 281 873 377 1132 428 1221
hey1 126 152 134 213 123 174 115 73 184 187 141 198
hnf1b 462 536 361 1547 543 1829 321 1213 445 1731 583 1774
hoxa1-a 13 36 14 131 38 133 18 175 34 216 34 216
hoxa1-b 166 327 223 884 246 939 191 874 267 1190 251 1219
hoxa2-a 12 15 17 29 17 21 11 8 12 23 19 23
hoxa3 62 59 62 335 53 466 1 216 31 416 40 485
hoxa5 1 5 1 52 8 58 1 131 6 198 1 133
hoxb1 142 168 175 496 197 486 63 248 168 428 178 383
hoxb3 13 21 12 64 23 85 1 50 15 96 18 113
hoxb4 37 42 45 119 44 143 31 118 53 136 44 160
hoxd1 1469 2214 1279 2764 1198 2568 1738 3466 1823 3237 1362 2784
hoxd4 116 137 169 389 129 612 25 275 117 725 212 889
hunk 695 778 629 1183 598 1339 642 1879 611 1598 745 1472
igf3 75 94 97 226 113 268 60 155 141 317 112 319
kiaa1182 312 284 327 518 272 592 434 531 432 659 458 696
kirrel2 196 229 187 277 245 333 266 442 412 393 368 392
lhx1 87 164 112 317 97 322 57 346 93 476 80 441
gene
A B
st. 12 st. 13 st. 14 st. 12 st. 13 st. 14
Tab. 6.14 Normalized data of RA-inducibility in whole embryos  
Indicated are the Nanostring counts which were normalized to the internal positive controls 
and Odc and with substracted mean of the negative controls as described in the “Materials 
and Methods” section. 




CE RA CE RA CE RA CE RA CE RA CE RA
m_Chordin 1462 1786 1348 836 1398 977 2155 2322 1815 1467 1414 1221
m_Xbra-a/b 1170 1223 889 428 683 213 1545 1236 959 447 828 312
m_Xwnt8 439 395 448 230 294 173 652 717 439 523 315 358
me_ventx2.1-b 1491 1112 918 1114 224 869 1811 1771 1392 2165 1415 845
meis3-a 786 869 650 1699 646 1931 612 1724 731 1862 872 2134
mespa-a 25 55 14 36 34 49 21 26 35 62 29 37
mespb 214 191 157 189 114 135 256 295 183 242 169 155
mxi1 398 529 297 513 352 617 323 914 352 837 350 765
myc-a 92 132 111 146 123 163 67 63 98 125 122 147
myc-b 1196 1398 1384 1563 1167 1426 1154 1136 1517 1187 1627 1181
ndrg1-a 1 1 1 1 1 1 1 1 1 1 1 1
ndrg1-b 1 1 1 1 1 1 1 1 1 1 1 1
neurog2 98 93 66 59 56 61 122 132 132 114 67 59
nkx6-2 99 164 93 214 87 326 111 368 137 337 116 372
nodal1 7 3 5 2 5 1 1 5 1 1 1 1
nodal2 8 3 1 1 1 1 1 1 1 1 1 1
nr2f5 14 16 73 337 126 553 1 40 76 313 122 431
pdgfb 10 12 8 13 17 18 1 8 12 10 7 18
pim1 189 236 144 343 164 345 242 342 237 362 286 311
pkdcc.1 233 318 237 256 289 318 383 486 386 478 353 478
prph 49 47 65 312 65 217 25 211 96 512 94 361
rara 54 50 72 88 62 131 27 78 60 172 95 182
rgs14 1 1 1 1 1 1 1 1 1 1 1 1
rgs2 67 189 157 263 146 322 74 152 111 200 113 132
sox9-a/b 114 232 196 472 215 443 112 434 217 437 243 662
spry2 320 451 313 454 312 515 381 482 393 592 355 514
stox2 232 193 147 196 191 185 199 199 191 175 227 211
tdgf1p2-a 21 39 28 63 41 79 16 68 25 92 29 111
tdgf1p2-b 3 3 1 1 4 8 1 2 1 2 1 3
tmem72 111 127 121 314 211 317 116 279 228 551 264 493
trib1 52 48 36 66 41 48 28 15 51 37 45 38
twist1-a 235 248 257 83 318 114 189 92 313 90 341 111
txnip 253 372 182 454 294 456 72 92 126 215 184 213
Xl.15091 1 1 1 1 1 1 1 1 1 1 1 1
Xl.16263 1 1 1 1 1 1 1 1 1 1 1 1
Xl.32109 5 1 1 5 1 1 1 1 4 1 1 8
Xl.45046 358 421 454 916 395 1155 381 952 549 1383 644 1334
Xl.47239 66 67 65 121 85 143 26 62 82 126 81 127
Xl.4906 673 617 530 557 626 588 862 1185 860 792 993 619
Xl.51509 67 112 76 329 88 417 32 195 76 426 112 439
Xl.57027 32 39 30 52 38 62 20 83 36 44 52 64
Xl.57926 255 466 247 681 199 813 320 932 352 1132 471 820
Xl.58101 1 1 1 1 1 1 1 1 1 1 1 1
Xl.59256 1 1 1 1 1 1 1 1 1 1 1 1
Xl.6091 4 7 3 2 1 4 1 1 8 10 2 7
Xl.67202 1 1 1 1 1 1 1 1 1 1 1 1
Xl.68408 1 1 1 1 1 1 1 1 1 1 1 1
Xl.71159 679 575 714 412 632 355 716 370 726 318 614 249
Xl.70850 1 3 1 1 1 1 1 1 1 3 1 2
Xl.74263 1 1 1 1 1 1 1 1 1 1 1 1
Xl.79790 26 26 45 73 57 62 25 84 47 117 67 114
Xl.81297 64 98 56 124 71 120 72 189 82 134 51 117
Xl.85251 1 1 1 1 1 1 1 1 1 1 1 1
Xl.8753 1 1 1 1 1 1 1 1 1 1 1 1
Xl.9822 8 12 10 1 6 1 5 12 12 14 16 1
Xl.9874 1 1 1 1 1 1 1 1 1 1 1 1
znf703 2815 3641 2122 5945 2119 6246 2145 5539 2914 6511 3248 6915
gene
A B







































































D D + CYP D D + CYP
bhlhe40 25 20 40 18
c10orf140 3 2 3 3
cass4 107 154 274 254
cdx4 381 345 517 485
cebpd 66 47 77 34
cxcr7 146 136 206 169
cyp26a1 813 527 1572 546
dact1-a 227 263 420 348
dact1-b 1191 1406 1947 1700
dhrs3 757 449 972 286
dusp5 950 994 1417 1051
dusp6 512 477 644 447
e_Cerberus 1191 2085 2607 2209
e_darmin 179 196 225 120
e_Sox17alpha 601 777 1121 770
e_Sox17beta 503 778 735 702
e_TGIF2 420 486 889 792
e_vpp1 135 198 85 56
ec_Sox2 1054 1003 1252 1169
ec_tubb2b 24 27 20 30
ec_xk81a1 4 12 17 24
em_BMP2-a/b 305 324 410 298
em_BMP4-a/b 683 675 783 752
erf 246 316 416 377
fgfr4-a 421 524 557 507
fgfr4-b 221 345 364 342
foxh1 314 353 613 567
fst 1177 705 1039 373
fzd4 197 233 302 342
gbx2.1 36 26 59 48
hey1 87 66 125 86
hk_g6pd 150 211 286 268
hk_gapdh 128 151 297 280
hk_H4 69695 88424 135977 123588
hk_ODC 5149 5869 7514 7283
hnf1b 174 205 250 193
hoxa1-a 8 6 14 6
hoxa1-b 36 13 58 22
hoxa2-a 12 11 16 10
hoxa3 5 1 2 5
hoxa5 4 1 2 1
hoxb1 14 3 9 6
hoxb3 7 8 21 8
hoxb4 25 43 45 39
hoxd1 356 363 669 526
hoxd4 8 9 11 5
hunk 381 534 1017 889
igf3 51 35 42 26
kiaa0182 283 338 519 469
kirrel2 328 331 325 192
lhx1 469 450 611 404
m_Chordin 10753 11169 11641 8870
m_Xbra-a/b 3423 5124 4320 4792
gene A B
D D + CYP D D + CYP
m_Xwnt8 210 299 395 333
me_ventx2.1-b 535 880 754 863
meis3-a 273 254 568 360
mespa-a 12 15 34 18
mespb 221 253 316 278
mxi1 277 296 371 278
myc-a 46 33 64 41
myc-b 454 523 490 415
ndrg1-a 1 1 1 1
ndrg1-b 1 2 2 1
neurog2 33 21 59 47
nkx6-2 539 316 457 203
nodal1 88 76 115 78
nodal2 56 127 110 91
nr2f5 3 7 2 2
pdgfb 15 12 21 24
pim1 164 151 341 234
pkdcc.1 511 626 709 563
prph 15 35 10 15
rara 25 26 34 30
rgs14 1 3 2 3
rgs2 262 233 241 152
sox9-a/b 61 75 61 71
spry2 1018 1418 1544 1522
stox2 171 237 259 262
tdgf1p2-a 18 5 23 7
tdgf1p2-b 7 16 17 11
tmem72 37 34 66 40
trib1 48 36 47 32
twist1-a 195 114 52 47
txnip 97 87 92 79
Xl.15091 1 1 1 1
Xl.16263 1 2 1 3
Xl.32109 11 5 5 10
Xl.45046 175 146 271 157
Xl.47239 35 42 67 59
Xl.4906 316 442 470 520
Xl.51509 40 18 39 34
Xl.57027 36 71 106 109
Xl.57926 598 701 624 379
Xl.58101 1 2 2 4
Xl.59256 1 3 1 2
Xl.6091 13 16 21 22
Xl.67202 2 1 1 1
Xl.68408 2 1 2 1
Xl.70850 9 15 13 9
Xl.71159 365 462 462 440
Xl.74263 4 1 3 3
Xl.79790 12 13 24 12
Xl.80297 210 201 424 171
Xl.85251 1 1 1 1
Xl.8753 3 1 3 5
Xl.9822 27 13 30 33
Xl.9874 1 5 4 1
znf703 1109 921 1600 1143
NEG_A 1 5 2 1
NEG_B 5 2 3 5
NEG_C 1 1 1 1
NEG_D 2 2 1 1
NEG_E 4 3 9 3
NEG_F 12 10 6 7
NEG_G 1 1 2 1
NEG_H 3 1 4 1
POS_A 4833 6975 6828 5936
POS_B 1783 2551 2451 2069
POS_C 567 745 711 596
POS_D 118 150 175 164
POS_E 15 27 21 20
POS_F 7 12 14 8
gene A B





































D D + CYP D D + CYP
bhlhe40 27 17 33 12
c10orf140 1 1 1 1
cass4 152 197 277 267
cdx4 570 452 532 516
cebpd 90 54 71 29
cxcr7 212 173 216 175
cyp26a1 1228 695 1633 581
dact1-a 335 342 430 368
dact1-b 1814 1872 2125 1825
dhrs3 1143 591 1116 311
dusp5 1437 1320 1471 1125
dusp6 769 629 664 475
e_Cerberus 1814 2779 2714 2373
e_darmin 262 253 226 122
e_Sox17alpha 915 1130 1162 823
e_Sox17beta 756 1131 759 749
e_TGIF2 629 642 920 846
e_vpp1 195 255 80 53
ec_Sox2 1596 1332 1299 1253
ec_tubb2b 26 27 12 25
ec_xk81a1 1 7 9 19
em_BMP2-a/b 454 424 419 314
em_BMP4-a/b 1131 893 819 813
erf 364 413 425 399
fgfr4-a 632 691 573 539
fgfr4-b 326 452 371 361
foxh1 468 463 631 614
fst 1783 934 1176 395
fzd4 289 312 316 361
gbx2.1 44 25 53 45
hey1 122 79 122 86
hk_g6pd 218 273 290 282
hk_gapdh 184 193 311 295
hk_H4 116227 118242 142126 133181
hk_ODC 7838 7839 7840 7842
hnf1b 254 265 252 212
hoxa1-a 1 1 6 1
hoxa1-b 44 8 52 17
hoxa2-a 7 5 8 4
hoxa3 1 1 1 1
hoxa5 1 1 1 1
hoxb1 11 1 1 1
hoxb3 1 1 13 1
hoxb4 27 48 38 35
hoxd1 532 476 690 560
hoxd4 1 3 2 1
hunk 570 715 1153 952
igf3 67 38 35 22
kiaa0182 421 443 533 498
kirrel2 489 433 331 200
lhx1 714 592 629 428
m_Chordin 16381 14927 12152 9552
m_Xbra-a/b 5217 6843 4513 5157
gene A B
D D + CYP D D + CYP
m_Xwnt8 319 392 414 352
me_ventx2.1-b 814 1168 779 923
meis3-a 415 331 584 382
mespa-a 7 12 26 12
mespb 326 329 321 292
mxi1 411 387 378 292
myc-a 59 35 58 37
myc-b 681 691 513 441
ndrg1-a 1 1 1 1
ndrg1-b 1 1 1 1
neurog2 39 19 53 43
nkx6-2 812 413 468 212
nodal1 123 92 111 77
nodal2 74 162 116 92
nr2f5 1 1 1 1
pdgfb 12 7 13 19
pim1 239 193 347 245
pkdcc.1 768 828 732 600
prph 12 38 1 9
rara 27 25 26 25
rgs14 1 1 1 1
rgs2 388 312 243 157
sox9-a/b 82 92 55 69
spry2 1542 1887 1614 1633
stox2 250 318 261 275
tdgf1p2-a 16 1 15 1
tdgf1p2-b 1 12 9 5
tmem72 45 36 60 36
trib1 62 39 41 27
twist1-a 286 143 45 43
txnip 137 117 87 78
Xl.15091 1 1 1 1
Xl.16263 1 1 1 1
Xl.32109 6 1 1 4
Xl.45046 256 186 274 162
Xl.47239 42 47 62 56
Xl.4906 472 582 482 553
Xl.51509 50 15 32 29
Xl.57027 44 86 112 111
Xl.57926 912 928 643 411
Xl.58101 1 1 1 1
Xl.59256 1 1 1 1
Xl.6091 9 12 13 17
Xl.67202 1 1 1 1
Xl.68408 1 1 1 1
Xl.70850 3 12 5 3
Xl.71159 545 619 474 467
Xl.74263 1 1 1 1
Xl.79790 7 8 16 6
Xl.80297 319 259 434 177
Xl.85251 1 1 1 1
Xl.8753 1 1 1 1
Xl.9822 31 8 22 28
Xl.9874 1 1 1 1
znf703 1679 1222 1662 1225
gene A B
Tab. 6.16 Normalized data of RA-dependency in dorsal tissue  
Indicated are the Nanostring counts which were normalized to the internal positive 
controls and Odc and with substracted mean of the negative controls as described in the 
“Materials and Methods” section. 





































CE BMS CE BMS CE BMS CE BMS CE BMS CE BMS
bhlhe40 21 16 29 28 22 34 19 12 32 29 49 42
c10orf140 5 6 4 4 5 6 6 7 3 1 1 9
cass4 189 162 241 164 151 218 207 137 172 161 273 266
cdx4 1484 1467 1873 959 1313 1637 1863 1156 1615 1457 2163 2023
cebpd 42 64 28 40 63 64 82 48 47 46 38 39
cxcr7 148 147 114 77 96 136 201 173 128 126 131 167
cyp26a1 814 407 884 364 612 575 1491 758 740 620 951 730
dact1-a 99 84 75 58 67 94 121 111 91 87 147 96
dact1-b 655 591 630 441 493 688 974 679 613 622 794 771
dhrs3 378 207 432 146 308 239 630 301 359 315 429 231
dusp5 308 171 308 128 245 288 390 270 339 339 433 364
dusp6 349 370 491 294 322 504 314 214 304 243 481 521
e_Cerberus 254 408 89 161 80 105 1461 1437 491 788 556 417
e_darmin 693 807 480 836 911 1262 959 638 530 629 1209 710
e_Sox17alpha 525 642 623 432 516 642 807 623 565 598 725 629
e_Sox17beta 563 626 570 340 426 561 736 644 577 551 684 641
e_TGIF2 192 251 310 240 186 339 460 441 299 252 243 285
e_vpp1 70 95 35 76 71 70 162 100 93 138 123 88
ec_Sox2 890 720 1139 674 812 895 1430 1140 1001 1096 1067 900
ec_tubb2b 43 48 70 59 52 151 39 31 43 32 55 84
ec_xk81a1 3456 2773 6564 2941 5765 7215 4112 2439 6402 4839 10511 7752
em_BMP2-a/b 457 499 324 355 368 591 661 476 443 511 668 598
em_BMP4-a/b 1624 2012 1377 1005 1026 1612 2915 2402 1660 1893 1863 2073
erf 221 196 193 120 174 213 304 233 219 224 308 252
fgfr4-a 1100 1220 1113 825 894 1361 1742 1376 1357 1322 1511 1611
fgfr4-b 469 519 526 350 396 538 781 649 468 546 608 634
foxh1 236 177 282 97 165 206 290 180 257 184 338 238
fst 169 86 241 105 183 149 407 192 215 280 276 267
fzd4 450 267 311 130 328 247 641 453 383 261 448 285
gbx2.1 384 182 351 161 253 259 379 232 330 188 466 294
hey1 118 136 156 79 101 140 165 95 165 160 163 132
hk_g6pd 186 188 192 105 124 186 296 222 137 212 207 209
hk_gapdh 125 126 165 90 125 173 123 100 120 114 120 150
hk_H4 66093 64900 86152 51542 62183 91163 146073 113620 93587 121011 112190 126582
hk_ODC 7511 9063 8871 5742 6875 11303 9779 6880 6549 7906 8264 8734
hnf1b 416 199 398 94 425 263 432 280 388 194 630 198
hoxa1-a 18 5 27 3 35 12 40 13 36 12 51 15
hoxa1-b 153 60 251 38 196 37 264 89 236 107 280 80
hoxa2-a 17 14 31 8 19 18 30 19 17 20 35 27
hoxa3 61 20 79 20 47 64 12 6 33 16 57 36
hoxa5 4 1 11 5 12 7 5 2 12 5 12 6
hoxb1 132 71 199 64 158 138 98 49 151 73 203 156
hoxb3 18 12 24 19 24 25 16 15 20 7 34 27
hoxb4 39 40 60 22 40 55 57 48 52 53 62 48
hoxd1 1309 890 1378 618 931 752 2262 1388 1570 1092 1451 1051
hoxd4 100 70 193 72 106 245 49 37 107 79 228 255
hunk 623 463 684 352 468 523 846 578 531 443 801 698
igf3 73 50 116 57 93 170 94 51 127 97 123 143
kiaa0182 274 203 361 161 215 303 578 378 376 350 498 471
kirrel2 180 141 212 166 195 253 361 332 360 276 403 346
lhx1 83 79 120 51 81 80 90 55 87 68 99 79
m_Chordin 1302 1497 1451 1055 1085 1452 2672 1809 1554 1811 1495 1992
m_Xbra-a/b 955 1354 961 647 533 699 2013 1624 829 1118 888 1049
m_Xwnt8 396 477 491 182 233 358 859 800 383 624 337 428
me_ventx2.1-b 1328 2695 992 610 179 754 2356 1430 1200 889 1507 909
meis3-a 703 344 706 322 505 655 794 463 633 426 934 630
gene
A B
st.12 st.13 st.14 st.12 st.13 st.14




CE BMS CE BMS CE BMS CE BMS CE BMS CE BMS
mespa-a 28 21 27 18 32 30 43 14 37 28 46 30
mespb 196 231 180 133 94 162 348 256 164 234 193 166
mxi1 359 253 330 185 278 287 434 211 309 284 384 300
myc-a 88 83 130 60 101 144 103 62 91 61 144 104
myc-b 1067 1046 1490 855 907 1730 1378 991 1299 1101 1730 1868
ndrg1-a 1 1 2 3 3 4 1 1 1 3 1 2
ndrg1-b 1 1 2 2 2 1 1 1 2 2 6 5
neurog2 93 72 83 62 49 68 174 129 119 128 86 86
nkx6-2 94 45 112 53 73 108 159 102 124 101 138 137
nodal1 12 13 18 6 10 3 10 9 3 6 3 8
nodal2 13 11 13 4 1 7 14 11 6 7 8 8
nr2f5 19 6 90 35 103 144 18 8 72 27 144 108
pdgfb 15 13 21 9 19 19 17 11 16 12 23 20
pim1 174 174 166 112 133 216 328 204 210 149 317 243
pkdcc.1 213 250 265 187 229 226 512 366 338 322 387 322
prph 50 19 82 27 56 60 49 27 89 43 114 77
rara 54 30 88 40 54 60 52 39 58 64 115 95
rgs14 1 3 1 2 1 1 1 1 1 1 1 3
rgs2 66 72 180 82 119 220 112 65 93 98 124 91
sox9-a/b 107 111 222 122 164 373 147 86 184 128 271 275
spry2 290 337 347 232 239 357 509 374 344 406 389 405
stox2 211 204 169 123 153 223 274 162 171 194 254 224
tdgf1p2-a 25 25 42 17 38 58 37 10 28 33 46 35
tdgf1p2-b 9 6 3 6 9 8 3 5 4 1 11 4
tmem72 104 86 142 84 169 181 154 114 202 149 293 213
trib1 52 60 51 37 37 62 53 30 51 58 63 60
twist1-a 215 238 287 260 244 522 261 190 267 279 374 512
txnip 231 288 207 204 233 406 110 81 115 96 209 147
Xl.15091 1 1 6 1 2 1 2 3 1 3 4 1
Xl.16263 2 2 1 2 1 2 3 2 2 1 5 1
Xl.32109 11 6 8 3 3 4 11 13 10 12 5 10
Xl.45046 324 156 497 210 311 385 508 217 478 236 694 495
Xl.47239 65 42 82 29 72 101 50 34 76 53 101 127
Xl.4906 603 636 578 426 489 724 1131 902 744 704 1062 881
Xl.51509 66 54 94 36 74 68 58 23 72 48 133 79
Xl.57027 35 26 44 23 35 35 42 26 38 24 70 63
Xl.57926 232 148 276 102 160 178 430 277 309 256 511 329
Xl.58101 2 4 2 2 1 1 3 1 2 3 2 1
Xl.59256 1 1 1 1 1 2 1 1 1 1 2 3
Xl.6091 10 6 16 7 7 17 17 15 14 19 17 24
Xl.67202 2 3 4 3 3 4 7 4 3 1 5 6
Xl.68408 1 1 3 1 1 1 1 1 1 1 1 2
Xl.70850 3 4 5 2 4 4 17 11 7 6 10 6
Xl.71159 608 916 775 544 494 756 929 796 629 870 652 921
Xl.74263 6 2 1 1 2 2 2 2 1 1 2 1
Xl.79790 29 15 60 30 50 66 49 54 47 60 86 66
Xl.80297 63 54 72 42 61 77 110 75 77 86 69 92
Xl.85251 1 2 5 1 2 2 6 5 3 4 4 1
Xl.8753 1 2 1 1 1 3 2 1 2 3 5 2
Xl.9822 13 11 23 9 11 16 23 21 16 12 32 11
Xl.9874 4 6 8 2 5 6 5 4 2 4 2 3
znf703 2494 1393 2278 965 1642 1713 2789 1514 2505 1443 3439 2292
NEG_A 2 1 6 1 2 4 5 6 2 5 5 6
NEG_B 2 1 3 3 1 3 5 1 3 4 5 7
NEG_C 1 1 1 1 1 2 1 1 1 1 1 2
NEG_D 1 2 2 2 2 3 1 1 2 2 4 4
NEG_E 2 5 6 1 2 3 4 2 3 6 4 1
NEG_F 8 10 12 4 9 8 14 8 9 10 16 15
NEG_G 1 1 1 1 1 1 1 1 1 1 1 1
NEG_H 1 1 1 1 1 2 1 2 1 1 2 2
POS_A 4427 4213 6295 4057 5094 5428 6726 5523 5441 7361 7964 6236
POS_B 1739 1768 2557 1674 2053 2292 2829 2204 2058 2961 2986 2478
POS_C 511 536 814 473 616 662 787 629 592 827 938 762
POS_D 124 100 160 92 144 141 158 145 133 192 176 168
POS_E 15 20 31 17 18 17 22 25 16 47 38 33
POS_F 4 8 13 7 13 9 13 6 17 27 20 13
gene
A B






































































CE BMS CE BMS CE BMS CE BMS CE BMS CE BMS
bhlhe40 17 8 15 41 21 22 2 4 29 17 32 22
c10orf140 1 1 1 2 1 1 1 1 1 1 1 1
cass4 206 165 214 259 188 181 147 131 193 142 245 214
cdx4 1666 1569 1743 1537 1693 1410 1429 1169 1876 1371 2038 1719
cebpd 40 60 15 60 74 48 51 41 47 33 22 19
cxcr7 160 149 95 120 117 110 143 168 141 109 110 129
cyp26a1 911 429 816 581 785 490 1141 764 855 577 888 611
dact1-a 105 81 59 89 79 74 81 105 98 72 125 68
dact1-b 731 626 579 705 631 588 741 683 707 579 739 646
dhrs3 419 213 393 231 391 199 475 298 411 288 393 184
dusp5 340 175 277 202 310 242 289 267 387 311 396 298
dusp6 386 389 448 468 409 429 230 210 347 220 442 432
e_Cerberus 279 430 72 255 96 83 1118 1455 565 737 513 343
e_darmin 774 859 438 1339 1172 1085 729 641 610 586 1133 594
e_Sox17alpha 585 681 572 690 661 549 612 626 651 557 673 525
e_Sox17beta 628 664 522 542 544 478 557 648 665 512 634 535
e_TGIF2 209 261 279 382 233 286 343 441 341 229 216 230
e_vpp1 72 93 21 118 84 53 112 94 100 121 102 61
ec_Sox2 996 765 1055 1079 1044 768 1094 1153 1160 1029 998 757
ec_tubb2b 41 42 54 91 60 123 17 23 42 20 38 58
ec_xk81a1 3890 2974 6138 4722 7459 6241 3169 2475 7459 4576 9957 6625
em_BMP2-a/b 508 528 292 566 469 504 499 476 509 474 619 498
em_BMP4-a/b 1824 2155 1278 1611 1321 1389 2243 2438 1928 1784 1753 1761
erf 242 202 169 189 218 177 222 229 247 202 278 202
fgfr4-a 1233 1303 1031 1322 1150 1171 1335 1393 1575 1243 1419 1366
fgfr4-b 522 549 481 558 505 458 592 653 538 507 562 529
foxh1 259 181 252 152 206 171 212 175 292 164 306 190
fst 184 83 214 165 229 122 302 187 243 255 247 215
fzd4 500 278 280 205 417 206 483 453 439 237 411 230
gbx2.1 426 187 317 255 320 217 280 228 377 168 428 238
hey1 126 137 134 123 123 114 115 89 184 141 140 99
hk_g6pd 203 193 168 165 153 154 216 218 152 191 182 165
hk_gapdh 134 126 143 141 154 142 82 94 132 98 99 114
hk_H4 74512 69800 80701 82824 80536 78943 113028 115679 109154 114673 106415 108403
hk_ODC 8462 9739 8299 9223 8897 9781 7555 6997 7631 7482 7825 7466
hnf1b 462 205 361 147 543 220 321 277 445 174 583 155
hoxa1-a 13 1 14 1 38 3 18 5 34 1 34 1
hoxa1-b 166 55 223 57 246 25 191 82 267 91 251 54
hoxa2-a 12 6 17 9 17 8 10 11 12 9 19 9
hoxa3 62 12 62 28 53 48 -4 -2 30 5 40 17
hoxa5 1 1 1 4 8 1 1 1 6 1 1 1
hoxb1 142 67 175 99 197 112 63 42 168 59 178 119
hoxb3 13 4 11 26 23 14 -1 7 15 -4 18 9
hoxb4 37 34 45 31 44 40 31 41 53 40 44 27
hoxd1 1469 948 1279 989 1198 644 1738 1405 1823 1025 1362 886
hoxd4 106 66 169 112 129 205 25 29 117 65 202 204
hunk 695 489 629 562 598 445 642 580 611 410 745 584
igf3 75 45 97 88 113 140 60 44 140 82 102 108
kiaa0182 302 209 327 255 271 255 434 377 431 322 458 389
kirrel2 196 142 187 263 245 212 266 330 412 251 368 282
lhx1 87 76 101 78 97 62 57 48 93 54 80 53
m_Chordin 1461 1601 1348 1691 1398 1250 2055 1834 1805 1706 1404 1692
m_Xbra-a/b 1070 1447 889 1036 683 598 1545 1645 959 1049 828 884
gene
s23
st.12 st.13 st.14 st.12 st.13 st.14
s22
Tab. 6.18 Normalized data of RA-dependency in whole embryos 
Indicated are the Nanostring counts which were normalized to the internal positive 
controls and Odc and with substracted mean of the negative controls as described in the 




CE BMS CE BMS CE BMS CE BMS CE BMS CE BMS
m_Xwnt8 439 504 448 288 294 303 652 806 439 581 305 352
me_ventx2.1-b 1490 2890 918 976 224 645 1810 1448 1392 832 1415 764
meis3-a 786 361 650 513 646 560 602 463 730 394 872 525
mespa-a 25 13 14 25 34 18 20 6 35 16 29 12
mespb 214 239 157 210 114 133 256 252 183 212 169 128
mxi1 398 263 297 293 352 241 323 207 352 259 350 243
myc-a 92 80 110 92 123 117 67 55 98 48 122 75
myc-b 1196 1116 1384 1370 1167 1491 1054 1001 1507 1033 1627 1586
ndrg1-a 1 1 1 1 1 1 1 1 1 1 1 1
ndrg1-b 1 1 1 1 1 1 1 1 1 1 1 1
neurog2 98 68 66 96 56 51 122 123 131 111 67 59
nkx6-2 99 39 93 81 87 86 110 96 137 86 116 103
nodal1 7 5 5 6 5 1 1 1 1 1 1 1
nodal2 8 3 0 2 1 1 1 3 1 1 1 1
nr2f5 14 1 73 52 126 117 1 1 76 15 122 78
pdgfb 10 5 8 10 17 9 0 3 11 1 7 3
pim1 189 178 144 176 164 180 241 200 237 131 286 194
pkdcc.1 233 260 237 296 289 188 383 364 386 295 353 262
prph 49 11 65 39 65 44 25 19 96 31 94 52
rara 54 23 71 60 62 44 27 32 60 51 95 67
rgs14 1 1 1 1 1 1 1 1 1 1 1 1
rgs2 67 68 157 128 146 183 74 58 100 83 103 64
sox9-a/b 114 110 196 192 205 316 101 79 207 111 243 221
spry2 320 353 313 369 302 302 381 373 393 375 355 333
stox2 231 210 147 194 190 186 199 157 191 174 227 178
tdgf1p2-a 21 18 28 23 41 43 16 2 25 21 29 16
tdgf1p2-b 3 1 1 6 4 1 1 1 1 1 1 1
tmem72 110 83 121 131 211 149 106 108 228 131 264 168
trib1 52 55 36 55 40 46 28 22 51 45 45 37
twist1-a 235 247 257 414 308 445 189 185 303 254 340 424
txnip 253 301 182 324 294 344 72 74 126 81 184 112
Xl.15091 1 1 1 1 1 1 1 1 1 1 1 1
Xl.16263 1 1 1 1 1 1 1 1 1 1 1 1
Xl.32109 5 1 1 1 1 1 1 5 4 1 1 1
Xl.45046 358 159 454 333 395 326 380 213 549 214 644 410
Xl.47239 66 36 65 43 85 80 26 26 81 40 81 95
Xl.4906 673 675 530 681 626 620 862 910 860 657 993 740
Xl.51509 67 49 76 54 88 51 32 15 76 35 112 53
Xl.57027 32 19 30 33 38 23 20 18 36 13 52 40
Xl.57926 255 150 247 160 199 147 320 274 352 232 470 268
Xl.58101 1 1 1 1 1 1 1 1 1 1 1 1
Xl.59256 1 1 1 1 1 1 1 1 1 1 1 1
Xl.6091 4 1 3 7 1 7 0 7 8 8 2 6
Xl.67202 1 1 1 1 1 1 1 1 1 1 1 1
Xl.68408 1 1 1 1 1 1 1 1 1 1 1 1
Xl.70850 1 1 1 1 1 1 0 3 0 1 1 1
Xl.71159 679 976 714 870 632 647 706 802 726 814 604 775
Xl.74263 1 1 1 1 1 1 1 1 1 1 1 1
Xl.79790 26 7 45 44 57 50 25 47 47 47 67 42
Xl.80297 64 49 56 63 71 59 72 68 82 71 51 65
Xl.85251 1 1 1 1 1 1 1 1 1 1 1 1
Xl.8753 1 1 1 1 1 1 1 1 1 1 1 1
Xl.9822 8 3 10 10 6 6 5 13 11 1 16 1
Xl.9874 1 1 1 1 1 1 1 1 1 1 1 1
znf703 2805 1489 2122 1547 2119 1476 2145 1533 2914 1357 3248 1949
gene
s22 s23





































6.8 Nanostring analysis data for expression characteristics of 

































CE DE VE D V CE DE VE D V
bhlhe40 6 10 3 47 21 12 8 8 40 25
c10orf140 1 5 3 2 10 4 7 1 3 10
cass4 320 329 482 151 305 188 422 400 274 608
cdx4 480 7 217 522 2156 723 4 384 517 3075
cebpd 20 144 44 31 17 37 297 50 77 34
cxcr7 163 105 80 123 110 119 64 49 206 173
cyp26a1 724 847 466 922 2029 973 1014 379 1572 1948
dact1-a 168 276 95 240 207 165 264 103 420 236
dact1-b 718 941 692 1055 926 640 866 404 1947 1474
dhrs3 269 745 221 599 286 344 777 248 972 402
dusp5 411 326 451 892 903 447 217 280 1417 1083
dusp6 405 353 317 514 531 295 220 233 644 723
e_Cerberus 2006 7729 1565 1119 137 1601 9325 1841 2607 392
e_darmin 160 859 612 102 13 611 3674 2037 225 115
e_Sox17alpha 884 2049 2028 890 872 799 2587 2321 1121 1070
e_Sox17beta 976 1522 1953 590 790 814 2006 2712 735 1055
e_TGIF2 309 322 416 357 635 218 483 312 889 1160
e_vpp1 34 315 2 89 1 65 423 5 85 7
ec_Sox2 463 8 22 501 389 603 23 11 1252 412
ec_tubb2b 9 25 12 19 7 22 30 25 20 17
ec_xk81a1 293 8 8 6 79 1685 3 15 17 386
em_BMP2-a/b 320 1695 551 308 167 265 2393 518 410 278
em_BMP4-a/b 1397 920 2076 878 3364 1452 1031 2125 783 4052
erf 229 170 290 201 248 229 162 240 416 574
fgfr4-a 772 1241 1212 472 269 565 1428 1167 557 625
fgfr4-b 518 676 583 239 118 396 542 505 364 249
foxh1 299 194 264 211 285 304 304 382 613 645
fst 59 453 119 1535 56 91 224 66 1039 50
fzd4 348 418 280 119 35 296 467 173 302 98
gbx2.1 88 23 18 17 46 64 26 50 59 151
hey1 64 33 62 102 73 62 42 54 125 195
hk_g6pd 122 100 97 112 133 160 126 113 286 350
hk_gapdh 152 134 146 123 139 146 108 106 297 224
hk_H4 108920 60805 63372 88804 111328 83610 55389 45520 135977 133543
hk_ODC 4311 3689 3620 4479 4987 3902 3908 3172 7514 9518
hnf1b 185 650 519 230 96 232 774 590 250 138
hoxa1-a 1 5 1 1 11 6 2 1 14 18
hoxa1-b 33 2 7 54 93 63 3 7 58 188
hoxa2-a 12 7 12 14 15 6 6 7 16 29
hoxa3 2 1 4 6 5 6 4 6 2 10
hoxa5 1 1 1 1 1 3 1 1 2 1
hoxb1 2 2 3 2 12 5 1 2 9 28
hoxb3 9 2 3 14 26 8 1 3 21 29
hoxb4 46 20 17 26 50 23 25 12 45 62
hoxd1 746 24 258 464 1581 1015 44 390 669 3080
hoxd4 3 6 3 9 21 4 6 6 11 25
hunk 314 515 562 200 620 707 976 753 1017 1844
igf3 60 53 49 53 43 49 79 32 42 31
kiaa0182 213 150 199 158 223 310 254 223 519 594
kirrel2 140 387 450 306 344 258 653 746 325 552
lhx1 125 307 260 424 92 80 276 151 611 119
Xl.47239 55 28 51 26 55 31 34 40 67 89
m_Chordin 1128 3549 3 10256 2 1432 1895 2 11641 5
m_Xbra-a/b 2321 175 946 4491 6800 2525 133 616 4320 8718
m_Xwnt8 1041 509 2214 386 3180 518 246 1150 395 3426
me_ventx2.1-b 759 366 1149 448 1880 1207 747 1965 754 3757
meis3-a 266 203 257 244 312 377 254 203 568 453
mespa-a 13 10 34 12 18 10 10 17 34 40
mespb 257 61 579 248 841 194 52 386 316 1308
A Bgene
Tab. 6.19 Raw data of expression characteristics  
(CE = control-embryo; DE = dorsal endoderm; VE = ventral endoderm; D = dorsal 




CE DE VE D V CE DE VE D V
mxi1 234 98 138 206 178 250 191 179 371 307
myc-a 33 55 58 44 106 38 68 58 64 98
myc-b 454 147 585 583 2514 922 201 792 490 2530
ndrg1-a 1 1 1 1 1 2 2 1 1 2
ndrg1-b 1 2 2 1 1 1 3 1 2 4
neurog2-b 32 19 12 22 19 30 15 21 59 38
nkx6-2 24 19 7 355 17 33 11 6 457 15
nodal1 57 49 61 103 62 24 24 77 115 142
nodal2 117 14 12 108 113 26 15 12 110 131
nr2f5 22 23 27 18 20 6 7 9 2 6
pdgfb 29 16 18 9 16 10 15 9 21 16
pim1 304 199 128 230 229 261 228 97 341 410
pkdcc.1 196 776 182 407 34 253 674 87 709 33
prph 16 3 1 19 13 27 1 2 10 15
rara 13 14 20 26 42 20 11 22 34 54
rgs14 4 1 1 1 1 2 7 3 2 5
rgs2 24 30 24 140 30 26 8 27 241 129
sox9-a/b 84 89 82 47 187 74 77 57 61 275
spry2 551 375 229 933 815 434 368 115 1544 854
stox2 197 193 127 162 156 175 200 98 259 280
tdgf1p2-a 3 10 2 18 1 6 44 7 23 2
tdgf1p2-b 1 1 4 3 1 3 4 7 17 2
tmem72 33 48 52 63 37 41 111 96 66 46
trib1 26 24 18 31 14 25 12 11 47 24
twist1-a 21 99 37 162 17 53 230 14 52 16
txnip 72 150 118 71 34 76 222 188 92 87
Xl.15091 1 1 1 1 1 1 2 1 1 1
Xl.16263 5 1 1 1 3 1 3 2 1 3
Xl.32109 10 3 3 8 5 6 7 2 5 10
Xl.45046 122 68 168 155 294 157 60 163 271 556
Xl.4906 899 368 626 332 686 629 227 214 470 1003
Xl.51509 11 4 5 59 93 24 3 3 39 70
Xl.57027 11 57 48 19 56 111 100 62 106 158
Xl.57926 290 222 267 641 575 303 137 152 624 918
Xl.58101 3 2 2 1 1 1 3 1 2 1
Xl.59256 2 3 2 2 1 1 2 1 1 3
Xl.6091 19 11 10 26 34 16 6 13 21 32
Xl.67202 4 3 1 1 3 1 2 2 1 4
Xl.68408 1 1 1 2 1 1 1 1 2 1
Xl.70850 6 1 1 3 2 4 1 3 13 17
Xl.71159 517 543 361 418 379 409 497 273 462 592
Xl.74263 2 1 1 2 4 1 1 1 3 4
Xl.79790 16 18 4 7 14 17 31 5 24 11
Xl.80297 30 6 5 280 164 63 1 2 424 120
Xl.85251 1 2 1 1 3 2 1 2 1 1
Xl.8753 1 1 1 2 1 2 1 1 3 2
Xl.9822 14 6 9 9 12 19 11 12 30 38
Xl.9874 7 1 3 2 1 3 5 1 4 5
znf703-a/b 999 171 492 1017 2099 1334 220 602 1600 4659
NEG_A 1 4 1 2 2 2 2 3 2 3
NEG_B 2 7 5 4 3 4 3 3 3 7
NEG_C 1 1 1 1 1 1 2 1 1 1
NEG_D 2 3 1 1 1 1 1 2 1 3
NEG_E 6 2 1 7 2 2 5 2 9 4
NEG_F 7 8 8 5 4 4 7 11 6 10
NEG_G 1 1 1 1 1 1 1 3 2 1
NEG_H 1 4 1 1 2 3 1 1 4 1
POS_A 4707 5150 4978 4878 5928 5579 5222 5051 6828 7020
POS_B 1824 1857 1811 1786 2104 2115 2239 2065 2451 2944
POS_C 577 652 631 587 742 706 690 647 711 881
POS_D 115 140 125 127 143 134 119 139 175 185
POS_E 24 23 24 29 31 24 24 22 21 27
POS_F 13 10 12 13 19 13 15 5 14 24






































































CE DE VE D V CE DE VE D V
bhlhe40 1 5 1 47 18 11 4 3 19 3
c10orf140 1 1 1 1 6 1 2 1 1 1
cass4 378 455 685 168 314 246 554 646 181 322
cdx4 571 1 304 599 2244 959 1 620 349 1670
cebpd 17 194 55 29 14 44 388 72 44 8
cxcr7 189 139 107 135 111 154 78 71 134 84
cyp26a1 866 1185 662 1063 2112 1292 1342 612 1079 1054
dact1-a 195 380 129 271 212 215 344 159 282 119
dact1-b 859 1317 986 1217 961 848 1145 653 1338 795
dhrs3 317 1041 310 688 294 454 1027 397 664 209
dusp5 488 451 640 1028 937 591 282 449 972 581
dusp6 481 489 448 589 550 388 286 372 437 385
e_Cerberus 2412 10886 2240 1292 139 2129 12401 3008 1795 204
e_darmin 185 1202 871 111 9 809 4882 3330 147 53
e_Sox17alpha 1059 2879 2905 1026 905 1060 3435 3795 767 574
e_Sox17beta 1170 2136 2798 678 820 1080 2662 4436 500 566
e_TGIF2 365 445 590 407 658 286 636 502 606 624
e_vpp1 33 435 1 96 1 82 556 1 50 1
ec_Sox2 551 2 24 574 401 799 23 8 857 215
ec_tubb2b 3 26 10 15 3 25 33 31 5 1
ec_xk81a1 346 2 4 1 78 2241 1 15 3 201
em_BMP2-a/b 378 2380 784 350 170 348 3177 839 275 142
em_BMP4-a/b 1678 1288 2974 1012 3504 1930 1365 3474 533 2204
erf 269 231 409 226 254 300 208 384 279 303
fgfr4-a 924 1740 1733 541 276 748 1893 1903 376 331
fgfr4-b 617 944 830 270 119 523 714 818 243 126
foxh1 353 265 372 238 293 400 397 617 415 342
fst 64 630 163 1775 54 116 291 98 710 17
fzd4 412 580 395 131 32 390 614 274 200 43
gbx2.1 99 23 18 12 44 80 27 72 32 72
hey1 70 38 81 111 72 78 49 79 77 96
hk_g6pd 140 132 132 123 135 208 161 176 189 181
hk_gapdh 176 180 202 135 141 190 137 164 196 112
hk_H4 131375 85703 91025 103093 116080 111420 73695 74614 94094 72950
hk_ODC 5193 5191 5192 5193 5196 5195 5193 5190 5191 5190
hnf1b 216 907 738 260 96 304 1023 957 164 65
hoxa1-a 1 1 1 1 7 3 1 1 1 1
hoxa1-b 32 1 2 55 93 79 1 2 31 92
hoxa2-a 7 1 10 9 12 3 1 2 2 6
hoxa3 1 1 1 1 1 3 1 0 1 1
hoxa5 1 1 1 1 1 1 1 1 1 1
hoxb1 1 1 1 1 8 2 1 1 1 5
hoxb3 3 1 1 9 23 6 1 1 5 6
hoxb4 48 19 17 23 48 26 26 10 22 24
hoxd1 892 25 363 531 1644 1348 51 630 454 1672
hoxd4 1 1 1 3 18 1 1 0 1 3
hunk 371 717 800 225 642 937 1292 1225 695 997
igf3 65 66 63 54 41 60 98 43 20 7
kiaa0182 249 202 278 176 228 408 331 356 350 314
kirrel2 161 537 639 348 355 339 862 1213 216 291
lhx1 143 424 366 485 92 102 360 238 414 55
Xl.47239 59 31 66 23 53 36 38 56 37 38
gene A B
Tab. 6.20 Normalized data of expression characteristics 
(Indicated are the Nanostring counts which were normalized to the internal positive controls 
and Odc and with substracted mean of the negative controls as described in the “Materials 
and Methods” section). CE = control-embryo; DE = dorsal endoderm; VE = ventral 




CE DE VE D V CE DE VE D V
m_Chordin 1353 4994 1 11900 1 1904 2514 1 8047 1
m_Xbra-a/b 2792 238 1351 5207 7086 3360 170 1000 2981 4753
m_Xwnt8 1248 709 3173 441 3312 686 320 1876 264 1862
me_ventx2.1-b 908 507 1643 513 1956 1604 987 3212 513 2042
meis3-a 313 277 361 276 321 498 331 323 384 237
mespa-a 8 5 41 7 15 9 6 18 14 12
mespb 302 77 824 281 873 254 62 623 210 704
mxi1 275 129 191 232 181 328 247 284 248 157
myc-a 32 69 76 44 106 46 83 85 35 43
myc-b 540 198 833 669 2617 1224 260 1289 330 1372
ndrg1-a 1 1 1 1 1 1 1 1 1 1
ndrg1-b 1 1 1 1 1 1 1 1 1 1
neurog2-b 31 18 10 18 16 35 13 25 32 11
nkx6-2 21 18 2 405 14 39 8 0 307 1
nodal1 61 60 80 112 61 27 25 116 71 67
nodal2 134 11 10 118 114 30 13 10 67 61
nr2f5 19 23 31 14 17 3 2 5 1 1
pdgfb 27 14 18 3 13 9 13 5 5 1
pim1 359 272 176 260 235 343 296 149 227 214
pkdcc.1 229 1085 254 465 31 332 890 133 482 8
prph 12 1 1 15 9 31 1 1 1 1
rara 8 11 21 23 40 22 8 26 14 19
rgs14 1 1 1 1 1 1 2 1 1 1
rgs2 21 33 27 155 27 30 4 35 158 60
sox9-a/b 94 117 110 47 191 94 95 84 33 140
spry2 657 520 321 1076 846 574 483 179 1059 456
stox2 230 263 175 181 159 228 259 151 170 143
tdgf1p2-a 1 5 1 14 1 3 51 2 7 1
tdgf1p2-b 1 1 1 1 1 1 1 2 3 1
tmem72 32 59 67 66 34 50 141 148 37 15
trib1 24 25 18 29 10 29 9 8 23 3
twist1-a 18 131 45 181 14 66 299 13 27 1
txnip 79 202 162 75 31 96 288 298 55 37
Xl.15091 1 1 1 1 1 1 1 1 1 1
Xl.16263 1 1 1 1 1 1 1 1 1 1
Xl.32109 5 1 1 2 1 3 2 1 1 1
Xl.45046 140 87 234 173 302 204 73 257 178 294
Xl.4906 1077 510 892 378 711 833 295 341 316 538
Xl.51509 6 1 1 61 93 27 1 1 18 28
Xl.57027 6 71 61 15 54 143 126 92 64 76
Xl.57926 342 304 376 737 595 399 175 239 423 491
Xl.58101 1 1 1 1 1 1 1 1 1 1
Xl.59256 1 1 1 1 1 1 1 1 1 1
Xl.6091 15 7 7 23 31 17 1 12 5 7
Xl.67202 1 1 1 1 1 1 1 1 1 1
Xl.68408 1 1 1 1 1 1 1 1 1 1
Xl.70850 1 1 1 1 1 1 1 1 1 1
Xl.71159 616 756 511 478 391 540 654 438 311 313
Xl.74263 1 1 1 1 0 1 1 1 1 1
Xl.79790 12 16 1 1 10 18 34 1 8 1
Xl.80297 29 1 1 318 167 79 1 1 284 55
Xl.85251 1 1 1 1 1 1 1 1 1 1
Xl.8753 1 1 1 1 1 1 1 1 1 1
Xl.9822 9 1 5 3 8 21 8 10 12 11
Xl.9874 1 1 1 1 1 1 1 1 1 1
znf703-a/b 1198 232 699 1173 2185 1773 286 977 1098 2535






































































CE DE VE D V CE DE VE D V
bhlhe40 6 4 2 33 11 5.09 0.81 1.19 14.28 7.17
c10orf140 1 2 1 1 4 0.24 0.59 0.00 0.00 2.65
cass4 312 505 665 174 318 66.37 49.80 19.33 6.32 4.03
cdx4 765 1 462 474 1957 193.62 0.04 157.89 124.96 287.11
cebpd 31 291 64 36 11 13.95 97.02 8.37 7.81 2.62
cxcr7 171 109 89 134 97 17.66 30.51 18.30 0.96 13.14
cyp26a1 1079 1264 637 1071 1583 213.04 78.57 25.05 7.90 528.76
dact1-a 205 362 144 276 165 9.97 17.97 15.18 5.17 46.50
dact1-b 853 1231 819 1278 878 5.23 86.15 166.88 60.45 83.17
dhrs3 385 1034 353 676 252 68.33 7.22 43.54 12.22 42.34
dusp5 540 366 545 1000 759 51.32 84.47 95.42 28.32 177.99
dusp6 435 387 410 513 467 46.34 101.51 37.71 76.37 82.39
e_Cerberus 2270 11643 2624 1543 171 141.70 757.48 383.98 251.68 32.61
e_darmin 497 3042 2101 129 31 311.98 1839.84 1229.12 17.81 21.59
e_Sox17alpha 1059 3157 3350 896 740 0.60 277.93 444.88 129.58 165.39
e_Sox17beta 1125 2399 3617 589 693 44.89 262.81 819.25 89.00 126.73
e_TGIF2 325 540 546 507 641 39.75 95.31 44.06 99.54 17.23
e_vpp1 58 495 1 73 1 24.16 60.33 0.00 23.09 0.00
ec_Sox2 675 13 16 716 308 123.91 10.58 7.79 141.56 93.31
ec_tubb2b 14 30 20 10 2 10.58 3.26 10.86 4.95 1.08
ec_xk81a1 1293 2 9 2 139 947.41 0.66 5.54 0.85 61.21
em_BMP2-a/b 363 2779 812 312 156 15.06 398.36 27.84 37.76 14.18
em_BMP4-a/b 1804 1326 3224 772 2854 126.31 38.43 249.75 239.57 650.03
erf 285 220 396 252 279 15.83 11.12 12.57 26.43 24.45
fgfr4-a 836 1817 1818 459 304 87.77 76.32 85.05 82.10 27.44
fgfr4-b 570 829 824 256 122 47.19 114.93 5.80 13.62 3.45
foxh1 377 331 494 326 318 23.59 66.44 122.50 88.79 24.56
fst 90 460 131 1242 36 26.40 169.33 32.38 532.38 18.58
fzd4 401 597 334 165 38 11.30 17.01 60.31 34.58 5.47
gbx2.1 90 25 45 22 58 9.08 2.01 27.05 9.71 14.22
hey1 74 43 80 94 84 4.07 5.60 1.27 16.79 12.16
hk_g6pd 174 146 154 156 158 34.39 14.27 21.95 33.11 23.22
hk_gapdh 183 158 183 166 126 6.96 21.67 18.99 30.53 14.33
hk_H4 121398 79699 82820 98594 94515 9977.92 6004.00 8205.45 4499.58 21565.32
hk_ODC 5194 5192 5191 5192 5193 1.35 0.92 1.01 0.84 3.05
hnf1b 260 965 848 212 81 44.37 57.74 109.84 47.85 15.40
hoxa1-a 2 1 1 1 4 1.09 0.00 0.00 0.18 3.17
hoxa1-b 56 1 2 43 93 23.43 0.00 0.30 12.11 0.18
hoxa2-a 5 1 6 5 9 1.88 0.03 3.89 3.43 2.95
hoxa3 2 1 1 1 1 1.09 0.00 0.45 0.00 0.04
hoxa5 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
hoxb1 1 1 1 1 7 0.42 0.00 0.00 0.00 1.65
hoxb3 5 1 1 7 14 1.25 0.00 0.00 1.70 8.68
hoxb4 37 23 13 22 36 11.07 3.46 3.38 0.36 12.18
hoxd1 1120 38 496 493 1658 227.76 13.28 133.36 38.70 14.04
hoxd4 1 1 1 2 11 0.24 0.07 0.45 1.04 7.17
hunk 654 1004 1012 460 820 283.07 287.29 212.56 234.97 177.43
igf3 63 82 53 37 24 2.18 16.12 9.97 17.07 17.00
kiaa0182 329 267 317 263 271 79.45 64.19 38.85 87.03 42.95
kirrel2 250 699 926 282 323 88.83 162.61 287.27 66.01 31.61
lhx1 123 392 302 449 73 20.73 31.83 63.98 35.55 18.51
Xl.47239 48 34 61 30 46 11.16 3.80 4.85 7.25 7.41
mean SEMgene
Tab. 6.21 Calculated mean and standard error of mean (SEM) 
Mean and SEM were calculated from the normalized Nanostring counts of two independent 
experiments 
CE = control-embryo; DE = dorsal endoderm; VE = ventral endoderm; D = dorsal tissue;  




CE DE VE D V CE DE VE D V
m_Chordin 1628 3754 1 9973 1 275.23 1239.68 0.00 1926.31 0.00
m_Xbra-a/b 3076 204 1176 4094 5920 284.01 33.94 175.54 1113.01 1166.81
m_Xwnt8 967 514 2524 353 2587 281.33 194.16 648.56 88.23 725.10
me_ventx2.1-b 1256 747 2427 513 1999 347.85 239.94 784.41 0.01 43.09
meis3-a 405 304 342 330 279 92.13 26.83 19.20 54.07 41.97
mespa-a 8 6 30 11 13 0.18 0.52 11.49 3.96 1.51
mespb 278 70 724 245 789 24.38 7.48 100.47 35.46 84.21
mxi1 302 188 237 240 169 26.81 58.92 46.60 7.96 11.99
myc-a 39 76 80 39 75 6.77 7.39 4.87 4.23 31.54
myc-b 882 229 1061 500 1995 341.90 31.04 228.01 169.71 622.63
ndrg1-a 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
ndrg1-b 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
neurog2-b 33 15 17 25 13 2.04 2.49 7.59 6.81 2.57
nkx6-2 30 13 1 356 7 8.87 5.15 1.12 48.78 6.30
nodal1 44 42 98 91 64 17.04 17.65 18.29 20.83 3.42
nodal2 82 12 10 93 88 51.89 1.03 0.21 25.47 26.18
nr2f5 11 13 18 7 9 7.92 10.64 13.03 6.26 7.86
pdgfb 18 13 12 4 7 9.47 0.38 6.56 1.20 5.77
pim1 351 284 163 243 224 8.08 12.35 13.43 16.36 10.44
pkdcc.1 281 987 193 473 20 51.73 97.59 60.42 8.23 11.76
prph 21 1 1 8 5 9.69 0.00 0.00 6.84 4.21
rara 15 9 24 19 29 6.84 1.63 2.66 4.17 10.19
rgs14 1 2 1 1 1 0.00 0.59 0.00 0.00 0.00
rgs2 26 18 31 156 44 4.20 14.91 3.88 1.28 16.55
sox9-a/b 94 106 97 40 165 0.00 10.58 13.18 7.01 25.42
spry2 615 501 250 1068 651 41.77 18.55 71.22 8.17 194.67
stox2 229 261 163 175 151 0.85 2.05 11.89 5.26 7.89
tdgf1p2-a 2 28 1 10 1 1.09 23.14 0.37 3.33 0.00
tdgf1p2-b 1 1 1 2 1 0.00 0.00 0.37 0.85 0.00
tmem72 41 100 107 51 25 8.77 40.94 40.33 14.57 9.77
trib1 26 17 13 26 7 2.33 8.01 4.92 2.57 3.79
twist1-a 42 215 29 104 7 24.00 84.16 16.11 76.88 6.30
txnip 88 245 230 65 34 8.57 42.90 68.34 10.22 2.99
Xl.15091 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.16263 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.32109 4 2 1 1 1 0.68 0.59 0.00 0.46 0.04
Xl.45046 172 80 246 176 298 32.39 7.09 11.94 2.96 4.44
Xl.4906 955 402 616 347 624 121.72 107.43 275.22 30.93 86.71
Xl.51509 16 1 1 40 60 10.71 0.00 0.00 21.59 32.41
Xl.57027 74 99 77 39 65 68.68 27.27 15.34 24.81 10.92
Xl.57926 371 240 308 580 543 28.35 64.40 68.19 157.01 52.06
Xl.58101 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.59256 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.6091 16 4 9 14 19 0.55 2.85 2.47 8.67 12.03
Xl.67202 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.68408 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.70850 1 1 1 1 1 0.24 0.00 0.00 0.00 0.00
Xl.71159 578 705 474 394 352 37.93 51.13 36.52 83.62 38.93
Xl.74263 1 1 1 1 1 0.00 0.00 0.00 0.00 0.48
Xl.79790 15 25 1 4 6 3.03 8.86 0.00 3.40 4.73
Xl.80297 54 1 1 301 111 25.24 0.00 0.00 16.66 55.77
Xl.85251 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.8753 1 1 1 1 1 0.00 0.00 0.00 0.00 0.00
Xl.9822 15 4 8 7 9 5.57 3.26 2.36 4.32 1.08
Xl.9874 1 1 1 1 1 0.04 0.00 0.00 0.00 0.00































































































































% pdx1 domain in 
the endoderm
Hnf1b injected 
Tab. 6.22 Quantification of Pdx1 domain in the endoderm 
Image J quantification of Pdx1 area size (orange dotted line) within the 






































d v d+v d v d+v
A 1.69 1.67 3.36 2.33 1.97 4.30
1.52 1.61 3.13 2.64 1.74 4.39
2.60 2.00 4.60 4.89 8.30 13.19
1.43 1.27 2.69 3.50 1.82 5.31
1.13 2.42 3.55 3.28 3.81 7.09
0.40 1.29 1.68 1.84 3.67 5.51
4.25 2.75 7.00 2.65 1.72 4.37
1.33 1.95 3.29 2.71 0.00 2.71
1.56 1.28 2.83 1.51 0.00 1.51
2.63 1.81 4.45 0.97 2.16 3.13
1.97 0.00 1.97 1.61 0.00 1.61
1.00 0.00 1.00 3.46 1.62 5.07
0.77 0.26 1.03 1.85 1.32 3.17
1.29 0.00 1.29 2.65 1.99 4.64
0.95 0.25 1.20 3.08 1.49 4.57
2.93 0.67 3.60 2.68 1.70 4.37
1.46 0.53 1.99 3.08 1.98 5.06
0.59 0.00 0.59 2.89 1.67 4.55
1.60 0.00 1.60 2.62 3.04 5.67
2.01 0.29 2.30 2.33 1.52 3.85
0.87 0.00 0.87 2.94 1.91 4.85
B 3.30 0.81 4.11 2.86 1.28 4.14
3.19 1.65 4.84 3.22 2.71 5.93
2.09 1.57 3.65 3.73 1.86 5.59
2.59 0.73 3.31 3.93 1.07 5.00
3.17 0.84 4.01 3.07 1.18 4.26
1.38 0.58 1.96 3.01 2.82 5.83
3.05 1.03 4.08 4.89 2.41 7.30
2.16 0.82 2.98 3.70 3.75 7.45
3.85 1.12 4.96 3.33 1.06 4.39
2.56 1.28 3.83 2.41 1.66 4.07
3.11 1.20 4.31 2.62 1.13 3.75
3.72 1.37 5.09 1.54 1.00 2.54
2.56 2.11 4.67 3.85 2.12 5.97
3.80 1.35 5.15 0.62 1.31 1.93
2.56 1.87 4.43 1.34 1.78 3.12















Tab. 6.23 Quantification of Ptf1a domain in the endoderm 
Image J quantification of Ptf1a area size (orange dotted line) within the endoderm (green dotted 
line). 
 



















































































+ 5 GGGAATTG[GTGATCCTGTTA] GGG gcdh
XB-GENE-
1016454
Tab. 6.24 Predicted Fzd4-gRNA off-target sequences in exonic 
regions of the Xenopus laevis genome 





6.10   Nanostring code sets 
Tab. 6.25 Nanostring Code set used for the confirmation of pancreatic 
organoid formation 
Target Accession Target Region Target sequence 































































































Target Accession Target Region Target sequence 






















































































































































Tab. 6.26 Nanostring Code set for the verification of RA-responsive 
candidates 
Target Accession Target region Target sequence 































































































Target Accession Target region Target sequence 



































































































Mespb NM_001135226.1 725-825 
TATTAAAGCAGGACATGACCTCCCCACAGTACAATAGCACA
GTAGCTACGCCTGTCAGTCAACAGTATGTGACAGGGCTCC




Target Accession Target region Target sequence 
AACACACGATTCACTGTAA 



































































































Target Accession Target region Target sequence 
































































































Xl.70850 BJ622644.1 207-307 CCCATAGAGAGTCGCCGACCCCTGGGAGCCGCATACAGA
GAAGATATTTATATACTGCTCATTGTGGCTCTAACTTAGGG




Target Accession Target region Target sequence 
CCACACATAGTGCTACACAG 



















































°C     degrees celsius 
µg    microgram 
µg    microgram 
µl    microliter 
µM    micromolar 
A    Adenine 
AP    Alkaline phosphatase 
BCIP     5-Bromo-4-Chloro-3-Indolyl-Phosphate 
BMB     Bohringer Mannheim blocking reagent 
bp    Base pairs 
C    Cytosine 
cDNA     complementary DNA 
dH2O    distilled water 
DIG    Digoxygenin 
DNA    deoxyribonucleic acid 
dNTP     deoxynucleoside triphosphate 
DTT    Dithiothreitol 
E . coli     E scherichia coli 
EDTA    ethylene diamine tetraacetic acid 
et al.     et alii 
G    Guanine 
GFP    green fluorescent protein 
h    hour(s) 
hCG    human chorionic gonadotropin 
LB    Luria-Bertani 
M    molar 
mg    milligram 
min    minute(s) 
ml    milliliter 




mRNA    messenger RNA 
NBT    Nitro-Blue Tetrazolium 
ng    nanogram 
nl    nanoliter 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
pH  negative decade logarithm of hydrogen ion 
concentration 
RNA    ribonucleic acid 
rpm    revolutions per minute 
RT    reverse transcriptase 
sec    second(s) 
T    Thymine 
T7E1    T7 endonuclease I 
Taq    Thermus aquaticus 
Tm    melting temperature 
Tris     Tris(Hydroxymethyl)Aminomethane 
U     uracil / unit(s) 
UTR     untranslated region 
w/v    weight per volume 
WMISH    whole mount in situ hybridization 
X-Gal     5-Bromo-4-Chloro-3-Indolyl-β-d-Galactoside 
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